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Abstract
Dendritic cells (DC) sense infection in their microenvironment and undergo a dynamic process 
of changes in phagocytic capacity, morphology and migratory activity in order to induce 
optimum T cell immunity. The acquisition of these properties is termed “ DC maturation” . In 
this study, key selected aspects of this DC maturation process have been explored.
One aspect of DC maturation is the signalling pathways that DC use to respond to micro­
environmental signals. DC respond to conserved microbial structures in their micro­
environment via pattern recognition receptors including Toll-like receptors (TLRs). Generally 
it is thought that this leads to activation of the mitogen-activated protein kinase (MAPK) 
pathways, p38, ERK, and JNK. JNK and p38 MAPK are also activated by reactive oxygen 
species, including hydrogen peroxide (H202), known to be present in the inflammatory DC 
milieu. Therefore the ability of H202 to stimulate DC, or modulate their response to TLR 
ligands such as lipopolysaccharide (LPS) was examined. Activation of JNK, associated with 
inhibition of tyrosine phosphatases, is linked to induction of DC apoptosis. JNK inhibition 
partially protected the DC from the pro-apoptotic effects of H202. Furthermore, H202 and LPS 
synergise in inducing JNK activation, and DC apoptosis. These studies suggest that excessive 
DC maturation, which may induce pathogenic T cell activation may be limited by DC 
apoptosis.
The second section of the thesis explores the mechanisms leading to MAPK activation upon 
TLR ligation. Biochemical studies demonstrated that mixed lineage kinase 3 (MLK3), a kinase 
not previously implicated in DC maturation, was phosphorylated upon TLR3 and 4, but not 
TLR2 ligation. Studies using a selective MLK inhibitor supported a role for the mixed lineage 
kinase (MLK) family of MAPK kinase kinase (MAP3K) proteins in regulation of DC signalling, 
phenotype and cytokine secretion, in response to TLR3 and 4, but not TLR2 ligation. Selective 
activation of MAP3K may therefore contribute to the heterogeneity and flexibility of 
DC/pathogen interaction.
A further feature of the DC sensory role is antigen uptake, but the relationship between 
morphology and phagocytic capacity has not been defined. Therefore a simple and flexible 
assay to examine this relationship was developed. DC with long dendritic processes were less 
efficient at antigen internalisation than round DCs.
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Introduction
1. Introduction
1.1 Introduction To Dendritic Cells
i . 1.1 The role of DC in adaptive immunity
First visualised as Langerhans cells in the skin in 1868, dendritic cells (DC) are now known to 
function as potent initiators and modulators of immune responses. As professional antigen 
presenting cells (APC), DC combine the tasks of detecting targets of potential immune 
responses with the identification and activation of antigen-specific naive T cells which may 
exist at extremely low frequency. To perform these diverse roles, DC undergo a maturation 
process, converting them from specialised antigen seeking cells to potent T cell activators 
(figure 1.1).
In the immature state, DC are optimised for antigen detection in a number of ways. They 
exist as a network in the body’s periphery, being particularly prevalent at the skin and 
mucosal sites where pathogen contact is most likely. In this state the DC possess a high 
endocytic capacity and internalise large volumes of extracellular tissue material either non- 
specifically via macropinocytosis, or in a specific manner via receptor mediated endocytosis. 
Internalised material is degraded and presented on .MHC class I and II molecules, and this 
process continues until the DC is induced to mature. The process of maturation is induced by 
ligation of specific DC receptors by a plethora of different molecular species, including 
conserved pathogen-derived molecular structures, cytokines, immune complexes, and ligands 
expressed on the surface of other activated immune cells. The maturation process involves 
migration from peripheral sites to draining lymph nodes, a reduction in the endocytic 
capacity, and a concomitant increase in the expression of peptide-loaded MHC complexes. In 
the lymph node, interaction between MHC class II molecules on the DC and T cell receptors 
and CD4 molecules on naive T cells form the antigen-specific central zone of an 
immunological synapse in which DC-T cell interaction is also facilitated by costimulatory 
molecules and adhesion molecules.
DC were originally identified on the basis of their morphology (Steinman and Cohn, 1973), and 
indeed their remarkable morphological capabilities are central to their function in T cell 
activation. Recent ex vivo imaging studies using fluorescently labelled cells has shown that 
rapid dendrite extensions by DC permits communication with about 5000 T cells per hour 
(Miller et al., 2004). Mature DC induced formation of stable immunological synapses that last 
for more than 8 minutes at a time (Miller et al., 2002), sufficient for naive T cells to receive 
appropriate stimulation from DC, both via surface molecule interaction and secreted 
cytokines.
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Figure 1.1. The DC life cycle
Immature DCs capture antigen and are induced to mature (1). During this 
process they migrate to lymphoid organs and display peptide-MHC 
complexes, which allow selection and thus activation of antigen-specific 
lymphocytes (2). These activated T cells help DCs in terminal maturation, 
which allows lymphocyte expansion and differentiation into helper, 
cytotoxic, or regulatory T cells (3). Activated T lymphocytes then migrate to 
the infected tissue (4). Helper T cells secrete cytokines, which permit 
activation of macrophages, NK cells, and eosinophils. Cytotoxic T cells 
induce lysis of the infected cells. B cells become activated after contact 
with T cells and DCs and then migrate into various areas where they mature 
into plasma cells, which produce antibodies that neutralize the initial 
pathogen (5). After interaction with lymphocytes, DCs die by apoptosis, 
terminating the response.
Banchereau et al Annual Review of Immunology 18; 767-811 (2000)
1. Introduction
In addition to the capacity to activate naive T cells, DC also have the ability to direct the 
adaptive immune system towards different types of immune response to best counteract the 
particular challenge. For example, viruses and intracellular bacteria generally stimulate DC to 
induce a Th1 response characterised by the production of IFNy by CD4+ T cells, resulting in 
the activation of cytotoxic CD8+ T cells, and the generation of reactive oxygen and nitrogen 
species by activated macrophages. In contrast, helminth parasites commonly induce a Th2 
response, driven by secretion of IL4, IL5, and IL13 by CD4+ T cells, and resulting in IgE and 
eosinophil-mediated pathogen destruction. DC are also capable of driving a regulatory 
outcome.
Whilst the cytokines that induce Th1, Th2, and regulatory T cell responses, and the nature of 
the responses themselves, have been thoroughly investigated, the decision-making 
mechanisms that determine the type of immune response are poorly understood. Clearly, the 
nature of the pathogen encountered by the DC is one important factor (Re and Strominger, 
2001), but, the concentration of pathogen (Boonstra et al., 2003a), the cytokine cocktail of 
the inflammatory microenvironment (Watford et al., 2003), and the DC subtype (Rissoan et 
al., 1999) have all been postulated to influence the response. Therefore DC provide the 
immune system with the ability to integrate stimuli from the nature and concentration of 
pathogens and inflammatory cytokines, and translate them via antigen presentation, 
costimulatory molecule expression, and cytokine production into distinct outputs including 
cytotoxicity, inflammation, tolerance, and memory.
DC that migrate from tissues to lymph nodes have a life expectancy of 2-3 days and can 
therefore be considered as disposable packets containing a finite amount of antigenic 
material. During the course of an immune response the nature of the predominant antigenic 
peptides may be altered, and thus this relatively short life span of mature DC is important in 
ensuring that the specificity of the activated T cells is relevant to the predominant 
pathogenic epitopes. Furthermore, in this way, the magnitude of the specific immune 
response is also matched to the scale of the infection. Apoptosis of DC is therefore an 
important process in permitting adaptability of the immune response.
Given the importance of DC in controlling specific immunity, and therefore the obvious target 
for therapeutic intervention that it offers, DC biology is the focus of intense research.
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1.1.2 DC subtypes
Two major types of DC exist, classical myeloid DC and plasmacytoid DC (PDC). Unlike the 
myeloid DC described in the preceding sections, PDC do not possess a dendritic morphology, 
but rather have a more rounded shape. They also express a different panel of surface 
proteins. PDC are also characterised by the ability to secrete large amounts of interferon 
when stimulated with viruses, and to produce this they possess extensive endoplasmic 
reticulum (Grouard et al., 1997). Like myeloid DC, exposure to pathogen-derived molecules, 
and in particular those derived from viruses, promotes maturation of PDC to yield cells with 
dendritic morphology and the ability to activate T cells (Yonezawa et al., 2003).
There is much debate over the developmental origin of the two cell types, which appears to 
be more plastic than originally thought. The lack of myeloid markers led to the belief that 
PDC were derived from lymphoid progenitors, however it has recently been shown that 
murine PDC can be reconstituted from both myeloid and lymphoid precursors (Shigematsu et 
al., 2004).
Clearly the existence of subtlety different DC subsets optimised to detect and respond to 
different pathogens is advantageous to the host. These DC populations are also present in 
different locations; in contrast to the ubiquitous myeloid DC, PDC have only been found in 
peripheral blood and lymphoid organs (Yoneyama et al., 2004). There have been very few 
studies into the intracellular signaling of PDC, although PDC have been shown to express 
different intracellular signaling apparatus to myeloid DC (Izaguirre et al., 2003). For this 
reason this thesis will focus exclusively on signaling studies undertaken on myeloid DC, and 
the term ‘DC’ will refer explicitly to this subset.
1.1.3 DC maturation
Via the ligation of specific receptors, various stimuli induce immature DC to undergo radical 
phenotypic and functional changes that involve the complete transition from tissue sampling 
sentinel cells to potent antigen presenters and naive T cell activators. In this section, the 
discrete processes of antigen capture and detection, DC migration and T cell stimulation, 
which together constitute the DC maturation program, will be discussed in more detail.
1.1.3.1 Antigen sampling
Immature DC in peripheral tissues capture pathogens, infected cells, dead cells, or their 
derived products to be degraded and presented on MHC molecules. Upon maturation, peptide
19
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loading and cell surface delivery of MHC molecules is increased, while internalisation of 
antigen is reduced. The remarkable capacity of immature DC to internalise antigen is a result 
of utilising several mechanisms of uptake including receptor-mediated endocytosis, 
phagocytosis and macropinocytosis. The quantification of the ability of DC to internalise 
antigen, and in particular, the relationship between this capacity and DC morphology will be 
investigated in chapter 5.
1.1.3.1.1 Receptor-Mediated Endocytosis
Ligation of specific uptake receptors results in recruitment of cytoplasmic adaptor proteins 
and ultimately the formation of clathrin coated endocytic vesicles (Slepnev and De Camilli, 
2000). DC express a large number of endocytic receptors. In particular, receptors specific for 
the Fc portion of immunoglobulins, and complement receptors CR3 and CR4, enable DC to 
internalise immune complexes.
Scavenger receptors (SRs) are glycoproteins that are important for the internalisation of 
various bacteria. An important scavenger receptor on DC is CD36, which is involved in the 
uptake of apoptotic bodies (Platt et al., 1998).
A further class of endocytic receptors are the C-type lectins, which bind ligands in a calcium- 
dependent manner, and possess a carbohydrate recognition domain (CRD) containing four 
cysteines forming two disulphide bonds. DC express several C-type lectins, including type I 
multi-CRD lectins such as DEC205 (10 CRDs) (Jiang et al., 1995), and the macrophage mannose 
receptor (MMR; 8 CRDs), which is the receptor for dextran, a commonly studied ligand in the 
measurement of DC endocytic capacity (Kato et al., 2000). Type II single-CRD lectins include 
Langerin (Valladeau et al., 2000) and Dendritic cell-specific ICAM3 grabbing non-integrin (DC- 
SIGN) (Steinman, 2000). DC-SIGN is also implicated in cellular adhesion during extravasation 
and T cell interaction in addition to antigen uptake (Geijtenbeek et al., 2000).
1.1.3.1.2 Phagocytosis
Particulate antigens are internalised by phagocytosis, which is actin-dependent and results in 
the formation of large intracellular vacuoles. Phagocytosis is generally receptor mediated and 
facilitated by the same receptors that are required for endocytosis. However, to facilitate 
phagocytosis, ligation results in actin polymerisation and is not clathrin dependent. Immature 
DC have been reported to be able to phagocytose most bacteria that have been examined. In 
gut epithelial monolayers, DC project dendrites through tight junctions and sample bacteria
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on the apical side of the epithelia by phagocytosis (Rescigno et al., 2001). DC also 
phagocytose apoptotic and necrotic bodies via the ligation of various receptors including 
integrins and CD36.
1.1.3.1.3 Macropinocytosis
Macropinocytosis is a cytoskeleton-dependent type of fluid-phase endocytosis (Sallusto et al., 
1995a), and is limited to few cell types including macrophages and DC. Macropinocytosis 
involves uptake of large vesicles (0.5-3^im) called macropinosomes, which form around areas 
of membrane ruffling, and is mediated by a rearrangement of the cytoskeleton. DC 
constitutively macropinocytose, facilitating rapid and non-specific sampling of large volumes 
of surrounding fluid. Indeed, Sallusto et al showed that immature DC can endocytose 
approximately an entire cell volume within one hour by this mechanism (Sallusto et al., 
1995b).
1.1.3.2 Induction of DC maturation
DC maturation is triggered by the ligation of various receptors on the surface of DC by two 
types of signals. Firstly, direct recognition of conserved structures of invading pathogens 
(called pathogen-associated molecular patterns (PAMPs)), by a diverse collection of surface 
and intracellular molecules (termed pattern recognition receptors (PRRs)), provide 
information to the DC regarding the presence, concentration, and identity of any foreign 
material (Pasare and Medzhitov, 2005). Maturation can also be induced via the indirect 
sensing of infection through a variety of sources: inflammatory cytokines and chemokines, 
internal cellular compounds, ongoing specific immune responses via the recognition of 
immune complexes, and molecules on the surface of activated immune cells such as CD40L 
(Moll H., 2003).
Clearly, many of these ligands will exist simultaneously at the site of an infection, and 
therefore DC maturation is likely to be triggered by the cumulative effect of multiple 
receptor ligation events. Receptor stimulation induces activation of intracellular signaling 
pathways leading to gene expression. An important property of DC is therefore the ability to 
integrate and interpret these multiple signals and translate this information into expression of 
the appropriate genes resulting in the induction of an optimally targeted specific immune 
response.
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Indeed, the idea of a uniform population of mature DC is an oversimplification, and in fact 
the precise phenotype of an individual mature DC is likely to reflect that cell’s cumulative 
microenvironmental experiences. Individual mature DC will therefore differ slightly in the 
cocktails of cytokines secreted and the levels of costimulatory molecules that are expressed, 
and therefore responding T cells will be activated accordingly. Microarray analyses of gene 
expression profiles of DC treated with different maturation stimuli support this model. DC 
uniformly express a set of ‘core’ response genes in combination with many other genes which 
are differentially expressed according to nature of the maturation stimulus (Huang et al., 
2001; Granucci et al., 2001).
1.1.3.3 Migration of DC
Studies of skin transplantation models and injection of labelled DC demonstrated that DC 
migrate out of peripheral tissues via the afferent lymphatic vessels. DC maturation stimuli 
induce DC migration into the T cell area of lymphoid organs. A coordinated program of 
chemokines controls the migration pattern of maturing DC. Upon stimulation DC upregulate 
the chemokine receptor CCR7. Accordingly DC acquire responsiveness to CCL19 and CCL21 
which are produced by cells in the T cell zone of the lymph node. CCR7-deficient mice have a 
specific deficiency in DC homing into lymph nodes (Forster et al., 1996).
In addition to controlling DC migration, CCL19 and CCL21 have also been shown to have an 
anti-apoptotic effect on DC (Sanchez-Sanchez et al., 2004), and CCL19 and CCL21 stimulation 
of mature DC has also been shown to induce a rapid increase in antigen uptake. This may 
reflect DC having a final sweep of the infected microenvironment prior to presenting these 
contents in the lymph node (Yanagawa and Onoe, 2003). Consistent with this interpretation, a 
transient increase in antigen uptake is also observed upon stimulation with TLR ligands (West 
et al., 2004).
Even in the absence of obvious maturation stimuli, a small proportion of DC migrate to the 
lymph nodes, and these DC are always present in afferent lymphatics. The function of these 
steady-state migratory DC is not clear. They may represent non-tissue restricted ‘patrolling’ 
DC. An alternative explanation is that since immature DC express a low but significant level of 
MHC class II molecules on their surface, which are loaded with self-derived peptides, these 
cells may be involved in maintaining peripheral tolerance. According to this hypothesis, any T 
cells that interact with these DC will be self-responders and could cause potential 
autoimmune complications. However these migratory immature DC will not offer sufficient
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stimulation to activate the responding T cells which will presumably be deleted or become 
anergic (Bonifaz et al., 2002).
1.1.3.3 DC - T Cell interaction
The unique ability of DC to stimulate naive T cells is probably a result of the high levels of 
expression of molecules involved in T cell interaction rather than the possession of DC- 
specific molecules (Inaba et al., 1997). In this section, these DC surface proteins, which are 
central to the control of T cell activation and are upregulated upon DC maturation, will be 
discussed.
DC adhesion molecules including pi and p2 integrins, and members of the immunoglobulin 
superfamily such as CD54 mediate DC-T cell clustering. Activation of naive T cells requires 
three levels of interaction. ‘Signal one’ involves recognition of MHC class ll-peptide 
complexes by antigen-specific T cell receptors (TCRs). Costimulatory molecules, which are 
required to sustain T cell activation, constitute ‘signal two’ . The most important of these for 
amplification of T cell responses are CD80 and CD86 on DC that ligate members of the CD28 
protein family on T cells. ‘Signal three’ is provided by cytokines and chemokines secreted by 
DC during T cell interaction, and via this signal DC are able to determine the effector 
phenotype of naive T cells. For example, T cells stimulated in the presence of IL12 terminally 
differentiate into Th1 cells, whereas IL10 leads to production of regulatory or Th2 cells (de 
Jong et al., 2002). Ligation of 0X40 on T cells by OX40L on DC is thought to promote a Th2 
outcome (Ohshima et al., 1998). However these soluble and cell-contact-mediated signals 
which induce DC to bias specific immune responses are numerous, complex and incompletely 
understood.
Interaction of DC and T cells is not a one-way process. For example, T cells express CD40 
ligand (CD40L), which binds to CD40 on DC. This induces increased CD80 and CD86 expression 
and also potently stimulates the release of cytokines including IL12. The activated T cells also 
express TRANCE (or RANK ligand), which ligates the RANK protein on DC and has a pro-survival 
function (Wong et al., 1997). TRANCE is also thought to reinforce the CD40-stimulated 
induction of cytokine secretion. Furthermore, it has recently been shown that ligation of 
CD80 and CD86 by CD28 on T cells induces production of IL6 and IL23 by dendritic cells 
(Orabona et al., 2004). It has been demonstrated in a murine system that one function of IL6 
is to make responding T cells refractory to suppression by regulatory T cells (Pasare and 
Medzhitov, 2003).
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1.2 Signaling Pathways Regulating DC Maturation
1.2.1 Introduction
DC control immune responses by detecting pathogens and activating naive T cells to respond 
appropriately. As discussed above, the DC maturation process required for the induction of T 
cell activation involves various DC modifications, including changes in the expression of 
surface proteins for chemotaxis and T cell interaction, and alterations in DC morphology and 
migratory capacity. DC maturation is stimulated by the detection of pathogen- and 
endogenously-derived immunostimulatory molecules via the ligation of specific receptors. 
This ligand recognition induces the activation of intracellular signaling pathways, of which NF- 
kB, and the AAAPK pathways p38, ERK, and JNK are important examples that will be discussed 
below. Intracellular signaling pathways are molecular signal transduction systems, which 
function to transmit signals derived from receptor ligation into cellular outcomes including 
activation of transcription, cytoskeletal rearrangement, cell migration, etc. Signaling 
pathways in DC are therefore responsible for translating the recognition of a specific 
pathogen into the appropriate mature DC phenotype to induce a T cell response. Signaling 
pathway networks also have the capacity to integrate signals from different receptors and 
thus allow the DC response to be sensitive to multiple stimuli.
Intracellular signaling pathways therefore offer an ideal target for pharmacological 
intervention to manipulate the ability of DC to induce specific immunity. Despite this, 
relatively little  is known about the signaling processes underlying DC physiology, and these 
processes form the focus of the investigations presented in this thesis. As model PAMPs, Toll­
like receptor (TLR) ligands are the most widely used maturation stimuli in studies of 
intracellular signaling pathways in DC. In the following sections, firstly what is known about 
the mechanism of activation of signaling pathways by TLR ligands will be discussed, and then 
the signaling pathways themselves and the roles of these pathways in various aspects of DC 
physiology will be addressed.
1.2.2 Toll-like receptors and induction of intracellular signaling
1.2.2.1 Introduction
Toll receptor was originally identified in Drosophila as an essential component regulating 
dorso-ventral axis formation during embryo development. However, toll-mutant flies were 
also found to be highly susceptible to fungal infection, suggesting a role for this protein in the
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immune system of the insect (Hashimoto et al., 1988; Lemaitre et al., 1996). Mammalian 
homologues of Toll, termed Toll-like receptors (TLRs) were subsequently identified and found 
to specifically recognise both pathogen- and endogenously-derived molecular structures. At 
least 11 mammalian TLRs are known to exist. They show a high degree of sequence similarity 
to each other and to the IL1 receptor family of proteins in the cytoplasmic domain, which is 
now termed the Toll/IL1 receptor (TIR) domain. The extracellular regions of the TLRs and 
ILIRs are structurally unrelated, however; in contrast to the immunoglobulin superfamily 
domain of the IL1R, TLRs possess leucine-rich repeats (LRRs), which are thought to facilitate 
ligand recognition. Individual TLRs elicit specific cellular responses via the differential 
association between the TIR and various intracellular adaptor proteins (Table 1.1).
Table 1.1 - TLRs; Ligands, localisation, and adaptor proteins
Ligand Location Adaptor(s)
TLR1/TLR2 Triacylated lipopeptides Plasma Membrane MyD88, TIRAP
TLR6/TLR2 Diacylated lipopeptides (including Zymosan) Plasma Membrane MyD88, TIRAP
TLR3 dsRNA, siRNA Endosomal TRIF
TLR4 LPS, sHA Plasma Membrane MyD88, TRIF, TIRAP
TLR5 Flagellin Plasma Membrane MyD88
TLR7 ssRNA, R848 Endosomal MyD88
TLR8 R848 in humans, but not mice Endosomal MyD88
TLR9 CpG DNA Endosomal MyD88
TLR10 Not known, expressed in humans, but not mice Not known MyD88
TLR11 Uropathogenic bacteria (mouse), not expressed in humans Plasma Membrane MyD88
1.2.2.2 TLR functions
Approximately 10 years before the discovery of TLRs, Charles Janeway hypothesised that 
signal 2 output by DC was regulated by innate recognition, and this has proved to be correct 
since all TLR ligands lead to increased expression of CD40, CD80, and CD86 (Janeway, Jr., 
1989). However the effect of TLR ligation on DC is not limited to this function. Indeed, it  may 
be argued that the most important DC output modulated by TLR ligands is in fact signal 3 
(Reis e Sousa, 2004). For example TLR ligation promotes production of IL12 family members, 
which promote T cell polarisation (Alber G et al., 2006). Furthermore, different TLRs, or even 
different ligands of the same TLR, can vary in their ability to modulate the effector T cell 
bias of the resulting immune response. For example, ligation of TLR3 (de Jong et al., 2002), 
TLR4 (Boonstra et al., 2003b), TLR7 (Ito et al., 2002), and TLR9 (Hemmi et al., 2000) promote 
DC to induce a Th1 phenotype. In contrast, some TLR2 ligands induce little  IL12 production 
and skew the immune response towards Th2 (Qi et al., 2003). Based on these observations it
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has been suggested that the primary function of TLRs on DC is not to induce maturation per 
se but to provide information about the nature of the insult and thus allow DC to respond 
appropriately.
In support of this model is the observation that mice deficient for IFNa/B receptors are 
impaired in their ability to upregulate CD40 in response to TLR ligands. This suggests that DC 
maturation induced by TLRs is at least partly due to autocrine effects mediated via TLR- 
induced production of type I interferons (IFN I) and possibly other DC-activatory cytokines 
such as TNFa (Hoshino et al., 2002). However recent findings have indicated that 
inflammatory mediators alone are insufficient to induce full DC activation, since in the 
absence of TLR stimulation, DC are able to promote T cell clonal expansion but do not induce 
Th1 or Th2 effector differentiation (Sporri and Reis e Sousa, 2005). Clearly both pathogen- 
and endogenously-derived ligands are required for full DC maturation. This underlines the 
important message that DC must integrate signals from multiple sources including pathogens 
and inflammatory mediators, but also chemokines, cell-cell contact, stress molecules, etc, in 
order to induce the most appropriate immune response.
If the upregulation of costimulatory molecules is not necessarily a direct consequence of TLR 
ligation, then there are many other functions of DC (in addition to signal 3 modulation), 
which are TLR mediated. For example TLR4 ligation has been shown to induce upregulation of 
TLR2, TLR4, and TLR9 (An et al., 2002), presumably as part of an amplificatory system since 
bacteria contain ligands for all three of these TLRs. Interestingly, however, these TLRs may 
differentially skew towards Th1 or Th2 and thus this system may also be immunoregulatory 
depending upon the context. TLR ligation also regulates antigen uptake and processing since 
TLR ligation in macrophages results in upregulation of expression of scavenger receptors such 
as MARCO and the mannose receptor (Doyle et al., 2004).
1.2.2.3 Interaction of TLRs with other receptors
To expand the model of DC maturation induced by cytokines in combination with TLR ligands, 
it should be emphasised that TLRs are not the only microbial recognition receptors. Indeed, 
pathogens have the potential to ligate many DC receptors and induce intracellular signaling; 
including C-type lectins, integrins, complement receptors, Fc receptors, and NOD receptors. 
Indeed, since many pathogens will contain ligands for multiple PRRs, the optimal DC response 
is likely to be determined by the sum of the intracellular signaling patterns induced by all of 
these PRRs, in addition to cytokine-induced signals and other inputs.
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There is growing evidence for the importance of multiple intracellular signaling events 
initiated by simultaneous ligation of TLRs and other PRRs in the modulation of the phenotype 
of the mature DC. For example, in the response of mice to 7. gondii, DC are activated by 
ligation of TLR11 (Yarovinsky et al., 2005). However there is also a requirement for a second 
parasite component, identified as a cyclophilin, which signals via the chemokine receptor 
CCR5. Consistent with these findings, mice deficient for CCR5 or MyD88 display a marked 
reduction in IL12 production in response to 7. gondii (Aliberti et al., 2003).
Another example of TLRs interacting with chemokine receptors is demonstrated by the 
observation that TLR4 and CXCR4 interact on cell membranes (Triantafilou et al., 2001).
TLR4 can also synergise with NOD2 in the response of myeloid cells to LPS (Nau et al., 2002), 
and furthermore, TLR4 has long been known to associate with CD14 and MD2 proteins in the 
initiation of LPS signaling. These accessory proteins were previously thought to concentrate 
the LPS signal but CD14 has recently been shown to be required for LPS-induced TNFa 
production (Jiang et al., 2005).
Dectin-1 is a C-type lectin, which binds p-glucans and hence acts as a PRR and phagocytic 
receptor for innate recognition of yeasts (Brown and Gordon, 2001). Inflammatory signaling in 
response to zymosan requires a heterodimer of TLR2 and TLR6. It was initially thought that 
dectin-1 facilitated uptake, while the TLRs were responsible for intracellular signaling and DC 
maturation. However, in TLR-deficient macrophages, some inflammatory responses are intact 
suggesting a more complex role for the C-type lectin (Gantner et al., 2003). It has since been 
shown that dectin-1 signals via syk tyrosine kinase and that syk-deficient DC are unable to 
produce IL2 and IL10 in response to p-glucans, but do produce IL12 (Rogers et al., 2005).
Another C-type lectin that has been suggested to modulate TLR signaling is DC-specific ICAM3- 
grabbing nonintegrin (DC-SIGN). The primary function of DC-SIGN is to mediate binding to 
ICAM2 during extravasation and to ICAM3 during DC-T cell interaction. However DC-SIGN also 
binds mannose-capped lipoarabinomannan (ManLAM) from M. tuberculosis. ManLAM binding 
has been shown to downregulate IL12 and to stimulate IL10 production by TLR-activated DC 
(Nigou et al., 2001).
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1.2.2.4 TLR signaling
The mechanism of activation of intracellular signaling and MAPKs in particular following 
ligation of TLRs is incompletely understood. In the following sections, the main features of 
TLR signaling w ill be outlined.
The first downstream protein of the TLR signaling cascade to be characterised was Myeloid 
Differentiation Factor 88 (MyD88), which contains a TIR domain for interaction with the TLR 
or IL1 receptor, and also a death domain (DD), which facilitates binding to IL1 receptor- 
associated kinases (IRAKs) (Muzio M et al., 1997). Several additional adaptor proteins have 
now been identified, including TIRAP (TIR domain-containing adaptor protein) (Fitzgerald K A 
et al., 2001), TRIF (TIR domain-containing adaptor inducing IFNB/ TICAM1) (Yamamoto M et 
al., 2002), SARM, and TRAM (or TICAM2) (Fitzgerald K A et al., 2003). Overexpression of 
MyD88, TIRAP, or TRIF leads to activation of NF-kB, however the precise roles of all of these 
adaptors in TLR-mediated signaling, and the differential control of cellular responses is not 
fully understood.
MyD88-deficient mice are unable to produce inflammatory cytokines such as TNFa, IL6, and 
IL12 in response to IL1, or any of the TLR2, 7, or 9 ligands, and activation of the NFkB and 
JNK signaling pathways is not observed in response to ligation of TLRs 2, 7, and 9 in these 
mice (Kaisho et al., 2001). However, NF-kB and JNK, and many interferon responsive genes, 
were activated in response to TLR4 ligation in the MyD88-deficient mice, clearly indicating 
the existence of a MyD88-independent pathway downstream of some TLRs. In this pathway, 
stimulation leads to the activation of the effector protein interferon response factor3 (IRF3), 
which induces interferon-responsive genes (Doyle et al., 2002).
TlRAP-deficient mice demonstrate impaired cytokine production, and JNK and NF-kB 
activation in response to TLR4 ligation. However, TLR4-induced activation of IRF3 is 
unaffected in TIRAP-deficient, or TIRAP and MyD88-double-deficient macrophages, suggesting 
that TIRAP is not the factor responsible for the MyD88-independent pathway. In addition to 
TLR4, TIRAP-deficient mice are retarded in TLR2 responses, but are not affected in their 
ability to respond to TLR3, 5, 7, or 9 ligands (Horng et al., 2002).
TRIF was first identified as a TLR3-associated molecule, and TRIF-deficient mice are unable to 
activate interferon-responsive genes in response to TLR3 and TLR4 ligation, suggesting that 
TRIF mediates the MyD88-independent pathway (Yamamoto et al., 2003). It has been shown 
that TRIF can associate with TRAF6 and TBK1 (Tank-binding kinasel) in activating the distinct
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transcription factors, NF-kB and IRF3, respectively (Sato et al., 2003). There is now evidence, 
however, that the idea of MyD88-dependent and -independent pathways is an 
oversimplification, since both pathways are required for some outcomes such as inflammatory 
cytokine production. LPS in particular exhibits a non-redundant requirement for MyD88, 
TIRAP, and TRIF, in the induction of inflammatory cytokines, whereas CpG DNA appears to 
require MyD88 alone (Kaisho and Akira, 2001). On the other hand, MyD88 and TRIF appear to 
be able to compensate for one another in the LPS-induced production of IFNB (Yamamoto et 
al., 2003).
TRAM shares sequence similarity with TRIF. The precise role of TRAM is controversial, and it 
has been suggested that TRAM interacts with various other signalling proteins. Bin et al 
demonstrated interactions of TRAM with IL1R, TRIF and TIRAP, IRAKs and TRAF6, but not with 
TLR2 or TLR4 (Bin et al.,2003). Overexpression of TRAM has been shown to induce IRF3 and 
IRF7 reporter activities (Fitzgerald et al., 2003). In the same study, TRAM was demonstrated 
to immunoprecipitate with TRIF, IRF3, IRF7, and the IRF3,7 kinases IKKe and TBK1 (Fitzgerald 
et al., 2003). A TRAM mutant was also shown to block NF-kB activation induced by TLR4, but 
not other TLRs. Inhibition by siRNA has confirmed that TRAM is not required for TLR3 
signaling, but is essential for both the MyD88 dependent and independent arms of the TLR4 
signaling pathway (Fitzgerald et al., 2003). In contrast to the immunoprecipitation results, 
neither TRIF, nor TRAM, bind to MyD88 or TIRAP in yeast two-hybrid experiments (Oshiumi et 
al., 2003). A TRAM knockout mouse has recently been generated, and is profoundly deficient 
in LPS responses, but retains TLR3 signaling capacity (Yamamoto et al., 2003).
Figure 1.2 outlines the key features of adaptor usage and intracellular signal propagation by 
different TLRs.
1.2.2.5 IRAKs
IL1 receptor-associated kinase (IRAK) was originally identified as a kinase that could be 
coprecipitated with IL1R (Martin et al., 1994). This protein, which we now know as IRAKI, 
was found to be approximately 90KDa (714 amino acids) and had homology to Pelle - a kinase 
in Drosophila Toll pathway (Cao et al., 1996a).
Four mammalian IRAK proteins have now been identified, IRAKI, -2, -4, and -m. The 
importance of the IRAK family members in TLR-mediated signaling pathways was first 
demonstrated in IRAKI knockout mice, which showed partial inhibition of IL1- or LPS-induced
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NF-kB, p38 and ERK activation. In particular, the inhibition was reduced at high stimulation 
(Swantek et al., 2000). However, IRAK4 knockout mice showed almost complete inability to 
respond to TLR2, -3, -4, or -9 ligands (Suzuki et al., 2002).
All IRAKs and Pelle consist of an N-terminal DD, which facilitates binding to the adaptor 
proteins, and a central Kinase domain (KD), which contains 12 subdomains and resembles 
typical catalytic domains of serine/ threonine kinases. Only IRAKI, IRAK4 and Pelle have 
catalytically competent kinase domains due to the presence of a critical aspartate residue in 
subdomain Vlb, whereas in IRAK2 and IRAKm this aspartate is an aspartamine or serine residue 
respectively, resulting in loss of function.
IRAKI, -2, and -m but not IRAK4 or Pelle contain a C-terminal region with no sequence 
similarity to any other proteins. This region facilitates the binding of IRAK and the 
downstream effector protein TRAF6 via a conserved QX P X E motif (Ye et al., 2002; Darnay 
et al., 1999). The IRAKs must be phosphorylated to permit this interaction, and this is 
facilitated by IRAK4, which is the closest human homolog to Pelle, and functions as an IRAK 
kinase. This was determined primarily by the observation that kinase-deficient IRAKI can be 
phosphorylated by IRAK4, but not vice-versa, and furthermore transfection of IRAK4 was 
insufficient to restore IL1 -induced NF-kB activation in IRAKI-deficient HEK293 cells (Li et al.,
2002). Unlike other IRAK proteins, IRAK4 does not heterodimerise with other IRAK molecules, 
although stimulation with IL1 induces a stable association between IRAKI, IRAK4 and TRAF6 
(Li et al., 2002).
IRAKm can bind both MyD88 and TRAF6, and can heterodimerise with both IRAKI and IRAK2. 
IRAKm knockout mice exhibit increased TLR/IL1R signaling, suggesting a negative role for 
IRAKm. This idea is supported by the observation that IRAKm-deficient macrophages produce 
higher levels of cytokines in response to TLR ligands, and IRAKm knockout mice exhibit 
greater intestinal inflammation following salmonella challenge. Interestingly, the most 
pronounced effects occurred in response to CpG DNA - suggesting TLR-specific roles for IRAK 
proteins (Kobayashi et al., 2002).
IRAK4 is required for the recruitment of IRAKI to the receptor complex. Reconstitution of 
IRAK4-deficient cells with wild-type IRAK4 is capable of restoring IL1 responses (Lye et al.,
2004). Interestingly, reconstituting with a kinase-deficient IRAK4 also partially restores IL1 
responses, and in a separate study, Qin et al showed that the kinase activity is dispensable 
for IL1 signaling (Qin et al., 2004). These studies suggest that IRAK4 is capable of transmitting
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signals via phosphorylation of substrate proteins, and through kinase-independent protein- 
protein interactions. It was previously thought that phosphorylation of IRAKI by IRAK4 
increases its catalytic activity resulting in multiple autophosphorylation events. However it is 
also possible that IRAK4 induces IRAKI autophosphorylation merely by direct protein-protein 
interaction; therefore the IRAKI kinase function of IRAK4 may in fact be replaced by that of 
IRAKI itself; the eventual goal of IRAKI hyperphosphorylation being achieved regardless.
Hyperphosphorylated IRAKI has a reduced affinity for MyD88 and an increased affinity for the 
effector protein TRAF6. Phosphorylation of IRAKI is therefore required for downstream 
signalling to NF-kB (Cao et al., 1996b).
IRAKI is degraded following IL1 stimulation, and it  is thought that this is signalled by IRAKI 
phosphorylation. Inhibition of the proteasome has been shown to prevent degradation of 
phosphorylated IRAKI and correspondingly increase the amount of IL-1 receptor that can be 
coprecipitated with IRAKI (Yamin and Miller, 1997). It has been suggested that this i n ­
dependent degradation of IRAKI represents a negative feedback mechanism to terminate the 
IL1 response, and may be the mechanism whereby cells become desensitised after prolonged 
exposure to IL1.
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Figure 1.2. TLR signaling pathways
Intracellular signaling downstream of TLRs is initiated by the cytoplasmic TIR 
domain which binds to the following TIR domain-containing adaptor proteins.
MyD88 recruits IRAK to the receptor upon ligand binding. IRAK then activates 
TRAF6, leading to the activation of the IkB kinase (IKK) complex consisting of 
IKKa, IKKG and NEMO/IKKy. The IKK complex phosphorylates IkB, resulting in 
nuclear translocation of NF-kB which induces expression of inflammatory 
cytokines.
TIRAP, a second TIR domain-containing adaptor, is involved in the MyD88- 
dependent signaling pathway via TLR2 and TLR4.
TRIF is essential for the MyD88-independent pathway in which activation of IRF-3 
and induction of IFN-fJ are activated downstream of TLR3 and TLR4. Non-typical 
IKKs, IKKj'/IKKe, and TBK1 mediate activation of IRF-3 downstream of TRIF.
A fourth TIR domain-containing adaptor, TRAM, is specific to the TLR4-mediated 
MyD88-independent/TRIF-dependent pathway.
Takeda and Akira International Immunology 17; 1-14 (2005)
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1.2.2.6 TRAFs
Currently there are seven known TNF Receptor associated factor (TRAF) proteins, 
characterised by a conserved C terminal TRAF domain, and an N terminal domain containing a 
RING finger, and five or seven zinc-finger structures (Lee and Lee, 2002). The C terminal 
TRAF domain is required for self-association and interaction with receptors and other 
signaling proteins, and the N terminal is the effector domain. TRAF6 is unique among TRAF 
proteins: TRAFs1-3, and 5 bind to CD40 and RANK via common binding sites in the cytoplasmic 
tails, whereas the binding site is distinct in TRAF6. Furthermore, TRAF6, but not other TRAF 
proteins, is involved in signaling downstream of IL1 /TLR family members, in addition to the 
TNFR superfamily (Kobayashi T et al., 2004). However, it  has recently been suggested that in 
addition to TRAF6, TRAF3 also functions downstream of TLRs Both (Hacker H et al., 2006, 
Oganesyan G et al., 2006). Analysis of mice deficient for TRAF3 indicate a requirement for 
this protein in the production of type I interferon and IL10 via both MyD88-dependent and - 
independent mechanisms. Interestingly no defect in NF-kB or MAPK activation was observed 
(Hacker H et al., 2006).
It has been shown that inducing clustering of the effector domains of TRAF6 is sufficient to 
activate the proteins (Lee and Lee, 2002). This suggests that IRAKI functions to activate 
TRAF6 via clustering its effector domain. The reduced affinity of IRAKI for MyD88 means that 
IRAKI and TRAF6 dissociate from the receptor complex and interact at the plasma membrane 
with a second heteromultimeric protein complex consisting of TGFp-activated kinasel (TAK1), 
and two TAK1 binding proteins, TAB1 and TAB2. TAK1 is a AAAP3K protein originally identified 
in TGFp-induced signal transduction (Yamaguchi et al., 1995).
IRAKI then mediates translocation of this multiprotein assembly to the cytosol where further 
proteins necessary for activation of TAK1 kinase activity associate. IRAKI itself does not 
translocate to the cytosol, but remains associated with the plasma membrane where it is 
degraded.
The E2 ligases Ubc13 and UevlA are thought to mediate TAK1 activation. These proteins have 
been shown to catalyse the assembly of a polyubiquitin chain on TRAF6 (Deng et al., 2000), 
and this promotes TRAF6-mediated activation of TAK1 (Wang et al., 2001). Activated TAK1 
then phosphorylates IKKs as well as MAP2Ks (see section 1.2.4)
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Other TRAF6 binding proteins have been demonstrated, suggesting activation of multiple 
downstream signaling cascades. For example, TRAF6 has been shown to activate p62, which in 
turn activates PKCC;, and TRAF6 is also capable of activating ECSIT (evolutionarily conserved 
signaling intermediate in Toll pathways), which is a MEKK1 activator. Although both PKC£ and 
MEKK1 have been suggested to activate IKK, no defects in NF-kB signaling were observed in 
the respective knockout mice, however this could reflect redundancy in IKK activatory 
proteins.
1.2.3 Limitations to studying intracellular signaling pathways in DC
The signal transduction events underlying the maturation process of DC have only recently 
started to undergo serious investigation. Such studies are limited by the fact that it  is 
relatively difficult to obtain DC of high quality and quantity, since cells are largely obtained 
by differentiation from peripheral blood monocytes or bone marrow precursors. A number of 
monocyte-like cell lines exist, although their suitability as dendritic cell models is 
controversial. A good understanding of the role of different signaling pathways in DC is 
therefore limited by the use in different laboratories of a large selection of dendritic cell 
models, differentiated from different species and tissue types or cell line precursors.
To induce signal activation, different maturation stimuli are employed throughout the 
literature, at hugely variable concentrations, for example, in the case of LPS, concentrations 
as diverse as 1ng/ml and 10pg/ml are frequently employed. The source of such variation lies 
in the difficulty in obtaining accurate measurements of physiological conditions. To overcome 
this problem, cocktails of known DC maturation stimuli are sometimes used to stimulate the 
cells. Whilst being physiologically more realistic, such an approach complicates conclusions 
about the activation of specific signaling pathways.
Dendritic cells are notoriously difficult cells to manipulate, and the results of many 
biochemical approaches must be interpreted with care. For example, it  has recently been 
shown that merely the process of transfecting DC is sufficient to activate them (Martin et al., 
2006).
Most of what is known about intracellular signaling pathways in DC has been elucidated using 
two approaches, transgenic mice lacking specific genes, and studies with pharmacological 
inhibitors. Both of these approaches have potential limitations. Frequently, mice engineered 
to lack a single specific signaling protein fail to demonstrate significant phenotypic
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alterations. This is almost certainly due to redundancy and hence reconstituted function 
between isoforms of target proteins, rather than a lack of function on the part of the protein 
per se. Given the ubiquitous nature of many of the signaling pathways under investigation, 
multiple knockout mice are frequently not viable, presumably due to roles of the signaling 
molecules in development. Clearly, mice models lacking multiple related genes in a dendritic 
cell-specific manner would be the optimum tools. However such models would be technically 
challenging to manufacture and have not yet been widely reported for signaling proteins.
By far the most commonly employed approach to analysing signaling pathways in dendritic 
cells is the use of pharmacological protein-specific inhibitors. This approach has the 
advantage of being cheap, easy, and quick. However, results of inhibitor studies should be 
interpreted with care. The first problem is that one can never truly be sure that the inhibitor 
does not interfere with additional unforeseen pathways. Manufacturers producing inhibitors 
usually assay for efficacy of the inhibitors using in vitro systems involving truncated proteins 
corresponding to just the catalytic domains. Clearly, the effect of the inhibitor on every 
possible protein cannot be examined. Also, unforeseen inhibitory mechanisms such as stearic 
effects rather than direct competitive inhibitory mechanisms cannot be fully assessed. The 
thalidomide tragedy, and the recent emergence of cerebrovascular disease in people treated 
with the cox2-inhibitory form of aspirin, are two amongst many other examples that testify to 
such unforeseen effects of inhibitors.
Furthermore, the specificity of a pharmacological reagent is a function of the concentration 
at which it  is used - and at higher concentrations other signaling proteins will also be 
inhibited. Many studies use inhibitors vastly in excess of the concentrations at which they are 
specific for their target protein. For example the p38 inhibitor SB203580 has been suggested 
to have non-specific effects at concentrations as low as 3pM (Lali et al., 2000), although i t ’s 
use at 50pM or even 100pM is frequently reported. Furthermore, this inhibitor directly inhibits 
the catalytic capacity of the p38 enzyme; it  does not therefore prevent p38 phosphorylation 
by upstream activatory proteins (Tong et al., 1997). However, in many studies, efficacy of the 
SB203580 inhibitor is shown as a simple prevention of p38 phosphorylation - the authors are in 
fact indicating their own misuse of the inhibitor, and non-specific inhibition of upstream 
kinases!
Despite the misgivings outlined above, important features of different signaling pathways in 
DC can be elucidated by comparing observations obtained using different experimental 
approaches for common themes or functional traits associated with particular signaling
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molecules. The following discussion attempts to clarify the most prominent themes of 
signaling pathways controlling dendritic cell maturation.
1.2.4 Mitogen-activated protein kinases
1.2.4.1 Introduction
Mitogen-activated protein kinase (AAAPK) pathways are found in all eukaryotic cells. They are 
a multi-purpose signal transduction mechanism that can be harnessed to couple diverse 
stimuli to various effector systems. It is useful to consider that cells use MAPKs to prime 
themselves to produce a particular outcome in response to a given stimulus. This is achieved 
by using a MAPK pathway to couple the appropriate receptor to a particular set of 
transcription factors or other effector proteins. In this way different cell types can respond 
differently to the same stimulus, or indeed produce the same outcome to different 
stimulations.
Considered in the simplest terms, MAPK pathways are composed of a central three-tiered 
core-signaling module in which the sequential members are activated by dual 
phosphorylation. The core modules consist of the effector AAAPKs, which are activated by 
upstream proteins, called AAAPK kinases, or MAP2Ks. In turn, AAAP2Ks are activated by AAAP2K 
kinases, or AAAP3Ks. AAAPKs and AAAP2Ks share a high degree of sequence and structural 
similarity, being composed of two lobes, representing the N- and C-terminal domains, joined 
by flexible hinge region at which the catalytic active site is found. The proteins are activated 
by dual phosphorylation on a disordered activatory region known as the T-loop. In AAAPKs dual 
phosphorylation is upon Thr and Tyr residues in a conserved T X Y motif, whereas in AAAP2Ks 
phosphorylation occurs on ser and ser/thr residues. The dual phosphorylation induces an 
ordering of the loop structure to stabilise the negative charges, which results in a realignment 
of the N- and C-terminal lobes and activation of the catalytic site. Clearly, dephosphorylation 
results in deactivation of the proteins via the reverse mechanism.
The number, diversity and enzymology of the ser/thr kinases that lie upstream of the AAAP2Ks 
and act as AAAP3Ks is immense. The enormous heterogeneity in this family of proteins is 
testament to the huge diversity in AAAPK-activating stimuli. Generally, AAAP3K activation is via 
membrane recruitment, oligomerization, and phosphorylation. One family of AAAP3Ks, the 
mixed lineage kinases, will be considered in more detail in section 1.3. In contrast to the 
AAAP3Ks, only three families of AAAPKs have been identified in mammals, the extracellular 
signal-regulated kinase (ERK), c-jun NH2-terminal kinase (JNK), and p38 kinase, and all three
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AAAPKs phosphorylate target substrates on serine or threonine residues followed by a proline; 
however, substrate selectivity is often conferred by specific interaction motifs located on 
physiological substrates.
ERK is mainly regulated by AAAP3Ks of the Raf family via two AAAP2Ks, AAEK1 and AAEK2. ERK 
exists in two alternatively spliced forms, of 42 and 44 KDa, and is characterised by an 
activatory Thr-Glu-Tyr activatory motif.
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JNK and p38 are often collectively referred to as stress-activated protein kinases, or SAPK, 
due to their important roles in stress and inflammatory responses. Three JNK isoforms exist, 
JNK1, JNK2, and JNK3, and all can be spliced into 46 and 54 KDa proteins, although the 
significance of the different isoforms is not clear. Four p38 isoforms exist, p38a-5, all of 
38KDa. The action of specific inhibitors known as cytokine-suppressive anti-inflammatory 
drugs (CSAIDs) facilitated the discovery of p38, the crystal structure of which has since been 
determined in complex with the most extensively characterised CSAID, SB203580 (Fitzgerald 
et al., 2003). JNK proteins possess a proline residue separating the Thr and Tyr residues of 
the phosphorylation motif, whereas p38 proteins are characterised by a glycine residue in this 
position. JNK is activated by MKK4 and MKK7 MAP2Ks, and p38 by MKK3 and MKK6 (Kyriakis 
and Avruch, 2001). The MAP3Ks upstream of these proteins are numerous, and are often 
promiscuous in their ability to target JNK and p38. Figure 1.3 outlines the organisation of 
MAPK pathways.
For reasons outlined in the section above, there are comparatively few studies into the roles 
of MAPKs in DC, and almost all such investigations have involved the use of specific inhibitors. 
However, JNK-specific inhibitors have only recently become available, and for this reason, 
the roles of p38 and ERK pathways in DC have been far more extensively studied. 
Investigations have demonstrated that activation of AAAPK is important for regulation of 
survival, maturation, cytokine secretion, and morphology of DC, and I will attempt to review 
the results of these studies in the following sections.
1.2.4.2 Control of DC maturation
As discussed above, ligation of various DC surface receptors, including TLRs, CD40, and TNFR, 
is associated with the induction of DC maturation and is always accompanied by activation of 
p38 and ERK AAAPKs to varying extents. Activation of JNK is not consistently observed, 
suggesting that this is a non-essential pathway in controlling DC maturation. Where it  is 
observed, activation of the ERK, JNK, and p38 pathways occurs rapidly (within 15-30 
minutes), is transient (absent by 4 hours), and with similar kinetics for each of the AAAPKs 
(figure 4.4).
Interestingly, alterations in the level of stimulation affect the degree of AAAPK 
phosphorylation observed, but never the kinetics of activation. Frequently, the threshold for 
activation of JNK is observed to occur at higher concentrations than that of p38 and ERK 
(Nakagawa et al., 2004; Bunyard et al., 2003). The idea of different signaling pathways 
activated at different concentrations is clearly an attractive one given that the level of
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stimulation is one of the determinants that has been hypothesised to regulate the phenotype 
of the mature DC (Luft et al., 2004).
Adding further weight to the importance of MAPKs in control of DC maturation, several 
immunosuppressive drugs have been identified which mediate their effects via interference of 
these pathways. For example, epigallocatechin-3-gallate (EGCG) inhibits the maturation of 
murine DC induced by LPS, as measured by upregulation of surface markers CD80, CD86, and 
MHC molecules, and secretion of IL12 (Ahn et al., 2004). Biochemical analysis indicates that 
EGCG mediates these effects via inhibition of p38, JNK, and ERK activation in response to 
LPS, although the mechanism for this is unclear. Similarly, parthenolide (PTL) inhibits 
upregulation of LPS-, but not TNFa-induced CD80, CD83, CD86, CD40, and HLA-DR, on DC. PTL 
also prevents LPS-, but not TNFa-induced p38 and MKK3/6 phosphorylation (Uchi et al., 
2002).
Clearly PTL mediates its effects in the LPS signaling pathway upstream of the point at which 
the LPS and TNFa signal pathways integrate. This observation is particularly interesting 
because it indicates that signaling pathways induced by different DC maturation stimuli, 
which operate though discrete surface receptors, converge to activate MAPKs, underlining the 
importance of these pathways in DC maturation. Indeed the idea of a central role for MAPK 
independent of the nature of the stimulus in the process of DC maturation is reinforced by 
numerous other examples. Lymphocyte activation gene 3 (LAG3) is expressed on activated T 
cells and ligates MHC class II molecules to induce DC maturation. Via the use of specific 
inhibitors, ERK and p38 activation was shown to be critical for TNFa secretion and 
upregulation of various surface markers in response to LAG3 stimulation (Andreae et al., 
2003). Other ligands including CD40L (Luft et al., 2004; Vidalain et al., 2000), TNFa (Cruz et 
al., 1999; Sato et al., 1999), TLR ligands (Ardeshna et al., 2000; Re and Strominger, 2001), 
contact sensitizers (Arrighi et al., 2001; Boisleve et al., 2004), and nicotine (Aicher et al.,
2003) have also been shown to induce DC maturation via a MAPK-dependent mechanism.
Current models suggest that by far the most important of the AAAPKs in controlling DC 
maturation is p38. The upregulation of surface markers such as CD40, CD54, CD80, CD83, 
CD86, HLA-DR and secreted cytokines including IL6, IL8, IL10, IL12, and TNFa are inhibited by 
p38 inhibition, (Messmer et al., 2004; Pollara et al., 2004; Arrighi et al., 2001; Nakahara et 
al., 2004), and the degree of p38 phosphorylation has been shown to correlate with the level 
of expression of markers of DC maturation such as CD86 (Pollara et al., 2004).
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Several of the physiological properties of DC that are altered upon maturation are also 
regulated by p38. Increased expression of a4 integrins, which mediate binding to the 
extracellular matrix protein fibronectin, and which are thought to reflect the DC migration 
process, are inhibited by p38, but not ERK inhibition (Puig-Kroger et al., 2000). CCR7 
expression and DC migration is prevented by p38 inhibition (Ardeshna et al., 2002; Boisleve et 
al., 2004). In vitro T cell stimulatory capacity is sensitive to p38 inhibition (Arrighi et al., 
2001; Nakahara et al., 2004; Yu et al., 2004) (although the results of these studies are 
difficult to interpret since it  is impossible to exclude effects of diffusion of the inhibitor out 
of the DC and into the T cells). The downregulation of endocytic capacity observed upon 
maturation has also been suggested to be mediated by p38 (Arrighi et al., 2001; Nakahara et 
al., 2004), although several studies refute this (Ardeshna et al., 2000; Puig-Kroger et al., 
2001), and indeed the regulation of DC endocytosis remains controversial.
Many of these functions of p38 have been deduced using the SB203580 inhibitor. A recent 
study using an SB203580-resistant p38a protein has confirmed the involvement of this isoform 
in the LPS-induced expression of IL6, IL10, and TNFa (Guo et al., 2003a).
In one of the few non-pharmacological-based investigations into the role of p38 in DC, 
germline MKK3-deficient mice were generated (Lu et al., 1999). Macrophages derived from 
the mice were found to be defective in p38 activation in response to some stimuli such as 
LPS, but not others, such as sorbitol. Given that p38 is activated by MKK3 and MKK6, this 
provides a useful insight into the relative contribution of the two MAP2Ks. Reconstitution with 
MKK3 restored LPS-induced p38 activation, suggesting that MKK3 is the most important MAP2K 
in activating p38 in response to TLR4 stimulation. In MKK3-deficient DC, LPS- and CD40L- 
induced IL12 production was significantly inhibited, suggesting that p38 is important for IL12 
production.
Despite being significantly diminished by p38 inhibition (Arrighi et al., 2001), secretion of 
TNFa and IL6 were not reduced in the MKK3 knockout mouse suggesting that the regulation of 
these two cytokines is MKK6-dependent although the mechanism underlying the AAAP2K 
preferences of different DC maturation markers is unclear (Lu et al., 1999).
Interestingly, two p38 MAPK isoforms have been identified in Drosophila that appear to 
regulate anti-microbial gene expression (Han et al., 1998). These D-p38 proteins are also 
sensitive to inhibition by the SB203580 p38 inhibitor. As in mammalian cells, LPS was shown to 
activate D-p38 AAAPK. However, in contrast to the role of p38 in mammals, activation of D-p38
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was associated with a suppression of immune gene transcription, as demonstrated by 
overexpression of D-p38, and enhanced LPS-induced expression of anti-microbial genes in the 
presence of SB203580. Nonetheless, these studies illustrate the importance of p38 in the 
control of immune responses in higher organisms.
Interestingly, D-JNK has also been identified, and shown to be activated during the immune 
response in Drosophila. In mammalian systems the role of JNK in controlling DC maturation is 
not well understood. However, it has recently been demonstrated that JNK inhibition does 
not prevent induction of T cell proliferation, cytokine production or endocytosis, although 
there is a small reduction in the level of expression of CD54 and CD80 in response to LPS 
(Nakahara et al., 2004), suggesting that JNK plays only a minor role in the control of DC 
maturation.
Several studies indicate that the ERK pathway has a negative regulatory role in controlling DC 
maturation (Puig-Kroger et al., 2001), while other studies indicate that ERK has no apparent 
role (Ardeshna et al., 2000). This discrepancy appears to result from the utilisation of 
different levels of stimulation. For example, with low stimulation, such as 10ng/ml LPS or 
using TNFa or CD40L, ERK negatively regulates the expression of surface markers, including 
CD83, CD49d, CD86, and HLA-DR (Arrighi et al., 2001; Puig-Kroger et al., 2001; Aicher et al.,
1999). However, when 100ng/ml or more of LPS is used to stimulate the DC, ERK inhibition 
has no effect on the maturation program (Kikuchi et al., 2003; Puig-Kroger et al., 2000). 
Rather than being a straightforward negative regulator, it is now thought that the role of the 
ERK pathway in modulating DC maturation is in fact more complex than this, and regulates 
the effector T cell phenotype of the resulting immune response.
1.2.4.3 Effector T cell polarization
In all published studies of AAAPK signaling induced by CD40L in DC, inhibition of p38 prevents 
DC maturation in terms of migration (Luft et al., 2004), IFNy (Yu et al., 2004), and IL12 
secretion (Vidalain et al., 2000; Kikuchi et al., 2003; Aicher et al., 1999), upregulation of 
surface molecules CD80, CD83, CD86, HLA-DR, and allostimulatory capacity (Yu et al., 2004). 
The effects of JNK inhibition on CD40L-induced DC maturation have not been reported, 
possibly reflecting an absence of phenotype. CD40L-induced ERK phosphorylation occurs with 
identical kinetics to that of p38. ERK inhibition has no effect on the upregulation of surface 
markers (Yu et al., 2004), but does result in increased IL12 production and DC migration in 
response to CD40L (Luft et al., 2004). This is interesting because it  not only suggests that 
different aspects of DC maturation are regulated independently, but it  also implicates the
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ERK pathway in a negative-regulatory capacity in some facets of this maturation program. 
According to this hypothesis, relative to DC in which ERK is activated, absence of ERK 
activation would induce DC with mature surface phenotype, but greater capacity to secrete 
IL12. Such DC would be archetypal Th1-inducers, and thus the function of the ERK pathway in 
response to CD40L may be to suppress the Th1-like response.
The capacity of ERK to suppress Th1 responses appears to be a general theme regulating the 
phenotype of the mature DC in response to all DC maturation stimuli. ERK2 knockout mice are 
not viable. ERK1 knockouts however, demonstrate significantly enhanced production of 
IL12p70 in response to LPS, whereas the induction of IL10 is significantly reduced in these 
mice. Secretion of other cytokines, such as IL6, is unaffected (Dillon et al., 2004). 
Accordingly, a 5-fold increase in IL12 production in response to TNFa is observed following 
preincubation with a pharmacological ERK inhibitor (Puig-Kroger et al., 2001), and this is 
mirrored in response to LPS (Dillon et al., 2004; Xia and Kao, 2003), and the ability to 
synthesise IL10 is significantly retarded (Dillon et al., 2004; Xia and Kao, 2003). DC derived 
from mice engineered to lack the ERK-dependent transcription factor c-fos respond in an 
identical fashion to ERK1-deficient DC, and demonstrate an enhanced Th1 phenotype, 
suggesting that the suppression of Th1 responses by ERK occurs via a c-fos dependent 
mechanism.
Despite these findings on ERK- or c-fos-deficient mice, variable effects of ERK inhibition on 
the level of IL12 secretion have been reported, ranging from no effect (Kang et al., 2004; 
Nakahara et al., 2004; Dillon et al., 2004; Vidalain et al., 2000) to a strong enhancement 
(Aiba et al., 2003; Kikuchi et al., 2003; Puig-Kroger et al., 2001). This is may reflect the 
utilisation of different stimuli at different concentrations. There is no argument, however, 
that ERK is required for IL10 synthesis, and it  is therefore possible that the reported increases 
in IL12 production upon ERK inhibition are actually mediated indirectly via reduced IL10 
secretion. Indeed, addition of exogenous IL10 can reverse the upregulation of IL12 observed 
following ERK inhibition (Xia and Kao, 2003). Regardless of the exact mechanism, the 
observations that p38 controls IL12 production, and ERK is not required for IL12, but is 
essential for IL10 synthesis suggest that the T cell profile of the resulting immune response is 
largely controlled by the relative activities of these two AAAPKs. Interestingly, many 
investigations report that inhibiting either of the p38 or ERK AAAPKs results in enhanced 
phosphorylation of the other upon stimulation (Wilflingseder et al., 2004; Valentinis et al., 
2005; Puig-Kroger et al., 2001). These experiments are performed with an incubation period 
of only 60 minutes, ruling out a cytokine feedback system in this case. A possible mechanism
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for this antagonism between the p38 and ERK AAAPK pathways is via the regulation of 
phosphatase activity. Indeed, phosphorylation and stabilisation of a JNK phosphatase, AAKP7, 
by ERK has recently been demonstrated, suggesting a mechanism for ERK-induced JNK 
inactivation (Masuda et al., 2003; Katagiri et al., 2005), and a similar interaction may 
mediate regulation of ERK by p38 and vice-versa.
IL12 treatment of DC stimulates p38 phosphorylation (Nagayama et al., 2000), and IL10 
induces ERK activation (Mathur et al., 2004). This observation, in combination with the 
proposed ERK-p38 antagonism outlined above, suggests that IL12 and IL10 present in the 
extracellular milieu will enhance p38 or ERK signaling respectively within the DC, thus 
stimulating their own production and therefore reinforcing the prevailing T cell polarization. 
A similar mechanism has been proposed to operate in macrophages in response to CD40 
(Mathur et al., 2004), and CpG DNA stimulation (Yi et al., 2002; Hacker et al., 1999). In 
support of this model is the observation that MKK3 knockout mice demonstrate impaired Th1 
responses (Lu et al., 1999).
To evade immune detection, many organisms are known to skew the effector T cell profile of 
an immune response. It has been suggested that Leishmania amastigotes, for example, 
exploit this mechanism of MAPK regulation to inhibit a Th1 outcome by enhancing ERK 
activation following CD40 stimulation (Mathur et al., 2004).
It was outlined above that the outcome of DC maturation is controlled by the integration of 
multiple signals from pathogens, inflammatory mediators, chemokines, cell-cell contact, etc. 
Many of these ligands will induce AAAPK signaling and clearly the balance of p38 and ERK that 
is induced will be critical in the determination of the Th1 /Th2/Treg bias of the mature DC.
One of the major factors implicated in the control of the effector T cell profile is the identity 
of the DC maturation stimulus. Recently several studies have been published comparing the 
ability of different TLR ligands to induce Th1 and Th2 responses. In particular, TLR2 ligands 
such as Pam3cys and schistosome egg antigen (SEA) have been shown to direct the T helper 
cell phenotype towards the Th2 pathway, and in agreement with the above model, this has 
been shown to occur via a mechanism dependent on the ERK pathway and the c-fos 
transcription factor (Dillon et al., 2004; Agrawal et al., 2003; Kane et al., 2004). In 
particular, via ERK activation and c-fos stabilisation, these two stimuli induced upregulation 
of surface markers in the absence of IL12p70 secretion, and induced T cell proliferation with 
subsequent IL4 and IL5 production. ERK inhibition, or use of ERK1- or c-fos-deficient DC is
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sufficient to increase IL12p70 and decrease IL10 production in response to these TLR2 ligands 
to levels comparable to those induced by LPS or flagellin (Dillon et al., 2004).
In view of these studies, it would seem reasonable to assume that ligation of different TLRs 
activates DC to induce Th1 or Th2 responses by the preferential activation of p38 or ERK, 
perhaps via different intracellular adaptor proteins. However LNFPIII is a helminth 
carbohydrate ligand of TLR4, which induces DC to stimulate high IL4 and low IFNy from 
responding T cells, and thus can be considered a Th2 ligand. LNFPIII induces strong ERK and 
little  p38 phosphorylation (Thomas et al., 2003), whereas LPS induces the reciprocal pattern 
of MAPK activation via the same receptor. How is this achieved? Currently no structural 
studies of any TLRs have been reported, but one possible mechanism is that LNFPIII utilises a 
second, additional receptor, which favours ERK over p38 activation. Although TLR4-deficient 
mice do not respond to LNFPIII, an additional receptor may still exist which is incapable of 
inducing maturation per se, but can bias the outcome of TLR4-induced maturation. An 
alternative possibility is that strength of the signal is somehow capable of determining the 
polarization of the responding T cells.
Signal strength has previously been postulated to determine the Th1 /Th2 bias, with strong, 
persistent stimulation associated with a Th1-type response, and transient, weaker 
stimulation, inducing Th2 (Boonstra et al., 2003a). In support of this model, using modified 
CD40L molecules that induced strong or weak signaling, Luft et al recently showed that strong 
and sustained signaling was associated with IL12p70 production (Luft et al., 2004). With 
reference to the above example, if  LNFPIII has a lower affinity for TLR4 than does LPS, then 
the DC would translate this into a Th2 outcome. Indeed, it was recently reported that LNFPIII 
induces a rapid, but transient NF-kB activation, whereas LPS induces more persistent 
activation (Thomas et al., 2005). Furthermore, low dose LPS has previously been 
demonstrated to promote Th2 development (Eisenbarth et al., 2002). The precise mechanism 
for signal strength-mediated differential intracellular signaling is unclear, however.
1.2.4.4 Mechanisms of MAPK action in DC
In MKK3-deficient DC, as discussed above, LPS- and CD40L-induced IL12 production was 
significantly inhibited and this was found to occur at the level of IL12p40 transcription. The 
IL12p40 promoter has been well characterised and is controlled by several transcription 
factors including C/EBP, and ets-2-related factor, which are both phosphorylated and 
activated by p38 (Williamson et al., 2005; Yordy and Muise-Helmericks, 2000). This highlights
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the role of p38 in the control of cytokine production via the regulation of transcription 
factors.
In addition to directly regulating the activity of transcription factors, p38 can also control 
gene expression in DC by modulating higher order chromatin structure. Before transcriptional 
regulators can access their sequence-specific binding sites, a transition from a condensed to 
decondensed chromatin structure takes place. The activation of transcription is then 
accompanied by the remodelling of specific nucleosomes, and this is controlled in part by 
phosphorylation on the constituent histone proteins. Addition of electronegative phosphate 
groups results in a reduced affinity for DNA, mediated by the repulsive forces between the 
phosphate groups and the negatively charged backbones of the nucleic acid double helix. It is 
proposed that in response to appropriate stimulation, p38 induces phosphorylation of a serine 
residue (ser10) in histone H3. This sensitises the histone to hyperacetylation on neighbouring 
lysine residues, further increasing the local electronegativity and permitting transcriptional 
activation (Saccani et al., 2002). Serine to alanine mutation of this residue abrogates 
transcription of specific inducible genes underlining the importance of this mechanism. The 
serine of H3 is not followed by a proline, and is therefore not a direct p38 target. Several 
candidate proteins, however, may function as intermediates such as the mitogen and stress 
activated protein kinase-1 (MSK1), which is a p38 target protein and known to phosphorylate 
histone H3 on this serine residue (Thomson et al., 1999a).
MSK1 is also an ERK target, raising the possibility that the ERK and p38 pathways cooperate in 
the induction of histone H3 phosphorylation by this protein. However, other known histone H3 
kinases also exist, with differing AAAPK dependency, such as the ERK-specific ribosomal S6 
kinase-2 (RSK2) (Thomson et al., 1999b). This suggests that different stimuli could induce 
overlapping subsets of genes via different H3 kinases, depending upon the relative levels of 
ERK and p38 activation.
Following histone H3 phosphorylation, the transcription factor NF-kB is recruited to a subset 
of genes that are rapidly induced in response to microbial products, and regulated by the p38 
pathway (Saccani et al., 2002). The model therefore describes a system by which the p38 and 
NF-kB pathways, which are both known to be critical for DC maturation, cooperate via p38- 
dependent enhanced accessibility of NF-kB binding sites. Presumably, the enhanced promoter 
accessibility also facilitates binding of other transcription factors, such as those that are ERK 
or JNK dependent, further reinforcing the cross-talk between signaling pathways.
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Another mechanism by which p38 is known to control production of inflammatory proteins is 
via mRNA stabilisation. Many mRNAs contain in their 3’ untranslated regions an AU-rich 
element (ARE), which sensitises the transcript to degradation but also permits p38-dependent 
stabilisation. The mechanism for this stabilisation is not known (Dean et al., 2004). 
Interestingly, the anti-inflammatory TGF8 protein has been shown to selectively inhibit LPS- 
induced chemokine mRNA stabilisation (Dai et al., 2003).
MAPKs also regulate function at the protein level. For example, ERK activation in DC mediates 
IL1 secretion via activation of caspase 1, which is required for cleavage of pro-IL1 yielding the 
active IL1 molecule (Guo et al., 2003b).
The direct and indirect roles of p38 in gene modulation probably operate in parallel. Some 
genes, for example, such as IL8 and MCP1, are p38-dependent and associated with H3 
phosphorylation. Others, including MIP1a and TNFa, are not associated with H3 
phosphorylation. Since studies with the p38 inhibitor have shown that TNFa secretion is p38 
dependent, p38 must regulate different genes at different levels.
1.2.2.5 Survival
In addition to their role in regulating DC maturation, there is evidence to suggest that MAPKs 
function in the control of DC survival. The duration of stimulation of naive T cells is 
determined by the life span of the activatory DC - indeed it  has been postulated that CD40 
and MHC class II transmit antagonistic survival signals from T cells to DC (McLellan et al.,
2000). The control of DC survival and the induction of apoptosis is therefore a critical factor 
regulating specific immunity. All three AAAPKs have been implicated in this process, although 
in contrast to the control of maturation, there are very few studies into the role of AAAPKs in 
DC survival.
The p38 pathway appears to possess a pro-apoptotic capacity. The specific inhibitor SB203580 
inhibits caspase 3 activation and thus apoptosis of DC in response to the immunosuppressive 
drug triptolide (Liu et al., 2004). SB203580 also inhibits UV-induced DC apoptosis (Nakagawa 
et al., 2004).
The role of the JNK pathway in DC survival has not been well studied. However a pro- 
apoptotic capacity for JNK is well established in other cell types (Bharti and Aggarwal, 2004), 
and such a role in DC is suggested by the observation that in response to ligation of the 
receptor-activator of NF-kB (RANK) in raw cells, JNK is required for apoptosis (Bharti et al.,
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2004). The role of p38 and JNK in DC maturation and survival is explored in more detail in 
chapter 3 of this thesis.
Several studies implicate the ERK pathway in a pro-survival capacity (Rescigno et al., 1998). 
Human Osteoclast-Associated Receptor (hOSCAR) is Fc Receptor-associated and signals via the 
intracellular ITAM of this affiliated molecule. Ligation of hOSCAR results in expression of anti- 
apoptotic proteins such as BCLXl, and this was prevented by ERK inhibition (Merck et al.,
2005). Furthermore, LPS has been proposed to induce DC survival by activating the ERK 
pathway via a family of caspase-like proteins (Franchi et al., 2003). The pro-survival role of 
ERK is controversial, however, since several studies find no alteration in the level of DC 
survival upon ERK inhibition (Guo et al., 2003b; Park et al., 2002).
It is interesting that the p38 and ERK pathways apparently play opposing roles in survival, 
reminiscent of their roles in determining the T cell polarization. Thus, a model of the overall 
picture of AAAPKs in DC emerges. High levels of stimulation induce a Th1-like outcome via 
strong p38 activation and this is associated with apoptosis, perhaps reflecting a shortened 
window for T cell activation. On the other hand, weaker stimulation results in ERK activation 
and induction of Th2 responses, which are prolonged due to the pro-survival effect of the ERK 
pathway.
The MAPK pathways are obviously not the only signaling modules involved in regulating DC. 
The role of the PI3K and NF-kB pathways are reviewed below.
1.2.5 PI3K
Phosphatidylinositide-3’-OH kinases (PI3Ks) are a family of lipid kinases which catalyse the 
addition of a phosphate molecule specifically to the 3’ position of the inositol ring of 
phosphoinositides (Toker and Cantley, 1997). Pleckstrin homology (PH) domain-containing 
proteins are recruited by these second messengers to the plasma membrane, and are then 
activated by phosphorylation before phosphorylating numerous protein targets.
Several studies have proposed a pro-survival role for PI3K in DC, consistent with observations 
in other cell types (Datta et al., 1999). In particular, studies with the PI3K-specific inhibitor 
LY294002 demonstrate increased DC apoptosis in response to ligation of hOSCAR (Merck et al.,
2005), CD40 (Yu et al., 2004), TLR9 (Park et al., 2002), and TLR4 (Ardeshna et al., 2000). The 
mechanism for this is probably via the downstream PI3K effector protein, Akt1, which is 
known to phosphorylate and regulate a variety of pro-apoptotic regulators and also positively
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regulates proteins that promote survival. CCR7 induces Akt1-dependent survival via sequential 
activation of Gi proteins and PI3K (Sanchez-Sanchez et al., 2004). Despite being activated by 
CCR7 ligation, PI3K is not involved in the control of chemotaxis or migratory speed (Riol- 
Blanco et al., 2005).
The role of PI3K in the regulation of DC maturation remains unclear. PI3K and Akt are 
activated by ligation of TLRs and members of the TNF family that signal via TRAF6 such as 
TLR4 (Termeer et al., 2002) and RANK (Bharti et al., 2004), suggesting a role in regulation of 
maturation (Yu et al., 2004; Ardeshna et al., 2000). However PI3K inhibition does not prevent 
maturation induced by TLR4 ligation (Termeer et al., 2002). PI3K has been shown to play an 
important role in IL12 secretion, although this function is not consistent between mouse and 
man. PI3K is required for IL12 secretion in humans (Re and Strominger, 2001; Yu et al., 2004). 
However, a knockout mouse engineered to lack PI3K showed increased IL12 production, and 
this negative regulatory effect of PI3K was also observed when mouse BMDC were treated 
with LY294002 (Fukao et al., 2002). The authors propose that the mechanism of PI3K- 
mediated IL12 suppression in murine DC is via inhibition of p38 by PI3K, perhaps at the level 
of MAP3Ks (Fukao et al., 2002). This discrepancy in IL12 control could reflect species 
differences between human and mouse, or perhaps may relate to the DC models used in the 
two systems.
1.2.6 NF-kB
The NF-kB family of transcription factors contains 5 members called Rel proteins: p65 (Rel A), 
p50/p105 (NF-kB1), c-Rel, p52/p100 (NF-kB2), and RelB. Functional NF-kB molecules consist 
of homo- or hetero-dimeric complexes of Rel proteins. Rel proteins are characterised by an N- 
terminal Rel-homology domain (RHD), which mediates DNA binding, nuclear localisation, and 
subunit dimerisation. Prior to stimulation, NF-kB proteins are sequestered in the cytoplasm by 
inhibitory proteins called IkBs (inhibitors of NF-kB). Upon stimulation, IkBs are 
phosphorylated, targeting them for ubiquitination and ultimately proteolytic degradation, 
releasing NF-kB to translocate into the nucleus and modulate gene expression (figure 1.4). 
The transcriptional activity of some NF-kB dimers is additionally regulated by 
phosphorylation.
There are several IkB proteins, although the pathway leading to the degradation of IkBo has 
been characterised in the greatest detail, and is known as the ‘canonical’ NF-kB pathway. As 
shown in figure 1.4, IkBo is phosphorylated by an IkB kinase complex (or ‘signalosome’), 
comprising 2 kinase subunits IKK1 (or a), and IKK2 (or B), and a structural subunit NEMO. IKK1
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and IKK2 can each phosphorylate IkBo on two serine residues, ser32 and ser36, leading to the 
release of the NFkB heterodimer. Activation of the IKK complex by various agonists including 
TNFa and IL1 requires the MAP3Ks MEKK3 and TAK1, which are thought to phosphorylate the 
IKKs, thus providing a link between the MAPK and NF-kB pathways.
There is much evidence that NF-kB positively regulates DC maturation. Many DC maturation 
stimuli have been shown to induce NF-kB activation (Kang et al., 2004; Hegde et al., 2004; 
Ardeshna et al., 2000; Basu et al., 2000; Banki et al., 2003), and overexpression of IkBo in DC 
prevents the upregulation of CD40, CD80, CD83, CD86, and HLA-DR, and expression of 
cytokines including IL12, IL6, and TNFa (Yoshimura et al., 2001). Nuclear translocation of NF- 
kB subunits is observed following stimulation with DC maturation stimuli (Rescigno et al., 
1998; Kim et al., 2004), and DC Maturation is preceded by an increase in DNA binding capacity 
of RelB, p50, p52, and c-Rel (Verhasselt et al., 1999; Neumann et al., 2000).
Several NF-kB inhibitors have been described and inhibit DC maturation: TLR2- and TLR4- 
induced upregulation of CD86 and HLA-DR is inhibited by pyrrolidine dithiocarbamate (PDTC) 
(Kim et al., 2004); SN50 inhibition of NF-kB results in partial inhibition of CD80, CD83, CD86, 
and HLA-DR in response to LPS (Ardeshna et al., 2000); TNFa secretion in response to LPS is 
inhibited by the NF-kB inhibitor CAPE (caffeic acid phenethyl ester) (Termeer et al., 2002); 
TPCK (N-alpha-Tosyl-L-phenylalanine chloromethyl ketone), prevents the partial upregulation 
of CD83 and CD86 induced by Polymyxin B (Valentinis et al., 2005).
NF-kB subunits are differentially recruited by various DC maturation stimuli (Hofer et al., 
2001; Neumann et al., 2000). The role of individual NF-kB dimers has been addressed in the 
murine system using mice deficient for particular Rel proteins, and these studies indicate that 
a large degree of redundancy exists between the family members. Mice deficient for c-Rel 
showed no deficiency in IL12 production (Mason et al., 2002). Mice lacking both c-Rel and p50 
proteins demonstrated impaired IL12 production, despite DC from these mice expressing 
normal levels of MHC and costimulatory molecules (Ouaaz et al., 2002). In agreement with 
these studies, RNAi inhibition of p50 in DC resulted in reduced IL12 secretion, while 
expression of HLA-DR and costimulatory molecules were not affected. These DC also induced 
T cells, which secreted less IFNy revealing a requirement for p50 in DC for induction of Th1 
immune responses. (Laderach et al., 2003). Furthermore, p50-deficient mice demonstrate 
defective IL4, IL5, and IL13 production and induce increased INFy in response to the Th2 
stimulus SEA (Artis et al., 2005). This was accompanied by defective OVA-specific CD4+ T cell 
differentiation, IL4 and IL5 production. Interestingly, there is reduced ERK activation in the
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p50-deficient DC, which is consistent with an abrogated Th2 response, however the 
mechanism for this ERK deficiency is not clear (Artis et al., 2005). Consistent with this 
observation is the finding that the ERK signal transduction pathway negatively regulates NF- 
kB DNA binding during TNFa-induced DC maturation (Puig-Kroger et al., 2001).
NF-kB has also been implicated in regulating DC Survival. Importantly, ligation of Fas on the 
surface of DC by Fas ligand during DC-T cell interaction induces pro-survival NF-kB activity 
that prevents the DC from entering apoptosis (Rescigno et al., 2000; Guo et al., 2003b). 
Additionally, CCR7 ligands CCL19 and CCL21 induce IkB degradation and NF-kB nuclear 
translocation, and NF-kB inhibitors NAC and SN50 prevent the pro-survival effects of these 
chemokines (Sanchez-Sanchez et al., 2004). Ligation of another DC receptor, RANK also has a 
pro-survival phenotype, and this is thought to be mediated via transcription of anti-apoptotic 
genes such as BCLXl via NF-kB (Bharti et al., 2004). Furthermore, the NF-kB inhibitor PDTC 
makes DC susceptible to apoptosis, confirming that NF-kB-transcribed genes are involved in 
anti-apoptotic responses (Guo et al., 2003b).
I.2 .7  Other signaling pathways
Given the ability of DC to integrate multiple ligand-induced signals derived from pathogens, 
inflammatory mediators, chemokines, cell-cell contact, etc, and translate them into a 
particular mature phenotype, these cells are likely to utilise many different families of 
signaling proteins. While the MAPK and NF-kB pathways have been shown to play major roles 
in controlling the outcome of the DC maturation process, the roles of many signaling 
pathways in this process await detailed investigation.
The PKC pathway is a good example of a family of signaling proteins that may be involved in 
the control of DC maturation, but have not been thoroughly investigated. LPS stimulation of 
DC results in PKC phosphorylation, and inhibition of PKC activation using bisindolylmaleimide, 
a pan-PKC inhibitor, prevents IL-12 production, but does not affect up-regulation of MHC class
II, CD80 or CD86 (Aksoy et al., 2002). An identical outcome of inhibition of IL12 secretion but 
not surface marker expression was obtained in response to LPS in the presence of the PKA- 
specific inhibitor H89 (Galgani et al., 2004). In both studies IL12 inhibition was accompanied 
by activation of IL4-secreting T cells, suggesting that PKC and PKA are not involved in 
controlling maturation per se, but are involved in determining the resulting T cell profile. PKC 
has also been suggested to modulate the pro-apoptotic response of DC to MHC class II ligation 
(Bertho et al., 2002).
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1.3 Mixed Lineage Kinases
1.3.1 Introduction to Mixed Lineage Kinases
The Mixed Lineage Kinases (MLKs) are a family of serine/ threonine kinases all of which act as 
MAP3Ks (Gallo and Johnson, 2002). The name “Mixed Lineage Kinases” derives from the fact 
that of the 11 conserved subdomains found in all protein kinases, domains 1-8 of the MLK 
proteins resemble serine/ threonine kinases whereas regions 9,10 and 11 share sequence 
similarity with those of tyrosine kinases, such as the Fibroblast Growth Factor Receptor and 
Src (Gallo and Johnson, 2002).
Early experiments into the role of MLK proteins were performed with recombinant proteins or 
by overexpression in cell lines. Because of this, much of the data is contradictory. For 
example Merritt et al (Merritt et al., 1999) showed that one of the MLK proteins, DLK, 
activates MKK7 and not MKK4, whereas Hirai et al (Hirai et al., 1997) show that DLK activates 
MKK4. Six different reports can be summarised by the statement that in vitro MLK proteins 
can activate both p38 and JNK, via any of the relevant intermediary proteins, MKKs 3,4,6, or 
7 (Hirai et al., 1997; Merritt et al., 1999; Tibbies et al., 1996; Rana et al., 1996; Cuenda and 
Dorow, 1998; Hirai et al., 1998). Obviously this statement, like the early experiments it 
describes, fails to take into account subtleties of physiological regulation. It is likely that all 
MLK proteins activate JNK, and all act via MKK7. MKK4-mediated activation of JNK occurs to a 
lesser degree, although the regulation of this pathway is not clear. MLK proteins can also 
activate p38 and this is via MKK3 phosphorylation.
The role of MLK proteins in ERK activation remains somewhat clouded. Overexpression of 
MLK3 has been shown to induce moderate activation of the MEK1-ERK protein kinase pathway. 
This activation was prevented by the MEK-specific inhibitor PD98059 or by expression of a 
kinase-deficientMEK1 mutant (Hartkamp et al., 1999). In contrast to this however, Shen et al 
demonstrate that although MLK3 can phosphorylate and activate MEK-1 directly in vitro and 
can induce MEK phosphorylation in COS-7 cells, this induction of MEK phosphorylation does 
not result in ERK activation in vivo (Shen et al., 2003). However a recent study reported that 
silencing of mlk3 by RNAi suppressed mitogen and cytokine activation not only of JNK and 
p38, but of ERK as well (Chadee and Kyriakis, 2004b).
It therefore appears as though the picture of mixed lineage kinases as comparatively selective 
regulators of the JNK group of MAPKs is no longer valid. By discussing current theories 
regarding the regulation of activation and specificity of MLK proteins I will attempt to expand
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and clarify this issue in the following literature review. It should be noted that MLK proteins 
have not previously been studied in DC, and the role of these proteins in the regulation of DC 
survival, maturation and morphology is central to the investigations presented in this thesis.
1.3.2 Types of MLK
It is believed that there are eight mammalian MLKs, categorised into three subfamilies on the 
basis of domain organisation and sequence similarity (figure 1.5):
1) MLKs; MLK1-4 (Dorow et al., 1993; Ing et al., 1994)
2) DLKs (Dual Leucine Zipper-Bearing Kinases); DLK and LZK (Holzman et al., 1994; Sakuma et 
al., 1997)
3) ZAKs (Zipper Sterile-a-Motif Kinases); ZAKa and ZAKB (Liu et al., 2000; Gotoh et al., 2001)
MLK2, MLK3, DLK and LZK (Dorow et al., 1993; Ing et al., 1994; Sakuma et al., 1997) are the 
only MLKs whose biochemistry has been studied in any detail. This is probably because they 
are either widely expressed (MLK3, LZK), or are brain restricted (MLK2, DLK), and hence offer 
potential therapeutic targets for neurodegenerative diseases such as Parkinson's.
All eight MLKs contain a leucine zipper domain. These consist of one or two a-helices with 
predominantly non-aromatic lipophilic amino acids occupying one face, which facilitates 
protein multimerisation via hydrophobic interactions.
MLK1-4 share a high degree of homology in the N-terminal 500 or so amino acids, which 
incorporate several functional domains: an SH3, a kinase catalytic domain, the leucine zipper, 
a proline-rich region, and the CRIB domain which mediates binding to GTP-bound cdc42 and 
rac. In contrast to the amino terminal portion of the proteins, the carboxyl termini share 
little  homology and vary greatly in size, possibly to mediate specificity and orchestrate 
interactions with various other proteins.
The DLK subfamily is identified by possession of two leucine zippers separated by a 31 amino 
acid spacer region. DLK and LZK share a high degree of homology.
The most recently identified MLK subfamily have been termed ZAKs due to the fact that the 
first identified member of the family, ZAKa, contains a sterile-a-motif (SAM): an independent 
globular domain of about 70 amino acids found in many signal transduction proteins. 
Biochemical and structural studies suggest that SAM domains mediate protein dimerisation. 
The second ZAK protein, ZAKB, has a much smaller C-terminal domain than ZAKa and as a 
result lacks the SAM. The ZAK proteins are only loosely related to the other six MLKs, sharing
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sequence homology in the kinase catalytic region and bearing a small leucine zipper domain 
(Gotoh et al., 2001).
1.3.3 Activation Of MLKs
A diverse collection of MLK activatory proteins has been identified. Studies using dominant 
negative forms of MLK3 have indicated an essential role for this protein in mediating JNK 
activation in response to the closely related Germinal Centre Kinase (GCK) (Tibbies et al., 
1996) and Hematopoietic Progenitor kinases (HPK) (Kiefer et al., 1996), and the guanine 
nucleotide exchange protein CRK SH3-binding GNFP (C3G) (Tanaka and Hanafusa, 1998). 
However, the most well established MLK activatory proteins are the small GTPases cdc42 and 
rac (Teramoto et al., 1996), and it  is the activation of MLKs by these related proteins that has 
been examined in most detail. However, only HPK, Akt1, cdc42, and rac have been shown to 
directly interact with MLK3, and indeed, the mechanism of activation of MLK family proteins 
remains unclear. Interestingly, MLK3 has also been shown to be negatively regulated upon 
phosphorylation by Akt1 (Barthwal et al., 2003). In the following discussion I will review 
current evidence and attempt to assemble a tentative model of the mechanism of activation 
MLK proteins.
Phosphorylation is an important mechanism in the regulation of protein kinases in general, 
and there is much evidence suggesting that the activity of MLK proteins is also controlled in 
this manner. HPK has been shown to bind to, and phosphorylate MLK3 (Kiefer et al., 1996). 
MLKs have also been shown to be phosphorylated in vivo, and furthermore coexpression with 
a constitutively active cdc42 mutant (V12cdc42) alters the phosphorylation pattern and 
increases the in vitro catalytic activity of MLK3 (Bock et al., 2000), indicating that 
phosphorylation is an important mechanism of MLK regulation.
A recent study using phosphopeptide mapping and mass spectrometry analysis identified 
twelve potential MLK3 phosphorylation sites in total, most of which cluster at the C terminus 
(Vacratsis et al., 2002). It is important to emphasise, however, that these sites may not all be 
genuinely phosphorylated in vivo, although this result clearly emphasises the importance of 
phosphorylation in MLK regulation. The motif T T X X S (residues 277-281 of MLK3) is found in 
the putative activatory region of all MLKs, and mutagenesis studies support thr277 and ser281 as 
positive regulatory phosphorylation sites (Leung and Lassam, 2001; Durkin et al., 2004).
Interestingly, one of the potential MLK3 phosphorylation sites conforms to the consensus 
sequence for MAPK (including JNK) phosphorylation sites (P X S/T P), suggesting that JNK
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might phosphorylate MLK3 in a potential feedback mechanism (Vacratsis et al., 2002). A 
similar feedback loop exists in the ERK pathway where the MAPK Raf is phosphorylated by ERK 
in response to insulin and growth factors (Lee et al., 1992). It has also been shown that JNK 
can phosphorylate the C-terminal region of MLK2, although no specific phosphorylation sites 
were determined (Sakuma et al., 1997). Transfection of dominant-negative JNK inhibits MLK2 
phosphorylation in response to anisomycin-induced JNK activation (Sakuma et al., 1997). 
Further evidence for a positive feedback situation is provided by the observation that an MLK 
mutant lacking the C-terminal domain is sufficient to activate JNK, but the resulting 
apoptotic response is abrogated (Sakuma et al., 1997).
1.3.3.1 MLK activation by Rho family GTPases
The Ras-related Rho family of GTPases are small monomeric G proteins that function as a 
simple biochemical switch by cycling between two conformational states; a GTP-bound active 
conformation, and a GDP-bound inactive state. In the active state, these GTPases recognise 
and activate target proteins until their GTPase activity results in GTP hydrolysis and auto­
inactivation. Their activity is activated by GEFs (guanine nucleotide exchange factors), and 
terminated by GAPs (GTPase-activating proteins). The Rho family in mammals represents 23 
gene products including members of the rac and cdc42 subfamilies, and collectively these 
proteins have been implicated in a huge number of cellular functions, including maintenance 
of morphology (Tapon and Hall, 1997), motility (Aepfelbacher et al., 1994), adhesion (Nobes 
and Hall, 1995; Braga et al., 1997), cell division (Dutartre et al., 1996) and proliferation 
(Olson et al., 1995), smooth muscle contraction (Hirata et al., 1992), and vesicular transport 
(Murphy et al., 1996; Lamaze et al., 1996).
Many receptors have been implicated in the activation of Rho GTPases, including receptors 
for chemoattractants, cytokines, phagocytic particle uptake, growth factors, and recently 
TLRs. (Bokoch, 2005).
The CRIB (cdc42 and rac Interactive Binding region), characteristic of the MLK subfamily of 
proteins, was first identified by Burbelo et al (Burbelo et al., 1995) in the PAK-1 MAP3K. A 
functionally diverse repertoire of proteins possess CRIB domains and hence act as cdc42 and 
rac effector proteins. These include kinases such as the PAK and MLK families, but also 
proline-rich and SH3-containing adaptor proteins. The number and range of potential 
effectors for cdc42 and rac is perhaps unsurprising given the many functions with which the 
G-proteins have been associated. That cdc42 and rac activate MLK3 was first established by 
Teramoto et al (Teramoto et al., 1996) providing a pathway for JNK activation by these G-
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proteins. Two cdc42-inducible phosphorylation sites in MLK3 have been identified 
subsequently although it  is unclear how cdc42 induces MLK3 phosphorylation since it lacks 
kinase activity, and other kinases must be involved.
The p21-cdc42/rac-activated Kinase (PAK) family of AAAP3K have emerged as the model CRIB- 
containing kinases and the focus of the majority of the research in this area, and as such, 
examination of the mechanism of PAK-cdc42/rac binding provides clues to the mode of 
activation of the MLK subfamily. The CRIB domains of MLK and PAK differ slightly (Burbelo et 
al., 1995), and therefore might differ in function. However mutation of the MLK3 CRIB 
disrupts the ability of this protein to bind cdc42, indicating that this is indeed a functional 
CRIB motif.
Bock et al (Bock et al., 2000) provide an interesting insight into the mechanism of MLK3 
activation by cdc42. They observed that when MLK3 is in the resting, unphosphorylated state, 
the two proteins can be coprecipitated. However, following MLK3 phosphorylation, cdc42 is 
no longer detected. This suggests that upon activation by cdc42, MLK3 has a reduced affinity 
for the GTPase. In an exactly analogous fashion, the affinity of PAK-2 for cdc42 decreases 
following activation (Manser et al., 1995). Furthermore, the residues phosphorylated in MLK3 
in response to cdc42 stimulation are exactly the same as those of PAK-2 (Bock et al., 2000), 
as judged by tryptic phosphopeptides.
Cdc42 is geranylgeranylated (Maltese and Sheridan, 1990) resulting in its localisation to 
cellular membranes and cytoskeletal elements (Erickson et al., 1996); it is therefore possible 
that cdc42 recruits MLK3 to the vicinity of an activating kinase resulting in phosphorylation 
and hence activation. This mechanism is reminiscent of the activation of another MAP3K, Raf, 
which in being activated by ras, clusters at the plasma membrane and becomes a target for 
other membrane kinases (Stokoe et al., 1994).
1.3.3.2 Dimerisation and autophosphorylation
In addition to phosphorylation by activatory kinases, there is evidence that MLK 
phosphorylation can also occur via dimerisation and autophosphorylation (Leung and Lassam, 
2001). Indeed, the most striking feature of all MLK proteins is their ability to dimerise - 
suggesting that this is an important feature of their catalytic cycle. In addition to the leucine 
zipper domain characteristic of MLK proteins, all contain a second dimerisation mechanism: 
MLK1-3 possess both an SH3 domain and its substrate proline-rich region, the DLKs have a
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second leucine zipper region and the ZAKs a sterile a motif, however, the significance of this 
is not as yet clear.
The importance of leucine zipper dimerisation to MLK activity was first illustrated by Leung 
and Lassam (Leung and Lassam, 1998) who showed using immuno-precipitation and non­
reducing SDS PAGE that MLK3 forms homodimers that are stabilised by disulphide bonds, and 
that the leucine-zipper region is both necessary and sufficient for this homodimerisation. The 
precise mechanism by which leucine zipper-mediated dimers are reinforced by disulphide 
linkages, and the importance of these covalent bonds to the catalytic mechanism is not 
understood.
MLK3 proteins autophosphorylate following homodimerisation (Leung and Lassam, 2001), via a 
mechanism analogous to that of receptor tyrosine kinases (with which MLKs share sequence 
homology). Dimerisation is necessary for autophosphorylation because kinase-dead MLK3 can 
homodimerise but not autophosphorylate, whereas MLK3 minus the leucine zipper region lacks 
autophosphorylation activity. JNK is not activated by the MLK3 leucine-zipper deficient 
mutant suggesting that homodimerisation and autophosphorylation are critical steps in the 
catalytic mechanism of MLK3 (Leung and Lassam, 1998).
Some of these effects may have been because of the large protein structural alteration 
induced by domain deletion. To overcome this problem, using site directed mutagenesis, 
Vacratsis et al (Vacratsis and Gallo, 2000) introduced proline residues into the leucine zipper 
of MLK3 to disrupt the a-helical conformation with minimal protein structure disruption. They 
found that cdc42 was still able to activate this MLK3 mutant suggesting that dimerisation is 
not required for MLK3 activation by cdc42. Furthermore, Vacratsis et al report that the MLK3 
mutant retains a high autophosphorylation capacity (Vacratsis and Gallo, 2000). This is an 
intriguing result because although it  supports the idea that monomeric MLK3 binds to active 
cdc42, in this scenario dimerisation cannot subsequently occur, and yet autophosphorylation 
still results. Coexpression of cdc42 and MLK3 leads to a substantial increase in MLK 
dimerisation suggesting that cdc42 catalyses MLK3 dimerisation (Leung and Lassam, 1998). 
Taken together, these studies suggest that by binding to membrane-localised cdc42, the local 
concentration of MLK3 is increased sufficiently to allow autophosphorylation to occur in the 
absence of zipper-mediated dimerisation and disulphide reinforcement. Dimerisation is 
therefore not a prerequisite for autophosphorylation, but presumably increases the 
probability of fruitful MLK-MLK interaction.
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The idea that cdc42 and rac increase the local concentration of MLK2 is also supported by the 
observation that when overexpressed, MLK2 is constitutively active (Nagata et al., 1998). 
Presumably in this situation the local concentration does not need amplification by membrane 
localisation for homodimerisation and autophosphorylation to occur. In support of this 
interpretation, this constitutive MLK activation is unaffected by cotransfection with 
constitutively active or dominant negative cdc42 or rac (Nagata et al., 1998).
1.3.3.3 SH3 domain
As well as the CRIB domain, MLK1-4 are also different from other MLKs in possessing an N- 
terminal SH3 domain, an independently folding domain of about 60 amino acids which 
functions to bind proline-rich polypeptides in a consensus sequence P X X X P preceded or 
followed by several basic amino acids.
The SH3 region of MLK3 has been shown to bind Haematopoietic Progenitor Kinase 1 (HPK-1) 
(Leung and Lassam, 2001), although the physiological significance of this is unclear (Kiefer et 
al., 1996). It was recently shown that the SH3 domain in MLK3 binds to a non-consensus SH3 
binding site situated between the leucine-zipper and CRIB motifs. Point mutations introduced 
into this sequence or the SH3 domain increased the activity of the protein. Hence MLK3 is 
capable of negative regulation of its own activity (Zhang and Gallo, 2001). This was shown to 
be a specific autoregulation and not an inhibition by other SH3-containing proteins because an 
MLK3 with a mutated SH3 domain bound with much higher avidity to a GST-SH3 reporter. This 
suggests that in wild-type MLK3, intramolecular SH3 binding out-competes the reporter 
protein (Zhang and Gallo, 2001).
A similar mechanism of autoinhibition is observed in the Src family, where an intramolecular 
SH3-mediated association prevents ATP binding to the catalytic domain of the tyrosine kinase 
(Williams et al., 1998). Interestingly, in Src, the SH3 binds to the same non-consensus 
sequence as in MLK3. It is probable that this sequence induces a low affinity interaction 
because a more stable binding would prevent the release of autoinhibition. MLKsI, 2 and 4 
also posses this binding sequence suggesting that all members of the MLK subfamily are 
regulated in this manner.
1.3.3.4 Auto-inhibition
The mechanism of release of autoinhibition has not been elucidated. One speculation was 
that higher affinity ligands for the SH3 domain, such as HPK-1, might induce release of the
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intramolecular association (Zhang and Gallo, 2001). An alternative mechanism becomes 
apparent however, when one considers that in addition to the kinase domain, the leucine 
zipper also lies between the SH3 and its proline-rich binding region. Furthermore, the CRIB 
domain is adjacent to the proline-rich region and therefore this intramolecular bond may 
prevent MLK3 from dimerising or binding to cdc42 or rac. Activation of MLK3 may therefore 
involve the association of the CRIB domain with a GTP-bound G-protein resulting in 
displacement of the intramolecular SH3 bond, permitting homodimerisation via the leucine- 
zipper and autophosphorylation (figure 1.6). This model fits neatly with the observations 
outlined above regarding a model of cdc42 and rac increasing the local concentration of MLK3 
prior to dimerisation. In this modified scenario cdc42 serves not only to increase local 
concentration but also to release the MLK autoinhibition. The concentration of activated MLK 
is therefore increased sufficiently such that MLK3 proteins can dimerise and 
autophosphorylate.
Adding further support to the auto-inhibition model, Mata et al showed that DLK also forms 
homodimers, obviously indicating an identical mechanism of autophosphorylation (Mata et al., 
1996). Unlike MLK3 however, DLK does not contain a CRIB domain and hence cannot bind to 
the membrane-bound GTP forms of cdc42 and rac. Furthermore, DLK does not possess an SH3 
binding region indicating that it  is not capable of auto-inhibition, and therefore DLK doesn’t 
require a G-protein interaction to activate it (Zhang and Gallo, 2001). DLK dimerisation does 
not require DLK phosphorylation or catalytic activity (Mata et al., 1996) and furthermore a 
protein corresponding to just the DLK leucine-zipper domain readily binds to itself or wild- 
type DLK (Nihalani et al., 2000). These observations suggest that the DLK-DLK interaction is of 
high affinity, and DLK is probably capable of spontaneous homodimerisation. The stimulus and 
regulation of DLK activity remains unclear, although it  has been proposed that DLK is 
regulated by a sequestering protein.
1.3.3.5 Dimerisation and autophosphorylation revisited
With the auto-inhibition model in mind, one is forced to consider the question; if  cdc42 is 
sufficient to induce autophosphorylation and activation of MLK monomers, then why is MLK 
dimerisation important?
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Figure 1.6. Autoinhibition of MLKs
It is proposed that autoinhibition of MLKs is achieved via binding of the 
amino-proximal SH3 domain to a proline (Pro)-rich sequence preventing 
activity of the kinase domain. Binding of activated (GTP-bound) Cdc42 or 
Rac to the CRIB domain is not compatible with simultaneous autoinhibitory 
interaction, thus the inhibition is released and the kinase domain of the 
MLK becomes catalytically competent. GTP hydrolysis is accompanied by 
reduced affinity of the GTPase for the MLK CRIB domain and hence 
dissociation and spontaneous reformation of MLK autoinhibition.
Gallo and Johnson Nature Reviews Molecular Cell Biology 3; 663-672 (2002)
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Dimerisation clearly is important, however, since expression of a peptide corresponding to 
just the leucine zipper domain inhibits MLK3; obviously preventing dimerisation inhibits 
catalytic capability.
An insight into this question is provided by the observations of Vacratsis et al who examined 
the ability of a leucine zipper-deficient MLK3 mutant to activate MKK4 which requires 
phosphorylation on both serine and threonine residues in a critical SXT activation motif. 
Mutation of either serine or threonine to a nonphosphorylatable amino acid prevents MKK4 
activation of JNK. They found that the monomeric mutant MLK3 could phosphorylate on the 
serine but not the threonine residue (Vacratsis and Gallo, 2000). The reason for MLK 
dimerisation is therefore that it is essential for activation of the substrate MAP2K, but in 
truth, the mechanism for this is also unclear.
The importance of dimerisation in the mechanism of MLK catalysis lead several authors to 
suggest that the ability of MLK proteins to heterodimerise would allow a small number of MLK 
proteins to induce MAPK activation in response to a wide selection of upstream signals (Leung 
and Lassam, 1998). In support of the heterodimerisation theory, coprecipitation of MLK2 and 
MLK3 was reported in this study. Further evidence is provided by Tanaka and Hanafusa 
(Tanaka and Hanafusa, 1998), who demonstrated interactions between MLK3 and DLK in 293T 
cells, and furthermore that kinase-dead DLK suppressed MLK3 activation of JNK, although 
they did not investigate the mechanism of this interaction. The authors interpret this as DLK 
lying downstream of MLK3 in the JNK activation pathway, but an alternative and more logical 
hypothesis in the light of the heterodimerisation model is that DLK and MLK3 bind via their 
leucine zippers. The catalytically inactive member would obviously be incapable of either 
autophosphorylation or substrate phosphorylation, resulting in termination of signal 
transduction.
However, this view is not universally accepted. In opposing the model of heterodimerisation, 
Nihalani et al (Nihalani et al., 2000) reported that DLK exclusively forms homodimers, and 
does not dimerise with the closely related LZK or more distantly related MLK3 proteins. They 
suggest that the inability of MLK proteins to heterodimerise is important to maintain signaling 
specificity and prevent cross-talk by limiting interactions between different MLK members in 
the same sub-cellular microenvironment.
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1.3.3.6 JIP scaffolds
Research into MLK protein biology took a huge stride forward in 1998 with the discovery by 
Whitmarsh et al (Whitmarsh et al., 1998) of a mammalian AAAPK scaffold protein, which they 
named JNK Interacting Protein-1 (JIP-1).
The JIP-1 is a homologue of scaffolds found in yeast such as Ste5p and Pbs2p, which 
coordinate components of the pheromone and osmoregulatory response pathways 
respectively. This initial investigation and a later study by the same group (Yasuda et al.,
1999) identifying a homologue, JIP-2, determined that these scaffolds bind to JNK, MKK7 (but 
not the other JNK activating MAP2K, MKK4), MLK3 and DLK. It has since been shown that other 
MLK family members such as MLK2 and LZK also bind JIP-1 and -2, but MAP3Ks of other 
families such as MEKKs, Raf, MTK-1, PAKs, ASK-1 etc do not bind, suggesting that the role of 
the JIPs is to provide specificity of MLK family members for JNK activation (Nihalani et al., 
2001; Ikeda et al., 2001a).
This model of a AAAPK scaffold also potentially reconciles the contrasting theories regarding 
MLK protein heterodimerisation. Studies examining such heterodimerisation were based 
primarily on co-precipitating different MLK family members. However the discovery of JIPs 
and the observation that JIP-1 can multimerise leads to the possibility that different MLKs are 
bound on each JIP scaffold and in this case co-precipitation would result in detection of 
different MLK family members. With this in mind, and given the report by Nihalani et al that 
DLK does not dimerise with the closely related LZK protein, it  is still controversial, but seems 
unlikely that heterodimerisation occurs between any of the MLKs.
Furthermore, a third interpretation of the data presented by Tanaka and Hanafusa is that the 
transfected kinase-dead DLK out-titrates active MLK3 and hence out-competes for binding to 
the JIP scaffold, thus inhibiting MLK3-induced JNK activation.
In addition, the identification of JIP scaffolds has focused attention on the mechanism of 
scaffold specificity. Using truncated constructs, Nihalani et al demonstrated that the N- 
terminal domain of DLK binds to JIP-1 and is necessary for JNK activation (Nihalani et al., 
2001). This is in agreement with a study by Ikeda et al (Ikeda et al., 2001b) who found the 
analogous region on the closely related LZK protein to be important for binding to this 
scaffold.
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Furthermore Ikeda et al report that a region of 14 amino acids entirely conserved between 
DLK and LZK in the C-terminal portion of the protein are essential for the activation of MKK4 
but not MKK7 (Ikeda et al., 2001b). This is particularly interesting because like MKK7, MKK4 
specifically activates JNK, however, unlike MKK7, MKK4 does not bind to all of the JIP 
scaffolds and MKK4-binding scaffolds are not as fully understood. A picture is therefore 
beginning to emerge of an MLK protein containing distinct functional regions, such as a JIP- 
binding domain in the N-terminus, a leucine zipper dimerisation domain, and specific discrete 
regions containing consensus-binding sequences for activation of different substrate kinases.
It is now known that four JIP scaffolds exist (Morrison and Davis, 2003). JIP-1 and -2 (also 
called IB-1 and -2) share sequence homology, as do JIP-3 (also called JSAP-1) and -4. The two 
functionally related pairs bear no structural similarities. The JIP proteins show different 
patterns of expression and slightly different MLK affinities, although all bind MKK7 and JNK. 
JIP-2 is unique in that it  also binds MKK3 and p38 and has a higher affinity for p38 than JNK 
(Buchsbaum et al., 2002; Schoorlemmer and Goldfarb, 2001). JIP-3 and -4 bind MKK4 as well 
as MKK7 (Ito et al., 1999; Lee et al., 2002), and JIP-3 can also bind MEKK-1. MEKK-1 is a 
MAP3K which activates JNK (Yujiri et al., 1998) and has also been shown to activate ERK when 
overexpressed (Minden et al., 1994). MEKK-1 has also been shown to induce activation of the 
NF-kB transcription factor.
The scaffold proteins play a multi-regulatory role. Firstly they provide a mechanism for 
regulated activation of JNK by facilitating the sequential phosphorylation of the AAAPK 
pathway, and secondly they insulate the pathway to prevent cross-talk with other AAAPK 
systems transducing unrelated messages in the cytosol. JIP scaffolds have also been shown to 
bind phosphatases and therefore negatively regulate signal transduction (Willoughby et al., 
2003). It is also thought that JIP scaffolds regulate the signaling pathways via subcellular 
localisation (see below).
1.3.3.7 JIPs and MAPK activation
There is much evidence to support the physiological importance of the JIP proteins. For 
example JIP has been shown to be critical for cytokine-induced apoptosis (Haefliger et al., 
2003), and overexpression of the JNK binding domain of JIP-1 prevents apoptosis in 
sympathetic neurones (Harding et al., 2001).
Before the discovery of JIP scaffolds it  was believed that AAAPK were activated by a three-tier 
phosphorylation cascade to allow signal amplification. In other words, phosphorylation
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induces kinase activation and each active enzyme could phosphorylate many substrate 
proteins. Mathematical models based on initial observations regarding levels of activated 
proteins appeared to support this amplification idea (Levchenko et al., 2000). However, while 
the model of AAAPK enzymes bound to a scaffold protein in a “ phospho-relay” assembly is 
attractive because signal specificity is highly regulated, the ability to amplify the signal is lost 
because amplification requires free diffusion of component kinases.
Recently, much work has investigated the nature of the interaction between AAAPK pathway 
proteins and the JIP scaffolds, which may help to reconcile this conflict. Binding determinants 
have been identified mediating interactions at all levels of the pathway (Xu et al., 2001). 
JNK, MKK7 and MLKs bind to distinct regions of JIP-1 (Xu et al., 2001; Whitmarsh et al., 1998). 
Interestingly, studies using JIP-1 and DLK have suggested that the scaffold not only anchors 
the signaling proteins in the optimal orientation, but is also important in regulating the 
activity of the AAAPK signal transduction.
Using a mutagenesis approach, binding sites within MKK7 and DLK were identified that were 
involved in mediating interaction with JIP-1. Surprisingly, however, it  was also found that the 
leucine-zipper of DLK binds to a region in the N-terminal portion of MKK7. This suggests that 
dimerisation (and hence activation) of DLK, and binding to MKK7 may be mutually exclusive.
Furthermore it  has been shown that DLK and JNK do not bind JIP simultaneously. Stimulation 
results in recruitment of JNK to the scaffold protein (Nihalani et al., 2001; Kelkar et al.,
2000), and importantly, JNK recruitment coincides with decreased affinity of JIP for DLK. In 
the resting state, DLK is bound to JIP, and given the observation that in this state, MKK7 
protein prevents DLK dimerisation and hence activation, DLK is therefore held in a 
monomeric, unphosphorylated and catalytically inactive state.
A model has been proposed whereby appropriate stimulation induces an increase in the 
affinity of JNK for JIP. This induces a decrease in the affinity of the scaffold for DLK, 
presumably by some subtle structural alteration of JIP. Upon release, DLK spontaneously 
homodimerises and becomes activated. The activated DLK dimer can then phosphorylate 
MKK7 and induce AAAPK signal transduction (Nihalani et al., 2001).
The model solves two key problems. Firstly, it  suggests that JIP is the sequestory protein 
responsible for preventing spontaneous DLK activation. Secondly, and more importantly, 
according to this scenario, activated DLK is not irreversibly bound to JIP and hence can
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phosphorylate many MKK7 proteins. Thus, although the scaffold provides specificity, the 
observed signal amplification can still occur (Levchenko et al., 2000).
In addition to the data presented above regarding spontaneous DLK activation, other lines of 
evidence also support the model. Perhaps most important is that no-one has ever reported 
observing JIP bound to all three module components simultaneously. It is also reported that 
decreased JIP-DLK binding is observed in the presence of excess JNK or conditions that favour 
JNK activation. The affinity of activated DLK for MKK7 is sufficient for interaction to occur 
without stabilisation by a scaffold (Mata et al., 1996).
It is not clear, however, how JNK receives the initial signal to bind to JIP. Perhaps JNK 
activation occurs via an alternative MKK4-dependent system and the role of MKK7 and DLK is 
purely to amplify JNK activation. On the other hand, the system could work via the reverse 
mechanism to that described here. A stimulus might induce DLK release from JIP; this would 
have the dual effect of allowing spontaneous DLK activation, and would also increase the 
affinity of the JIP scaffold for JNK in readiness for MAPK signal transduction.
LZK shares a high degree of homology with DLK; it  has also been shown to bind JIP-1 (Ikeda et 
al., 2001a), and hence is probably also regulated in this manner. However, while some 
features are surely consistent, this mechanism probably does not apply universally to all MLK 
family members. As outlined above, MLK3 has been shown to regulate its own activity 
negatively and has been reported to remain associated with JIP-1 following stress (Kim et al., 
2002).
Other MLK-binding scaffold proteins have been reported including POSH (Plenty Of SH3s) 
which is thought to bind GTP-bound rac and mediate pro-apoptotic signaling via the JNK 
pathway (Tapon et al., 1998), because JNK-induced apoptosis is suppressed by POSH antisense 
oligonucleotides or siRNA (Xu et al., 2001). The POSH complex is negatively regulated by Akt- 
2, which induces complex dissociation (Figueroa et al., 2003). This is interesting because Akt- 
1 reduces the affinity of JNK for JIP-1 (Kim et al., 2002) suggesting that the Akt family might 
serve as negative regulators of JNK pathway signaling by disrupting scaffold complexes.
1.3.4 Subcellular localisation and MAPK-independent roles of MLKs
There have been several studies investigating the subcellular localisation of MLK proteins. The 
first of these, Nagata et al (Nagata et al., 1998) showed that MLK2 colocalises with dually 
phosphorylated JNK to discrete microtubule-associated structures. Before the discovery of JIP
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scaffolds they also identified that MLK2 colocalises with two members of the kinesin 
superfamily of motor proteins. Later all four JIP proteins were shown to be cargoes for the 
motor protein Kinesin-1 (Whitmarsh et al., 2001; Bowman et al., 2000) and this protein 
probably controls subcellular localisation of MAPK activation. This corroborated the 
intracellular staining for JIP-1 and -2 proteins, which were found to accumulate close to the 
plasma membrane in cytoplasmic projections that extend from the cell surface (Yasuda et al., 
1999). It is possible that the role of the kinesin motor is to localise the JIP-MAPK pathway 
cargo to the site of activation close to the cell membrane. Activated JNK phosphorylates its 
substrate c-jun in the nucleus, so following AAAPK signal transduction, kinesin may carry 
deactivated JNK signalling components towards the plus end of microtubules from the nucleus 
to the cell periphery to re-prime the cells for signal transduction. JIP proteins may therefore 
mediate complex regulation of MAPK pathways via subcellular localisation and transport.
This model is strongly supported by Hirai et al (Hirai et al., 2002) who showed colocalisation 
of DLK to “dotted structures” along microtubules in a neuronal cell line. The DLK staining was 
dispersed along the length of the microtubules with many such structures seen at the tips of 
the microtubules towards the cell periphery.
MLK3 has also been reported to accumulate along microtubules, but primarily towards the 
minus ends at the centrosome (Swenson et al., 2003). This suggests that MLK3 might associate 
with a selection of different motor proteins resulting in control of subcellular localisation in a 
cell-type specific manner.
Alternatively, different MLK proteins may not just bind microtubules for localisation, but may 
also regulate some selective microtubule-associated cell processes. For example, Rasmussen 
et al (Rasmussen et al., 1998) have shown that MLK2 binds to the microtubule-associated 
GTPase dynamin, which controls synaptic vesicle transmission. Furthermore, a recent report 
suggests that MLK2 can interact with clathrin and regulate clathrin-coated vesicle transport 
(Akbarzadeh et al., 2002).
Based upon their colocalisation, Hirai et al suggest that DLK might be involved in controlling 
microtubule organisation (Hirai et al., 2002). Prior to DLK transfection, Cos-1 cells possessed 
radially organised microtubules that were completely disrupted upon DLK overexpression. 
Although DLK did not induce depolymerisation of tubulin, the microtubules became organised 
in a random fashion or accumulated at the cell periphery. Importantly, cells expressing a 
kinase-deficient DLK mutant did not show this altered microtubule pattern, and
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microfilament organisation and formation of focal contacts were not affected by DLK 
overexpression. Hirai et al also studied neurones in the developing mouse cortex and reported 
that DLK expression was observed in a ring of cells in which migration is arrested. They 
conclude that expression of DLK is developmentally regulated and that the DLK-JNK MAPK 
pathway regulates neural cell migration in cortex development (Hirai et al., 2002).
Swenson et al (Swenson et al., 2003) also interpreted their findings in functional terms. They 
identified a region of human MLK3 in a search for proteins containing homology to an 
essential fungal cell cycle G2/M transition protein NIAAA. They also found that MLK3 
phosphorylation was observed at this stage of the cell cycle, although JNK activity was 
unaltered, suggesting that MLK3 has other functions independent of JNK. Providing further 
evidence for a role of MLK3 in cell cycle control, during the G2/M phase transition at which 
NIAAA is known to be important, the subcellular localisation of MLK3 is transiently altered. 
Reminiscent of the study by Hirai et al, Swenson et al found that MLK3 localised to the 
centrosomal region and induced microtubule depolymerisation during G2/M transition 
(Swenson et al., 2003). The microtubule effects were not observed after expression of kinase- 
deficient MLK3 and silencing of MLK3 expression using siRNA resulted in increased sensitivity 
to the microtubule stabilising agent taxol, suggesting that endogenous MLK3 plays a 
physiological role in destabilising microtubules during M phase entry.
Several investigations support the role of MLK proteins in promoting cell proliferation. For 
example, overexpression of MLK3 induces growth of NIH 3T3 cells on soft agar (Hartkamp et 
al., 1999), and silencing of mlk3 by RNAi prevents serum-stimulated cell proliferation and the 
proliferation of tumour cells (Chadee and Kyriakis, 2004a). Furthermore, in support of the 
data presented by Swenson et al, it  has recently been reported that inhibition of MLK proteins 
using the CEP11004 inhibitor blocked mitotic progression through a mechanism involving 
disruption of microtubule formation and spindle assembly (Cha et al., 2005). Interestingly, a 
region of the N-terminus of MLK2 has been shown to bind tubulin (Rasmussen et al., 1997) and 
may thus contribute to spindle formation. Although MLK proteins have therefore been 
investigated chiefly in dividing cells, MLK3 is also present in a wide spectrum of tissues 
including many cell types that are non-dividing. It is possible that in these cells MLK3 affects 
microtubule organisation during processes such as outgrowth and migration.
Hirai assumed that the cytoskeletal effects of DLK are mediated via JNK activation, but in the 
light of the Swenson report, it is possible that the MLK proteins have other functions than 
their AAAP3K role (Hirai et al., 2002). In fact this was not the first demonstration of a JNK-
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independent role for MLK3. A report by Hehner et al (Hehner et al., 2000) indicated that 
MLK3 is important in T cell stimulation-induced NF-kB activation. This is interesting because it 
suggests that one signal-transducing protein, MLK3, can induce activation of both 
transcription factors required for expression of a gene; in this case, c-jun (via JNK) and NF-kB 
transcription factors, and the IL-2 gene.
As described in section 1.2.6 (and figure 1.4), a cytoplasmic sequestory protein, IkB, controls 
NF-kB activity. IkB neutralisation is signalled by phosphorylation by an kKinase Complex (IKC) 
containing IkB kinases, IKKa and IKKB. These kinases are activated by IKKKs, all of which are 
also MAP3Ks and are attached to the IKC. Hehner et al show that MLK3 functions as an IKKK, 
and its activity is potentiated by the expression of other IKKKs, such as MEKK-1 (Hehner et 
al., 2000). However, MLK3-induced NF-kB activation was shown to be stimulus-specific, since 
CD3/CD28-induced NF-kB has been shown to be MLK3-dependent, whereas TNF-a and IL-1 
activation of NF-kB is independent of MLK3 activity. For some time it  has been known that rac 
and cdc42 are capable of activating NF-kB and therefore the identification of MLK3 as an IKKK 
obviously suggested a mechanism for this activation (Perona et al., 1997).
Further to the issue of spatial regulation of MLK proteins, it  has recently been reported that 
JIP3 associates with TLR2, TLR4 and TLR9 in a mouse macrophage cell line (Matsuguchi et al., 
2003). Obviously this makes good physiological sense because it  optimises JNK activation in 
response to potential pathogens. None of the other JIP proteins have been reported to 
associate with TLRs, which is perhaps surprising, as one might have anticipated that a p38- 
binding scaffold would also be regulated in this manner. However, it  may be that in this 
context, JIP is not just optimising JNK activation, but also acting to regulate NF-kB, a known 
effector of TLR stimulation. JIP3 has been shown to bind MEKK-1, a known IKKK that activates 
NF-kB. It is therefore probable that the true function of JIP3 in this situation is to localise 
MEKK-1 for optimal signal transduction from TLR to NF-kB.
An MLK3-deficient mouse has recently been reported (Brancho et al., 2005). Remarkably, 
despite the above evidence linking MLK proteins with important roles in the regulation of 
MAPKs and cell proliferation, the knockout mouse was viable and healthy. The only signaling 
phenotype observed was a defect in the ability of MEF cells to induce JNK activation in 
response to TNFa. Clearly an important regulatory role for MLK3 is not consistent with a 
phenotypically normal knockout mouse. This discrepancy may be due in part to functional 
reconstitution of MLK3 by other MLK proteins. However, many of the above reports are based 
upon MLK3 gene silencing using RNAi technology, and hence are more difficult to reconcile
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with the results of the knockout study. Further investigations will therefore be required to 
fully elucidate the role of MLK3.
1.3.5 MLK inhibition
The importance of the MLK family in activating JNK and the role of this AAAPK in neuronal cell 
death programs and many other degenerative diseases presents MLKs as a potential 
therapeutic target for drug development. A semi-synthetic MLK inhibitor, CEP1347, is 
currently in clinical trials for Parkinson’s disease and has also shown potential therapeutic 
effects in models of Alzheimer’s disease and hearing loss (Cheng et al., 2002).
CEP 1347 was developed following observations of the neurotrophic and survival promoting 
effects of K252a, a small molecule naturally produced by the actinomycetes group of gram- 
positive bacteria (Kase et al., 1986). K252a was initially observed to act as a relatively non- 
selective inhibitor of serine/ threonine kinases, but was later found to be a very potent 
inhibitor of the receptor tyrosine kinase TrkA. Specifically, by acting as a competitive agonist 
that binds to the ATP binding site, it blocks the autophosphorylation of TrkA with an IC50 of 
3nM (Angeles et al., 1998) in response to neurotrophic ligands (Nye et al., 1992). 
Interestingly, however, despite inhibiting the action of neurotrophins, K252a was shown to 
possess its own “ neurotrophic” activity. For example, neurones deprived of NGF were shown 
to survive for at least two weeks in culture in the presence of K252a (Borasio, 1990).
The drug was subsequently shown to exhibit these variable properties when present at 
different levels. At high concentrations, K252a inhibits neurotrophins, whereas at lower 
concentrations, K252a itself promotes survival. Compounds based on K252a were therefore 
synthesised to enhance the neurotrophic effects, while decreasing the inhibition of survival- 
promoting neurotrophins (Murakata et al., 2002). The 3, 9-bis-[ethylthio(methyl)]-substituted 
K252a was found to have the most potent neurotrophic effects and was subsequently named 
CEP1347 or KT-7515 (Murakata et al., 2002). CEP 1347 is not cytotoxic above 200nM, as is 
K252a, and does not possess the non-selective serine/ threonine kinase inhibition properties 
of K252a.
However, the true molecular target mediating the survival-promoting effects of CEP1347 was 
not known. In NGF-deprived neurones, CEP1347 was shown to prevent JNK activation (Xu et 
al., 2001), while having no inhibitory effects on other AAAPKS (Maroney et al., 1999). The 
possibility of direct JNK inhibition by CEP1347 was excluded because MEKK-1-mediated JNK 
activation in CHO cells was insensitive to CEP1347 addition.
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The ability of upstream regulators of JNK to induce c-jun phosphorylation in the presence or 
absence of CEP1347 was assayed by in vitro kinase assay (Xu et al., 2001). Direct activators of 
JNK were excluded because no inhibition of MAP2K-induced JNK activation was observed by 
addition of CEP1347.
Rac and cdc42 have been shown to signal NGF-deprivation-induced neuronal apoptosis 
(Bazenet et al., 1998) making them a candidate for CEP action. The G-proteins induced a 20- 
fold increase in JNK activity, and this activation was blocked by CEP1347, although no 
interaction between rac/cdc42 and CEP1347 could be demonstrated, indicating that CEP1347 
acts downstream of these proteins.
MLK proteins were shown to be activated by rac and cdc42 (Mota et al., 2001; Xu et al., 2001) 
and induce JNK activation, suggesting that these could be the targets of CEP1347 action, and 
indeed the drug was shown to prevent MLK3-induced activation of JNK in CHO cells. CEP1347 
was later shown to be highly specific for the MLK family, and inhibit these proteins with high 
potency (Murakata et al., 2002).
The specificity of CEP for MLK has been confirmed by genetic studies. For example cellular 
apoptosis induced by MLK transfection can be suppressed by CEP1347 treatment, (Xu et al.,
2001) and dominant negative MLKs and CEP1347 suppress death induced by constitutively 
active rac1 and cdc42 (Xu et al., 2001).
With respect to the role outlined above of MLKs in microtubule organisation, one of the 
earliest papers regarding the initial biochemical characterisation of the K252a compound 
reported that not only did the drug mimic neurotrophins and promote survival, but it  could 
also mimic growth factors and induce morphological change including neurite outgrowth. Such 
cellular alteration has not been mentioned again in any of the inhibitor studies. However in 
retrospect, an alternative explanation is that in the cells being studied, ciliary ganglion 
neurones, MLK proteins are involved in promoting microtubule instability. Inhibiting MLK 
therefore would induce microtubule polymerisation giving the appearance of outgrowth. Such 
an interpretation would be consistent with other observations of MLK-treated cells; for 
example Hirai et al observed loss of microtubule organisation in DLK-transfected neurones 
(Hirai et al., 2002), and Swenson et al suggest that MLK3 destabilises microtubules during 
prometaphase (Swenson et al., 2003).
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In summary, MLK proteins, initially thought to be specific activators of the JNK pathway, may 
in fact be involved in various cellular processes. Comparatively little  is known about these 
proteins, however, and almost all studies have been performed on neurones or neuronal cell 
lines. The MLK-specific inhibitors potentially provide a powerful tool for understanding MLK 
biology, in particular in non-neuronal cell death for which there are no reported studies, and 
in other physiological processes.
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1.4 Aims of Thesis
1.4.1
Against the background outlined in the above introduction, the aim of the studies described in 
this thesis was to investigate the roles of MAPKs in DC physiology. Therefore the objective of 
the first part of the study was a comparative analysis of the roles of the JNK and p38 MAPK 
pathways in the response of DC to oxidative stress and LPS.
1.4.2
Based upon the observations made in section 1.4.1, the aim of the subsequent experiments 
was:
a. To investigate the expression and function of MLK proteins in the response of DC to 
selected TLR ligands.
b. To design and optimise a novel assay which permits investigation of the relationship 
between the morphology of DC and the ability of DC to internalise antigen.
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Materials and Methods
2. Materials and Methods
2.1 Materials and Reagents
2.1.1 Materials and equipment
All cell manipulation work was performed in a M.D.H. Intermed class 2 safety cabinet, using 
sterile techniques. Reagents were of the highest grade available. Pipette tips were from Elkay 
(Hampshire, UK). All culture plates, flasks, and centrifuge tubes were from Nunc (Rochester, 
NY, USA) unless otherwise stated.
2.1.2 Solvents
Where possible, stimuli and inhibitors were obtained in pure solid or lyophilised form to 
minimise decomposition and were then dissolved in the relevant solvent (table 2.1).
Table 2.1 Solvents
Ref Name Structure Manufacturer Cat. #
DiHzO Water for Molecular Biology h 2 o Sigma Chemical Co. Poole, UK W4502
DMSO Dimethyl Sulphoxide
0
ii
CH3-S ~C H 3
Sigma D8779
EtOH Ethanol C H 3C H 2 0 H Sigma E7148
HBSS
Hanks’ Balanced Salt 
Solution
N/A Invitrogen, Carlsbad, CA, USA 14175-053
2.1.3 Stimuli
All stimuli were added in a 1:100 ratio to keep cell and cytokine concentrations constant. 
Where applicable, stimuli were dissolved in the appropriate primary solvents (table 2.2) and 
then diluted to working concentrations in CM.
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Table 2.2 Stimuli
Ref Name Origin Solvent Receptor Manufacturer Cat. #
FN Fibronectin Bovine Plasma DiH20 N/A Sigma F1141
h2o2
Hydrogen
Peroxide
N/A N/A
Redox Sensitive 
Molecules
Sigma H1009
LPS Lipopolysaccharides
Salmonella 
minnesota 
(ATCC 9700)
CM TLR4 Sigma L6261
Poly
(l:C)
Polyriboinosinic
polyribocytidilic
acid
N/A CM TLR3 Sigma P1038
U.V. Ultra Violet Light N/A N/A N/A N/A N/A
Zym Zymosan A
Saccharomyces
cerevisiae
HBSS
TLR2/ TLR6 
Dectin-1
Sigma Z4250
2.1.4 Inhibitors
Inhibitors were dissolved in the appropriate primary solvents (table 2.3) and then diluted to 
working concentrations in CM.
Table 2.3 Inhibitors
Ref Name RMM Solvent Cellular Target Structure Manufacturer Cat. #
CEP
CEP11004
(KT8138)
643.83 DMSO MLK1, 2, 3, DLK •> ; ' -/ C-/ \ /  .
;a
Cephalon, West 
Chester, PA, USA
N/A
Na3V04
Sodium
Orthovanadate
183.91 H20
Tyrosine
Phosphatases
Na3V04 Sigma S6508
PD PD98059 267.28 DMSO MEK Sigma P215
SB SB203580 377.43 DMSO p38a, p Sigma S8307
SP SP600125 220.23
DMSO/
EtOH
JNK1, 2, 3
J ~ *(Xp Celgene, San Diego, CA, USA N/A
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2.2 Cell Culture
2.2.1 Media
The complete medium (CM) used comprised Roswell Park Memorial Institute medium (RPMI)- 
1640 (Gibco BRL, Paisley, UK) supplemented with penicillin (100U/ml), streptomycin 
(100|ag/ml), L-glutamine (2mM) (all from Cancer Research UK Clare Hall Laboratories, London, 
UK) and foetal calf serum (FCS) (10% v/v) (Gibco BRL, Paisley, UK) (heat inactivated 56°C, 30 
minutes) unless otherwise indicated.
2.2.2 Culture condition
Unless otherwise stated, all incubations at 37°C were carried out in an incubator at 5% C02. 
Incubations at 4°C were carried out on ice.
2.2.3 Cell counting
Cell numbers were measured using a Neubauer haemocytometer. 10pl of cell sample was 
mixed with an equal volume of 0.04% trypan blue stain (Gibco BRL, Paisley, UK), and viable 
cells counted by light microscopy.
2.2.4 Isolation of peripheral blood mononuclear cells
PBMC were isolated from healthy volunteers. Peripheral blood was obtained by venesection 
into a syringe containing approximately 50pl heparin (5000IU/ml, CP Pharmaceuticals, Rexam, 
UK). The blood was diluted into an equal volume of HBSS, and then layered over Lymphoprep 
1077 (Nycomed Pharma, Oslo, Norway) and centrifuged for 30 minutes, 600g, at room 
temperature. The interface between aqueous and Lymphoprep layers containing the PBMC 
fraction was then aspirated and cells were washed three times with HBSS.
2.2.5 Derivation of monocyte-derived dendritic cells
The PBMC fraction was resuspended in CM and allowed to adhere to tissue culture plates 
(Falcon, Becton-Dickinson, Mountain View, CA, USA) for 2 hours. Non-adherent cells were 
then removed by washing with HBSS, leaving an adherent cell population of predominantly 
monocytes. These cells were then cultured in CM supplemented with 100ng/ml human 
recombinant GM-CSF and 50ng/ml IL-4 (both gifts from Schering-Plough Research Institute,
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Kenilworth, New Jersey, USA) to induce differentiation into monocyte-derived dendritic cells 
(MDDC).
Loosely adherent cells were collected on day 4 of culture and layered over Lymphoprep 1077 
(Nycomed Pharma, Oslo, Norway) as described above to remove dead cells and debris. Cells 
at the interface were washed in HBSS, and then the proportion of contaminating, non-MDDC 
cells was estimated by cell size by light microscopy. The cells were then incubated in CM at 
4°C for 30 minutes in the presence of mouse antibodies raised against human CD2, CD3, and 
CD19 to bind to the major contaminating cell populations: NK cells, T cells, and B cells 
respectively (table 2.4). Excess antibody was removed by washing in cold HBSS and the cells 
resuspended in cold CM. Immunomagnetic beads coated in sheep anti-mouse IgG (Dynal, 
Merseyside, UK) were added (approximately 1 bead: 1 contaminating cell) and the mixture 
rotated for 45 minutes at 4°C. Bead-conjugated cells were removed by magnetic separation 
and the remaining free cells, which contained the purified MDDC were cultured for a further 3 
days at 5 x 105 cells/ml in CM containing GM-CSF and IL-4. On day seven of culture, MDDC 
were removed and counted.
Table 2.4 Antibodies for Negative Selection of Monocyte-Derived Dendritic Cells
Target Origin Clone Isotype Manufacturer Cat. #
Human CD2 Mouse mAb RPA-2.10 lgG1 eBioscience, San Diego, CA, USA 14-0029
Human CD3 Mouse mAb UCHT1 lgG1
Gift, Prof P. Beverley, The Edward Jenner 
Institute, Compton, UK
N/A
Human CD19 Mouse mAb BU12 lgG1
Gift, D. Hardie, Birmingham Medical 
School, Birmingham, UK
N/A
2.2.6 293T Cells
293T cells were a gift from E. Willoughby and used to manufacture control lysates positive for 
activated p38 and JNK AAAPK.
2.2.7 Storage of cell lines
For storage in liquid nitrogen, approximately 5 x 105 cells/ml were resuspended in FCS 
containing 10% (v/v) DMSO. For recovery, cells were rapidly returned to room temperature 
and transferred into a 25cm2 flask containing the appropriate selection medium. Cell lines 
were regularly tested and shown to be negative for mycoplasma antigens.
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2.3 Cell Visualisation and Analysis
2.3.1 Light microscopy
Cells were visualised on a Wilovert microscope.
2.3.2 Confocal microscopy
2.3.2.1 Cell preparation
For analysis by confocal microscopy, MDDC were washed twice in CM and plated on FN-coated 
(Sigma) glass coverslips at 3 x 104 DC per group in 0.5ml CM containing GM-CSF and IL-4. Cells 
were incubated for two hours to allow adherence, prior to treatment.
2.3.2.2 Microscopy
Cells were visualised on a Zeiss confocal microscope using BioRad Lasersharp software, and 
Adobe Photoshop Elements.
2.3.3 Flow cytometry
Cells were examined using a FACScan (Beckton-Dickinson) and for each sample at least 10,000 
events were acquired. Data were analysed using WinMDI software (Joseph Trotter, Scripps 
Research Institute), and the median fluorescence intensity (MFI) was used for quantitative 
analysis of bound antibody levels.
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2.4 Analysis of Cell Viability
Several different and complementary assays of cell viability were used.
2.4.1 Trypan blue analysis
Cells were counted using trypan blue stain as outlined above. This technique allowed a rapid 
assessment of cell viability, since trypan blue is excluded from live cells.
2.4.2 MTT reduction
Cell viability was assessed by monitoring reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5- 
diphenyltetrazolium bromide (MTT). 100pl of 105 purified DC per group were incubated for 24 
hours in 96-well plates (Nunc, Roskilde, Denmark). 20|a.l of MTT (final concentration 1 mg/ml; 
Sigma) in PBS was added to triplicate samples and incubated at 37°C, 5% C02 for 4 hours. The 
reduction of MTT was stopped by the addition of 100pl of 10% w/v sodium dodecyl sulphate 
(SDS) (Sigma). Absorbance was measured after a further 18 hours incubation in the dark. 
Optical absorbance was measured at a wavelength of 570nm with wavelength correction at 
630nm.
2.4.3 Analysis of cell size and granularity
Cells were analysed by flow cytometry as described above and the laser deflection data 
plotted according to Forward Scatter (FSC), and Side Scatter (SSC), which give an indication 
of cell size and granularity respectively. FSC/SSC parameters of healthy cells were defined 
and the percentage of cells from treated samples possessing these parameters was 
calculated.
2.4.4 PI staining
Apoptosis was assessed by measuring cellular DNA content following disruption of cell 
membrane integrity. For permeabilisation, 5x105 DC per group were resuspended in 1ml of 
70% ethanol at -20°C and stored on ice for 30 minutes. The cells were then washed twice and 
treated with DNase-free RNase A (Sigma) (final concentration 500pg/ml) at 37°C for 10 
minutes. To stain DNA, Propidium Iodide (PI) (Sigma) was added (final concentration 
50pg/ml), and the cells were analysed immediately by flow cytometry.
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2.4.5 Annexin V/ PI staining
For Annexin V/ PI experiments, 2x105 DC per group were stained using the TACS™ Annexin V- 
FITC apoptosis detection kit (R&D Systems, Minneapolis, USA) according to the manufacturer’s 
instructions prior to analysis by flow cytometry. Briefly, cells were washed in HBSS and 
resuspended in 100pl of full staining buffer for 30 minutes. In parallel, control groups were 
prepared by resuspending in 100pl of Annexin V control buffer, PI control buffer, or negative 
control buffer. Cells were washed, resuspended in 1x binding buffer, and then immediately 
analysed by flow cytometry.
Table 2.5 Buffers for Annexin V/ PI Staining
Buffer Constituents Manufacturer
100mM HEPES pH 7.4 (pH with NaOH) Sigma
1.5M NaCl Sigma
10x Binding Buffer 50mM KCl Sigma
10mM MgCl2 Sigma
18mMCaCl2 Sigma
Full Staining Buffer
1x Binding Buffer 
PI 5pg/ml R&D Systems
Annexin V 0.5pg/ml R&D Systems
DiH20 Sigma
Annexin V Control Buffer
1x Binding Buffer 
Annexin V 0.5pg/ml R&D Systems
DiH20 Sigma
PI Control Buffer
10x Binding Buffer 
PI 5pg/ml R&D Systems
DiH20 Sigma
Negative Control Buffer
1x Binding Buffer R&D Systems
DiH20 Sigma
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2.5 Detection of Secreted Proteins
2.5.1 Cytometric bead array
DC were incubated at 5 x 10s cells per group before collection of supernatants and cytokine 
concentration determination by cytometric bead array (Beckton-Dickinson) according to 
manufacturer’s instructions. Briefly, 10p.l of the provided mixed capture bead suspension and 
50|il of PE detection reagent were added to 50|a.l of sample and incubated for 3 hours. In 
parallel, dilutions of cytokine standards of known concentration were also prepared. Samples 
were then washed with the provided wash buffer and then examined using a FACSArray Flow 
cytometer (Beckton-Dickinson) and analysed with BD CBA software (Beckton-Dickinson).
2.5.2 Data and statistical analysis
Where appropriate, to facilitate comparison, concentrations of secreted cytokines were 
adjusted such that the level of the control-treated group was indicated as 100%.
Statistical significance of changes in the level of secreted cytokine was determined using a 
paired student’s T-test (on the raw data and not the adjusted figures).
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2.6 Detection of Surface Proteins
2.6.1 Extracellular immunofluorescence staining
For phenotypic analysis, 5 x 104 - 2 x 105 cells per group were harvested (within individual 
experiments the number of cells in each group was the same to ensure a constant cell: 
antibody ratio). Cells were resuspended in 100|xl of the appropriate blocking buffer for 15-30 
minutes at 4°C.
Table 2.6 Buffers for Immunofluorescence Staining
Lysis Buffer Constituents Manufacturer
HBSS Invitrogen
Rabbit Blocking Buffer
NaN3 0.1% Sigma
(Mouse Primary Antibodies)
Rabbit Serum 10% Gibco BRL
FCS Blocking Buffer
HBSS Invitrogen
NaN3 0.1% Sigma
(Rabbit Primary Antibodies)
Foetal Calf Serum 10% Gibco BRL
HBSS Invitrogen
Washing Buffer
NaN3 0.1% Sigma
HBSS Invitrogen
Fixation Buffer
Formaldehyde 3.7% (v/v) BDH, Poole, UK
50jxl of the appropriate primary antibody (table 2.7) were mixed with the cell suspension in a 
96-well round bottomed plate (Nunc), and then incubated for a further 30 minutes at 4°C. For 
experiments where the primary antibodies were not directly conjugated to fluorochromes, 
cells were washed twice with the appropriate blocking buffer to remove excess primary 
antibody, and then incubated for 30 minutes at 4°C with the relevant secondary antibody 
diluted in blocking buffer.
Finally, cells were washed twice in washing buffer and then fixed by resuspension in 50jj.I 
washing buffer followed by 100^ 1 fixation buffer. Samples were stored at 4°C in the dark, and 
then analysed by flow cytometry as outlined above.
2.6.2 Data and statistical analysis
Changes in median fluorescence intensity were adjusted to 100% for comparison purposes, 
and to investigate statistical significance, raw data was analysed by paired student's T test.
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Table 2.7 Primary Antibodies for Immunofluorescence Staining
Target Conjugate Origin Clone Isotype Manufacturer Cat. #
Human CD1a Unconjugated
Mouse
mAb
NA1/34 lgG2a
Gift, Prof. A. McMichael, John 
Radcllffe Hospital, Oxford, UK
N/A
Human CD3 Unconjugated
Mouse
mAb
UCHT1 lgG1 Gift, Prof P. Beverley N/A
Human CD11c Unconjugated
Mouse
mAb
ICRF 319 IgG 1
Gift, Prof N. Hogg, Cancer Research 
UK, London, UK
N/A
Human CD13 FITC
Mouse
mAb
WM15 lgG1
DPC Biermann, Bad Nauheim, 
Germany
SM1070F
Human CD14 Unconjugated
Mouse
mAb
HB246 lgG2b Gift, Prof. P. Beverley N/A
Human CD19 Unconjugated
Mouse
mAb
BU12 lgG1 Gift, D. Hardie N/A
Human CD25 PE
Mouse
mAb
B1.49.9 lgG2a IO Test, Beckman Coulter 0497
Human CD36 Unconjugated
Mouse
mAb
SMO IgM
Cymbus Biotechnology, Southampton, 
UK
CBL168
Human CD54 Unconjugated
Mouse
mAb
HA58 lgG1 eBioscience 14-0549
Human CD80 PE
Mouse
mAb
MAB 104 lgG1 IO Test, Beckman Coulter IM1976
Human CD83 Unconjugated
Mouse
mAb
HB15e lgG1 Dako Cytomation LS109
Human CD86 Unconjugated
Mouse
mAb
BU63 lgG1 Gift, D. Hardie N/A
Human MHC I Unconjugated
Mouse
mAb
W6/32 lgG2a Serotec, Oxford, UK MCA81
Human HLA-DR Unconjugated
Mouse
mAb
L243 lgG2a Gift, Prof. P. Beverley N/A
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Table 2.8 Secondary Antibodies for Immunofluorescence Staining
Target Conjugate Origin Clone Isotype Manufacturer Cat. #
Mouse IgG FITC Rabbit Polyclonal Dako Cytomation, F0261
Mouse IgG PE Goat Polyclonal Dako Cytomation, R0480
Table 2.9 Isotype Control Antibodies for Immunofluorescence Staining
Target Conjugate Origin Clone Isotype Manufacturer Cat. #
Isotype Control PE
Mouse
mAb
679.1MC7 lgG1
IO Test, Beckman Coulter, Fullerton, 
CA, USA
IM0670
Isotype Control PE
Mouse
mAb
DAK-G05 lgG2a Dako Cytomation, Glostrup, Denmark X0950
Isotype Control FITC
Mouse
mAb
DAK-G01 lgG1 Dako Cytomation X0927
Human CD2 Unconjugated
Mouse
mAb
MAS 593 lgG2b Harlan Sera-lab, Crawley Down, UK N/A
Human CD19 Unconjugated
Mouse
mAb
BU12 lgG1 Gift, D. Hardie N/A
Isotype Control Unconjugated
Mouse
mAb
HB38 IgM Prof. B. Chain N/A
Isotype Control Unconjugated
Mouse
mAb
DAK-G05 lgG2a Dako Cytomation X0943
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2.7 Detection of Intracellular Proteins
2.7.1 Sample preparation
MDDC were incubated in CM containing 0.5% FCS v/v for at least 24 hours prior to treatment. 
Total cell extracts were prepared by resuspending the cells in 50pl of reducing sample buffer 
(table 2.10) at approximately 5 x 106 cells/ ml. Where necessary, samples were stored at - 
20°C, and were sonicated and boiled for 5 minutes prior to gel loading. Samples were then 
analysed by polyacrylamide gel electrophoresis.
Table 2.10 Lysis Buffers
Lysis Buffer Constituents Manufacturer
Reducing Sample Buffer
60mM Tris pH 6.8 
10% Glycerol 
2% SDS
Bromophenol Blue 
2% 2-Mercaptoethanol
Sigma
Calbiochem, CA, USA
BDH
Sigma
Gibco
2.7.2 Control lysates
293T cells were irradiated (positive control lysate) or not (negative control) with UV light for 
60 seconds and then incubated at 37°C for a further 20 minutes. Cells were then washed, 
lysed in reducing sample buffer, sonicated, and stored in aliquots at -20°C. Control lysates 
were boiled prior to use.
Table 2.11 Western Blotting Buffers
Buffer Constituents Manufacturer
192mM Glycine Sigma
Running Buffer 25mM Tris-base Sigma
0.1% SDS Sigma
192mM Glycine Sigma
Transfer Buffer 25mM Tris-base Sigma
20% methanol Sigma
2.7.3 Gel running and analysis
Within individual experiments, a consistent volume of between 10pl and 40pl of lysate was 
resolved by running on a 12.5% polyacrylamide gel and transferred to ECL nitrocellulose
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membrane (Amersham Pharmacia Biotech, Bucks, UK) for analysis by immunoblotting. Buffers 
for electrophoresis and migration of proteins to nitrocellulose membranes are indicated in 
table 2.11.
2.7.4 Immunoblotting
Following transfer of electrophoresed lysates, nitrocellulose membranes were washed in TBS 
(table 2.12) and then incubated in blocking buffer for 1 hour at room temperature or 
overnight at 4°C. Membranes were then washed in TTBS prior to incubation with the primary 
antibody under the conditions indicated in table 2.13. The process of washing and incubation 
with antibody buffer was repeated for the secondary antibody (table 2.13). ECL detection 
reagent and ECL hyperfilm (both Amersham Pharmacia Biotech) was used to visualise the 
membranes.
Where necessary, membranes were stripped of bound antibodies by incubating at 60°C for 1 
hour in stripping buffer (table 2.12). Membranes were then washed at least 5 times in TTBS 
before immunoblotting was performed as described above.
Table 2.12 Buffers for Immunoblotting
Buffer Constituents Manufacturer
TBS
NaCl
KCl
Tris pH 7.5
Sigma
Sigma
Sigma
TTBS
TBS
0.1% Polyoxyethylene sorbitan 
monolaurate (Tween-20)
Sigma
Blocking Buffer
TTBS
5% Skimmed low fat milk powder Tesco, Cheshunt, Hertfordshire, UK
Milk Antibody Buffer
TTBS
1% Skimmed low fat milk powder Tesco
BSA Antibody Buffer
TTBS
5% Bovine Serum Albumen Sigma
Stripping Buffer
2% SDS
60mMTris pH 6.7 
2% 2-Mercaptoethanol
BDH
Sigma
Sigma
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Table 2.13 Antibodies for Immunoblotting
Target Buffer Conjugate Origin Clone Isotype Manufacturer C at.#
Primary Antibodies
Total p38 Milk 20°C
Unconjugated
Rabbit Polyclonal
Cell Signaling Technology, 
Beverly, MA, USA
9212
Phospho p38 Milk 20°C Unconjugated Rabbit Polyclonal Cell Signaling Technology 9211
Total JNK Milk 20°C
Unconjugated Mouse
mAb
N/A lgG1 Santa Cruz Biotechnology sc-7354
Phospho JNK Milk 20°C Unconjugated Rabbit Polyclonal Promega, Madison, Wl, USA V9731
Phospho ERK BSA 4°C
Unconjugated Mouse
mAb
N/A IgG 1 Cell Signaling Technology 9106
Total c-jun Milk 20°C Unconjugated Rabbit Polyclonal Santa Cruz Biotechnology sc-1694
Phospho c-jun
Milk 20°C Unconjugated Mouse
mAb
N/A lgG1 Santa Cruz Biotechnology sc-822
Phospho tyrosine Milk 20°C
Unconjugated Mouse
mAb
4G10 lgG2b Upstate Biotech, NY, USA 05-321
Total IkBcc Milk 20°C Unconjugated Rabbit Polyclonal Santa Cruz Biotechnology sc-371
Phospho teBa Milk 20°C HRP
Mouse
mAb
N/A lgG2b Santa Cruz Biotechnology sc-8404
Total MUG BSA 4°C Unconjugated Rabbit Polyclonal Cell Signaling Technology 2187
Phospho MUG BSA 4°C Unconjugated Rabbit Polyclonal Cell Signaling Technology 2811
Secondary Antibodies
Mouse IgG Milk 20°C HRP Rabbit Polyclonal Dako Cytomation P0260
Rabbit IgG Milk 20°C HRP Swine Polyclonal Dako Cytomation P0399
2.7.5 Densitometry and analysis
Densitometric analysis of autoradiographs was performed using GeneSnap software (Syngene). 
Densities of the Phospho- and Total-protein bands were calculated and the ratios of Phospho 
to Total densities were then calculated to give an indication of the proportion of kinase 
phosphorylated in each condition.
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2.8 Detection of Messenger RNA
2.8.1 Polymerase chain reaction
2.8.1.1 Genomic DNA preparation
5 x 106 immature DC were resuspended in 500pl lysis buffer (table 2.14) at 55°C with shaking 
overnight. Genomic DNA was then precipitated using propan-2-ol (BDH, Poole, UK), and 
resuspended in dH20 (Sigma) prior to concentration determination by spectrophotometry and 
storage at -20°C.
Table 2.14 Lysis Buffers
Lysis Buffer Constituents Manufacturer
100mMTris pH 8.5 Sigma
5mM EDTA Sigma
Lysis Buffer (for DNA Prep) 0.2% SDS BDH
200mM NaCl Sigma
1% Proteinase K Sigma
2.8.1.2 Total RNA preparation
5 x 106 immature DC were lysed using TRIzol (Invitrogen) and RNA was collected by addition of 
20% chloroform (BDH) and centrifugation (12,000g/ 10 min/ 4°C). The top (RNA containing) 
layer was collected and the chloroform addition and centrifugation procedure repeated. RNA 
was then cleaned by sequential addition, centrifugation (12,000g/ 10 min/ 4°C) and 
supernatant removal of propan-2-ol and ethanol (twice; BDH). Contaminating DNA removed by 
resuspension in DNase buffer (Promega, Promega, Madison, Wl, USA) at 37°C for 1 hour. RNA 
was extracted by addition of PCI (Phenol, chloroform, isoamylalcohol (24:24:1 ratio; BDH)), 
centrifugation (13,000rpm/ 10 min) and top layer collected. This process was repeated twice 
and finally an equal volume of chloroform was added. RNA was precipitated by addition of 8M 
ammonium acetate (Sigma) followed by ethanol addition and RNA precipitation (repeated 
three times). Finally RNA was resuspended in dH20 prior to concentration determination by 
spectrophotometry and storage at -20°C.
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2.8.1.3 Reverse transcription and PCR
Oligo-dT (Promega) was added to 5pg RNA and incubated at 70°C for 10 mins prior to addition 
of RT mixture (AMV 5x buffer, dNTPs, 5% AMV RT (all Promega), 10% DTT (Sigma)), incubation 
at 42°C for 50 mins and then 70°C for 15 mins.
2.8.2 PCR primers
To maximise stringency and sensitivity of detection of MLK protein synthesis, a nested 
strategy was used whereby one or two primers were designed to be used in a second PCR 
reaction using the first round product as template. The sequences of all the all primers used 
are given in table 2.15.
Table 2.15 Primers for detection of MLK Proteins
Name Sequence (5’-3’)
FMLK1 CTTGCTGGCAGCCAGTTG
RMLK1 ATCTCGTTTGAAGCGCTC
FnestMLKI TGGTGCCCATCGACATTG
RnestMLKI GACCCTCCCGTCTTTTCTTC
FMLK2 T GGAGCT GGAGAGCTTCAAGAAG
RMLK2 GGAAGTCCAGAAGGTCACGA
FnestMLK2 CAGTCGCTCACGCCCACCCACG
FMLK3 AGCCCATTGAGAGTGACGAC
RMLK3 CGTCGAAGAGACCCTGGAT
FnestMLK3 AGTGGCACAAAACCACACAA
RnestMLK3 CTGCATGGAATGGAAGGAGT
FMLK4 TGGAGTGCTGCTGTGGGA
RMLK4 CTTTTCCTTT GTTCTCAACTC
RnestMLK4 GTTTCCAGTCATCTTGCATGG
FDLK AGTGGCACAAAACCACACAA
RDLK TCAACGCTGTTGGAGTTGTC
FnestDLK TAGTGAACCTTCCCCCAGTG
BactinF GACGAGGCCCAGAGCAAGAGACG
BactinR GATCCACATCTGTGGAAGGTGGAC
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2.8.3 PCR conditions
Table 2.16 PCR Conditions
Reagent Concentration Source Volume (Total 50pl)
PCR Buffer 10x Promega 10pl
MgCl2 25mM Promega 2pl
dNTPs 2.5mM (each dNTP) Promega U1240 1pl
DMSO 100% Sigma 2pl
Taq Polymerase 5u/pl Promega M1665 0.5pl
DiH20 - Sigma W4502 33.5pl
Template
gDNA 0.3pg/pl 
cDNA 0.8pg/pl
2pl
Primers 10pM Sigma Genosys 2pl
2.8.4 PCR program
Table 2.17 PCR Program
Temperature Duration Repeat
94 (°C) 2 minutes x1
94 (°C) 1 minute
x3558 (°C) 1 minute
72 (°C) 2 minutes
72 (°C) 2 minutes x1
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2.9 Quantification of Antigen Internalisation
2.9.1 Uptake of FITC-conjugated dextran
5 x 104 MDDC were allowed to adhere to FN-coated glass coverslips as described above and 
treated overnight as indicated. FITC-conjugated dextran was prepared in CM containing GM- 
CSF and IL-4 and added to the cells to a final concentration of 30pg/ml. Cells were then 
incubated at 37°C or 4°C as appropriate for 90 minutes. Cells were removed by five-minute 
treatment with trypsin and were then washed three times in washing buffer (table 2.6). Cells 
were fixed in 100pl of fixation buffer (table 2.6) and incubated at 4°C in the dark prior to 
analysis by flow cytometry.
2.9.2 Preparation of microbeads
The experimental procedure is outlined in figure 5.4. Beads coated with polyclonal sheep 
anti-rat IgG antibodies (Dynal) were used at 2 x 105 per group (approximately 4 beads: 1 
cells).
Beads were washed once in HBSS and resuspended in 200pl of CM containing 5pl of PE- 
conjugated rat anti-human DC-SIGN antibody (final concentration 3pg/ml), or isotype control 
antibody (specificity unknown, 0.2mg/ml). Following agitation for one hour at 4°C, beads 
were washed to remove excess antibody and resuspended in 100pl of CM (containing GM-CSF 
and IL-4) and then added to the cells.
Beads coated with PE-conjugated antibodies raised against CD80, CD83, MHC class I, and CD1a 
were treated in exactly the same way, except that rabbit anti-mouse IgG coated beads 
(Dynal), and FITC-conjugated rabbit anti-mouse secondary antibodies (Dako) were used.
2.9.3 Analysis of microbead internalisation
To analyse the ability of MDDC to internalise microbeads, following treatment, the medium 
was carefully removed and replaced with 100pl of microbeads in CM prepared as described 
above.
After incubation under the indicated conditions and time period, the medium was removed 
carefully and replaced with 500pl of fixation buffer (table 2.6).
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2.9.4 Determination of internal versus external microbeads
To distinguish between internalised (protected) and externally bound (accessible) 
microbeads, a second round of staining was performed (see figure 5.4). For secondary 
staining, formaldehyde was removed and cells washed twice in washing buffer (table 2.6) 
prior to incubation for one hour at 4°C in 500pl of Rabbit Blocking Buffer (table 2.6). To this 
was added 100pl of FITC-conjugated rabbit anti-rat antibody (4mg/ml) diluted 1 in 25 in 
Rabbit Blocking Buffer (final concentration 0.27mg/ml) for a further one hour at 4°C. Finally, 
cells were washed three times in washing buffer before addition of 500pl of fixation buffer 
and incubation at 4°C in the dark until visualisation by confocal microscopy.
2.9.5 Confocal microscopy and quantification of microbead capture or internalisation 
Cells were visualised on a Zeiss confocal microscope using BioRad Lasersharp software. An 
example of the images obtained is shown in figure 5.5. Three randomly selected fields of each 
group were imaged at low magnification. Images were studied subsequently using Adobe 
Photoshop Elements software. Three internalisation parameters were determined according 
to the following formulae:
a, ~ . . . . . Number of cells containing one or more beads% Cells containing beads = ----------------------------- -----------------------  x 100
Total number of cells
Total number of internalised beads 
Number of beads per cell = -----------------------------------------
Total number of cells
■ «. _« u Total number of internalised beads% Cell-associated beads internalised = -----------------------------------------------------------  x 100
Number of external cell associated beads
+ Total number of internalised beads
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Table 2.18 Antibodies for Microbead Internalisation Assay
Target Conjugate Origin Clone Isotype Manufacturer Cat. #
Primary Antibodies
Isotype Control PE Rat mAb
N/A
lgG2a eBioscience 12-4321
Isotype Control PE
Mouse
mAb
679.1Mc7 lgG1 IO Test, Beckman Coulter IM0670
Human CD1a PE
Mouse
mAb
BL6 lgG1 IO Test, Beckman Coulter IM1942
Human CD80 PE
Mouse
mAb
MAB104 IgG 1 IO Test, Beckman Coulter IM1976
Human CD83 PE
Mouse
mAb
HB15a lgG2b IO Test, Beckman Coulter IM2218
Human CD209 PE Rat mAb eB-h209 lgG2a eBioscience 12-2099
Human MHC I PE
Mouse
mAb
G46-2.6 lgG1 BD Pharmingen 555553
Secondary Antibodies
Rat IgG FITC Rabbit Polyclonal Dako Cytomation F0234
Mouse IgG FITC Rabbit Polyclonal Dako Cytomation, F0261 Mouse IgG
2.9.6 Data handling
Data handling and statistical analysis were performed using Microsoft Excel.
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Chapter 3 
Oxidative Stress
3. Oxidative Stress
3.1 Introduction
3.1.1 Oxidative stress
For life in an aerobic environment, exposure to reactive oxygen species (ROS) is continuous 
and unavoidable. Partially reduced metabolites of oxygen are formed during electron transfer 
reactions. They include superoxide anion, hydrogen peroxide (H202), and hydroxyl radical. As 
the name suggests, each of these species is capable of oxidising surrounding biomolecules, 
with potentially damaging consequences for the organism. As a result, a homeostatic balance 
exists between the formation of ROS and their removal by antioxidant scavenging compounds 
such as superoxide dismutase, catalase, vitamins C and E, and reduced glutathione. 
“Oxidative stress” arises when cellular production of ROS overwhelms its antioxidant 
capacity. Indeed, the overall level of oxidative stress, and the response to it, has been 
suggested as a major determinant of eukaryotic lifespan (Golden et al., 2002).
ROS have traditionally been regarded as toxic by-products of metabolism, however it has long 
been known that ROS production can be used to the advantage of the host as an innate 
response to invading microorganisms. Phagocytic cells such as neutrophils and macrophages 
produce ROS via the “ respiratory burst” , in which an NADPH oxidase system mediates a 
transient 100-fold increase in oxygen consumption with the consequent production of high 
concentrations of ROS, and the resultant death of engulfed microorganisms. The importance 
of this NADPH oxidase system to innate immunity is emphasised by the observation that 
defects in this system result in chronic granulomatous disease in which patients typically die 
in childhood of severe recurrent infections.
Oxidative stress, as a consequence of the production of ROS in the respiratory burst, is 
therefore a hallmark of inflammation. In the case of DC, whose role in pathogen detection 
and antigen presentation is central to the induction of adaptive immunity, this ROS exposure 
is particularly relevant. Oxidative stress is likely to be a common feature of the inflammatory 
microenvironment precisely when DC at these sites are receiving maturation signals provided 
by the invading microorganisms.
Furthermore, high concentrations of ROS can act indirectly as well as directly, by modifying 
the structure of proteins and other macromolecules (Alderman et al., 2002), and thus 
changing the repertoire of antigens that DC may process and present (Al Bukhari et al., 2002). 
During inflammation, damage mediated by ROS occurs at the plasma membrane leading to the 
generation of oxidised proteins and phospholipids and alterations in membrane permeability 
(Zimmerman, 1995). Cellular apoptosis is therefore an obligate outcome to prevent immune
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response to intracellular self-antigens. However apoptotic cells have also been implicated in 
the activation of autoimmunity, in particular atherosclerosis, due to the development of 
autoantibodies against oxidised phospholipids and low-density lipoproteins (Chang et al., 
2004). Hence the response of DCs to oxidative stress, and ROS - both how they protect 
themselves from excess injury, and the epitopes to which they are induced to respond - has 
been invoked as an important aspect of the physiology of these cells (Park et al., 2002). While 
it is important that DC respond and induce adaptive immunity to invading pathogens, it is also 
critical that responses to modified self antigens are not elicited, which could result in 
autoimmunity.
It is becoming increasingly apparent that in addition to their antimicrobial role, ROS also 
perform an essential function as second messengers in intracellular signaling. Indeed, even 
the respiratory burst may have more of a signaling than directly microbicidal role (Reeves et 
al., 2002). ROS have also recently been shown to be generated by specialised plasma 
membrane oxidases (which resemble the classical NADPH oxidase system of phagocytes) in 
response to various growth factors or cytokines (Thannickal and Fanburg, 2000). Major 
downstream targets of ROS production, whether physiological or pathological are AAAPKs. 
Several mechanisms have been proposed for this AAAPK activation, including receptor 
clustering (Peus et al., 1999), protein tyrosine phosphatase inhibition (Soberman, 2003), or 
MAP3K activation (Tobiume et al., 2001). JNK and p38 are therefore essential proteins in the 
response of cells to both physiological and hyper-physiological ROS production.
3.1.2 Chapter aims
Due to this ability to respond to both intracellularly produced low level ROS, and much 
greater concentrations of extracellular ROS and oxidative stress, the p38 and JNK AAAPK 
pathways are thus able to act as sensors for the level of oxidative stress at an inflammatory 
site. In addition to their ability to respond to ROS, AAAPK pathways, and p38 in particular, play 
an important role in the intracellular events that are associated with DC maturation (Bunyard 
et al., 2003; Xie et al., 2003). Therefore activation of p38 by ROS present at inflammatory 
sites might be predicted to initiate DC maturation, or modulate DC maturation induced by 
strong stimuli such as LPS. Less is known about the role of JNK in DC and the functional 
consequences of JNK activation have not been studied extensively, primarily due to the 
absence of selective inhibitors. We therefore wished to examine the ability of ROS to activate 
AAAPKs in DC and to investigate the effect of this activation on DC function.
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3.2 Results
3.2.1 Characterisation of dendritic cells
The purity of the DC population used for these studies was confirmed by flow cytometry. As 
figure 3.1a shows, the purified cells that were prepared from peripheral blood contained <1% 
of contaminating CD3- or CD19-positive cells (T or B cells).
Analysis of characteristic DC surface markers confirmed the identity of the DC differentiated 
from monocytic precursors. The DC expressed low levels of CD14 and CD25, which are both 
present at significantly higher levels on the monocytic precursors. The DC also expressed high 
levels of the myeloid marker CD13, and the characteristic DC surface proteins, CD11c, CD1a, 
and CD36 (figure 3.1b).
We next examined the ability of these purified DC to respond to strong DC maturation stimuli. 
As shown in Figure 3.2a, following 18-hour incubation with 100ng/ml LPS, the DC significantly 
upregulated the expression of MHC class I and II molecules, costimulatory molecules CD80 and 
CD86, the adhesion molecule CD54, and a surface marker present on mature DC, CD83.
Another characteristic of the maturation process is the striking ability of DC to undergo 
morphological alteration. Immature DC are mostly rounded cells in tissue culture, and upon 
overnight stimulation, the DC extend long dendritic processes. We therefore examined the 
ability of these purified DC to undergo morphological change upon incubation with 100ng/ml 
LPS. As figure 3.2b demonstrates, maturation of the DC was accompanied by extension of long 
dendritic processes.
Overall, we can therefore be confident that the cells used in these studies are characteristic 
of immature DC, and demonstrate a high level of purity.
3.2.2 Effects of H20 2 on DC phenotypic maturation
The ability of DC to mature in response to incubation with H202 and the TLR4 ligand LPS was 
followed, using the same flow cytometry approach. As expected, LPS (100ng/ml) induced up- 
regulation of the three surface markers examined, CD54, CD86 and HLA-DR (figure 3.3). In 
contrast, H202 over a range of concentrations failed to up-regulate any of the markers 
examined relative to unstimulated cells (figure 3.3). Incubation with 1mM H202 resulted in 
significant reduction in mean forward scatter, consistent with the induction of apoptosis
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(data not shown). The phenotype data obtained with this concentration was therefore not 
analysed further.
To examine the ability of H202 to modulate the response of DC to LPS, the cells were 
incubated with various concentrations of the two stimuli and examined for CD86 expression, 
as this was one of the most robust and sensitive markers of DC maturation (figure 3.4a). 
There was no evidence that H202 enhanced the effects of LPS at any combination of stimuli 
tested, either in terms of increased sensitivity of the DC to LPS, or by increased expression of 
CD86 above the level induced by LPS alone. On the contrary, levels of CD86 appeared to 
decrease in the presence of H202. Examination of the flow cytometry plots indicated that this 
decrease was accompanied by a progressive decrease in cell size (figure 3.4b), indicated by a 
reduction in forward scatter (FSC-H), suggestive of apoptosis.
For each treatment shown in figure 3.4a, the number of gated cells (those with the defined 
parameters of control DC) as a percentage of the total was calculated (figure 3.4c). As the 
concentration of LPS or H202 is increased, the percentage of gated cells is reduced, and there 
is clearly a correlation between the degree of stimulation and the decreased cell size. The 
level of apoptosis in the DC cultures was therefore investigated in more detail.
3.2.3 Effects of H20 2 and LPS on DC apoptosis
Apoptosis was assessed both by measuring DNA fragmentation seen as a sub-G0 peak on flow 
cytometric analysis of DNA content using PI staining (figures 3.5a and b), and by using a 
combination of surface annexin V and PI staining (figures 3.5c and d).
Analysis of DNA content revealed that culture of DC in the presence of 300pM H202 induced 
some apoptosis (figure 3.5a) with fewer cells in G0 (figure 3.5b), consistent with the shift in 
Forward Scatter observed by flow cytometry. Culture of DC in the presence of LPS did not 
induce a significant increase in apoptosis.
Unexpectedly, however, the combination of LPS (100ng/ml) and H202 (300pM) induced 
apoptosis in a large proportion of the cells (figures 3.5a and b). Thus LPS and H202 appeared 
to show synergistic ability to activate the apoptotic pathway in DC.
The results of annexin V/ PI staining were very similar. There are fewer PI/ annexin V double 
negative cells in the H202 (300pM) (lower left quadrants, figure 3.5c) than in the controls; LPS
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alone caused a small decrease, but the most striking findings were seen when the two 
modulating agents were used together.
3.2.4 Effects of H20 2 and LPS on p38 & JNK MAPK activation in DC
To investigate the activity of signaling pathways underlying these changes in DC maturation 
and survival, DC were exposed either to various concentrations of H202, or LPS, or both 
together, and phosphorylation of p38 and JNK was analysed by Western blot.
The level of phosphorylated p38 increases in proportion to H202 concentration in a time- 
dependent manner (figure 3.6a). Stimulation with 0.1 mM H202 for 15 mins induced strong but 
transient p38 activation, while 1mM H202 induced a similar but sustained level of p38 
phosphorylation. 0.1 mM H202 induced low-level transient JNK activation, while 1mM H202 
induced stronger and more sustained JNK phosphorylation, with some phosphorylated JNK still 
detectable after 4 hours of stimulation. Treatment with a hyperphysiological concentration of 
10mM H202 induced cell necrosis, reflected by the reduced level of total JNK protein at 4hrs.
Both p38 and JNK were also phosphorylated in response to LPS (figures 3.6b and c). 
Densitometry showed that p38 was ten-fold more sensitive to activation by LPS compared to 
JNK (figure 3.6c).
Signal pathway responses in DC after exposure to a combination of H202 and LPS are shown in 
figure 3.7. Neither H202 nor LPS altered the levels of total p38 and total p54JNK. The presence 
of H202 did not consistently enhance LPS-induced p38 phosphorylation (figure 3.7b). LPS 
(100ng/ml) and H202 (0.1 mM) synergised, however, in the induction of JNK phosphorylation 
(figure 3.7c). This experiment was performed three times. The mean fold activation of JNK 
due to H202 alone was 10, for LPS alone 3.3, and for the combination 19.6.
As a stimulus, hydrogen peroxide yielded qualitatively consistent, but quantitatively 
inconsistent responses. This is possibly due to the high reactivity and short half-life of 
hydrogen peroxide resulting in slightly different effective concentrations, in combination with 
donor-specific variations in susceptibility to oxidative stress. Experiments were therefore 
performed at least three times, and, where indicated, ‘representative’ results, reflecting 
common trends are shown.
The dichotomy between the ability of hydrogen peroxide to induce p38 phosphorylation and 
its failure to induce DC maturation was unexpected. As the NF-kB pathway has also been
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shown to be essential for DC maturation by LPS, and is activated in many cell types by H202, 
this pathway was also analysed. The basis for these experiments was that, prior to activation, 
NF-kB is sequestered in the cytoplasm by an inhibitory protein, IkB; but that upon activation, 
this protein is phosphorylated and then immediately degraded, allowing NF-kB to translocate 
to the nucleus and initiate transcription (Karin and Ben Neriah, 2000) (figure 1.4). Therefore 
using an anti-kBa antibody to determine the level of inhibitory protein present, the degree of 
NF-kB inhibition was examined. Only LPS, but not H202, induced kBa degradation, and hence 
NF-kB translocation (figure 3.7a).
3.2.5 Correlation between DC apoptosis and JNK phosphorylation
Given the reported role of JNK in pro-apoptotic signaling in other cell types (Chen and Tan, 
2000), and the observations that in DC, H202 and LPS synergised in the induction of apoptosis 
(figure 3.5) and JNK activation (figure 3.7), we decided to further analyse the role of JNK in 
DC apoptosis.
DC were treated with various concentrations of H202 and then examined in parallel for the 
level of JNK activation and the degree of induced cell death. The level of H202-induced JNK 
phosphorylation, expressed as the ratio of phosphorylated- to total-JNK by Western blot and 
band densitometry is shown in figure 3.8a. The degree of H202-induced cell death was studied 
by incubating DC with H202 for one hour before change of medium and overnight incubation. 
Cell viability was then assessed by total DNA content (figure 3.8b), annexin V/PI staining 
(figure 3.8c) and MTT reduction (figure 3.8d). The degree of JNK activation (figure 3.8a) 
correlates closely with DC death measured by the size of the sub-G0 population (figure 3.8b), 
and by annexin V/ PI positivity (figure 3.8c), and this correlation is shown in fig 3.8e. The 
cells treated with 10mM H202 were necrotic by light microscopy and trypan blue exclusion 
(data not shown), and this is consistent with the data shown in figure 3.8e because the 
percentage cell death measured by annexin V/ PI (81.15%) includes necrotic cells, whereas 
the Sub-Go quantification (21.2%) gives a measure of the apoptotic population only.
3.2.6 Inhibition of p38 & JNK MAPK
The involvement of the JNK pathway in DC apoptosis was examined further using two 
selective low molecular weight JNK inhibitors, CEP11004 (CEP), an inhibitor of Mixed Lineage 
Kinase (MLK), a MAP3K upstream of JNK (Murakata et al., 2002), and SP600125 (SP), an ATP- 
binding site analogue competitive inhibitor of JNK (Bennett et al., 2001). The 
pharmacological activity of these two inhibitors in DC was first confirmed by Western blot
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(figures 3.9a and b). CEP inhibited H202-induced JNK activation in a dose-dependent manner 
(figure 3.9a). No JNK phosphorylation is detectable after pre-treatment with 1pM CEP, 
suggesting that H202 induces JNK activation in DC exclusively via MLK activation. In contrast, 
SP is a competitive and reversible inhibitor of JNK itself, rather than an upstream kinase, and 
hence its efficacy was measured as the ability of the inhibitor to prevent phosphorylation of 
c-jun, a substrate of JNK. As predicted, activation of c-jun is inhibited in a dose dependent 
way by SP (figure 3.9b). At higher concentrations (10pM), SP did in fact also inhibit JNK 
phosphorylation, indicating that at this concentration, inhibition of additional kinases occurs. 
Indeed, in initial analysis of the inhibitor, the manufacturers determined that SP inhibits the 
JNK-specific AAAP2K MKK7 with an IC50 value approximately ten times greater than that for 
JNK inhibition, which supports the observations of this study (Bennett et al., 2001). However, 
at lower concentrations, there was significant inhibition of c-jun in the absence of JNK 
inhibition (figure 3.9b). Such non-specific inhibition is a limitation of inhibitor studies because 
the effects of the inhibitors on every protein kinase cannot be determined.
Finally, as expected, figure 3.9c shows that the control p38 inhibitor, SB203580 (SB), did not 
have a strong inhibitive effect on either JNK or c-jun phosphorylation at any concentration 
used (up to 10pM). Also in line with expectations, neither the p38- (SB), nor JNK-specific (SP) 
inhibitors prevented phosphorylation of p38. However, inhibition of MLK by CEP did prevent 
H202-induced p38 phosphorylation, suggesting that this protein lies upstream of both p38 and 
JNK in the H202 response pathway. This p38 and JNK activatory role of MLK in DC is examined 
in more detail in Chapter 4.
3.2.7 Effects of MAPK inhibitors on apoptosis
To determine the role of JNK in mediating H202-induced DC apoptosis, H202 was added 
overnight to cells pre-treated with CEP, SP and SB inhibitors. Cell viability was determined by 
measuring annexin V/PI (figure 3.10a), DNA content (figure 3.10b) and capacity to reduce 
MTT (figure 3.10c). Both JNK inhibitors increased the proportion of viable cells in all three 
assays, providing partial protection against H202-induced cell death (figure 3.10d). In 
contrast, the p38 inhibitor SB was much less effective in this regard. The percentage 
protection facilitated by each inhibitor was calculated and is shown in figure 3.10d. Neither 
the inhibitors themselves, nor their solvent DAASO affected cell viability under these 
conditions (figure 3.10b).
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3.2.8 Effects of p38 and JNK inhibition on DC maturation
The role of JNK in LPS-induced DC maturation has not previously been examined, and 
therefore the ability of the JNK inhibitor SP on LPS-induced CD86 upregulation was studied. 
As a positive control, the p38 inhibitor SB was used. As expected from previous reports, p38 
inhibition completely blocked the ability of LPS to induce CD86 up-regulation (representative 
histograms (figure 3.11a) and mean fluorescence intensity of three experiments (figure 
3.11b)) Partial inhibition was seen at 3pM, and total inhibition at 10|aM, as a result 10|oM was 
used in all further studies. In contrast the JNK inhibitor SP had no effect on phenotype (figure 
3.11a and b), suggesting that the JNK AAAPK pathway is not involved in modulating DC 
phenotype.
3.2.9 Effects of H20 2 on protein tyrosine phosphorylation
The mechanism of JNK activation by H202 has not been studied in DC. In other cell types the 
MAP3K protein Apoptosis Signal Regulating Kinase-1 (ASK-1) has been implicated in this 
process (Tobiume et al., 2001), but this is not consistent with the ability of CEP to inhibit 
H202-induced JNK activation and apoptosis as shown in figure 3.9a. The effects of the CEP 
inhibitor suggest that MLK, rather than ASK-1, is the main activator of JNK in DC in response 
to H202.
There is also an alternative proposed mechanism of H202-mediated JNK activation, via 
transient inhibition of protein tyrosine phosphatases (PTPs), due to reaction of H202 with the 
catalytic cysteine in the active site of this class of enzyme. If this were the case then 
phosphorylated tyrosine residues would accumulate upon H202 treatment. Physiologically, this 
phosphatase inhibition would need only to be very brief and hence would be difficult to 
observe; but hyperphysiological concentrations of H202 would induce more pronounced 
inhibition and accumulation of phosphorylated tyrosine residues would be observed. To test 
this hypothesis, DCs were treated with various concentrations of H202 and total protein 
tyrosine phosphorylation analysed by Western blotting.
Figure 3.12a shows that there was indeed a dose-dependent increase in the level of tyrosine 
phosphorylation upon treatment of DC with H202. Furthermore, figure 3.12b shows that the 
level of tyrosine phosphorylation rapidly diminished upon removal of H202. To further 
investigate the hypothesis that H202 activates AAAPK in DC via inhibition of PTPs, the protein 
tyrosine phosphatase inhibitor sodium orthovanadate (Na3V04) was used (Huyer et al., 1997). 
DCs were treated with different concentrations of Na3V04, lysed after 15 minutes, and then 
analysed by Western blot. As shown in Figure 3.12c, Na3V04 induces a high degree of tyrosine
104
3. Oxidative Stress
phosphorylation similar to that seen in the presence of H202. The membranes were stripped 
and re-probed for phosphorylated JNK and p38. Na3V04 induced phosphorylation of both JNK 
and p38 (figure 3.12c). Furthermore, in striking resemblance to H202 (and LPS), p38 was 
phosphorylated at a lower concentration (10pM) than JNK (100pM).
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Figure 3.1. Analysis of purity
(a) The DC population differentiated from blood monocyte precursors was 
examined for the presence of contaminating cells. Expression of surface 
marker proteins CD3 and CD19, characteristic of T and B cells, was analysed 
by flow cytometry. Unfilled histograms - Isotype control (see M&M). Filled 
histograms - test antibody, (b) Immature DC were incubated with (unfilled 
histograms) or without (shaded histograms) 100ng/ml LPS for 18 hours. 
Expression of surface marker proteins was then analysed by flow cytometry. 
Dashed histograms - Isotype control.
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Figure 3.2. Characterisation of DC Maturation
(a) Immature DC were incubated with (unfilled histograms) or without 
(shaded histograms) 100ng/ml LPS for 18 hours. Expression of surface 
marker proteins was then analysed by flow cytometry. Dashed histograms - 
Isotype control, (b) Morphological characterisation of immature DC in tissue 
culture analysed by light microscopy. Left panel - unstimulated. Right panel 
- incubation with 100ng/ml LPS for 18 hours. Scale bar represents 50(im.
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Figure 3.3. Effects of LPS & H20 2 on DC phenotype
Immature DC were incubated with or without 100ng/ml LPS or various 
concentrations of H202 as indicated for 18 hours. Expression of surface 
marker proteins was then analysed by flow cytometry. One representative 
of three experiments is shown.
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Figure 3.4. Effects of treatment with LPS and /  or 
H20 2on CD86 expression and viability of DC
(a) Effects of various combinations of LPS and H202 on CD86 expression. 
Immature DC were treated with various concentrations of LPS and H202 as 
indicated for 18 hours and then analysed for CD86 expression by flow 
cytometry. Representative of three independent experiments, (b) A 
representative forward scatter/ side scatter analysis of cell populations 
characteristic of healthy and apoptotic DC showing the decrease in the 
percentage of gated cells associated with cell death, (c) DC were treated 
with or without LPS and/ or H202 for 18 hours and then analysed by flow 
cytometry as in panel (b). The results show the percentage of 20,000 
counted events occurring within the size and granularity gate defined for 
untreated DC. Representative of three independent experiments.
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Figure 3.5. Analysis of DC viability upon treatment 
with LPS and / or H20 2
(a) DC were incubated overnight with medium only, or 100ng/ml LPS and/ 
or 0.3mM H202 prior to analysis of DNA content by propidium iodide staining 
and flow cytometry. Live cells show a single peak of DNA corresponding to 
cells in G0/G., stage of the cell cycle. During apoptosis, DNA is degraded and 
observed as a sub-G0 peak. One representative experiment of 4 is shown.
(b) Bar chart shows mean percentage of DC in G0 gate of four independent 
experiments. Error bars represent standard error of the mean (SEM). (c) As 
for panel (a) but cell viability was assessed by Annexin V/PI staining, (d) Bar 
chart showing mean viable cells (lower left quadrant) as measured in (c) 
from three independent experiments. Error bars represent standard error of 
the mean.
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Figure 3.6. AAAPK activation in DC treated with LPS 
or H20 2
(a) DC were treated with H202 at the concentrations shown. At various 
times post-stimulation cells were harvested, lysed and analysed by Western 
blot for the total and phosphorylated forms of the MAPK as indicated. 
Positive and negative control lysates were prepared from 293T cells 
stimulated or not with UV light for 60 seconds. Representative of three 
independent experiments, (b) DC were treated with various concentrations 
of LPS for 60 minutes, lysed and analysed by Western blot for total and 
phosphorylated forms of MAPK as indicated, (c) Density of bands on 
autoradiographs from (b) analysed by densitometry. Representative of three 
independent experiments.
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Figure 3.7. MAPK activation and licB-a degradation 
in DC treated with LPS and H20 2
Response of DC to dual stimulation by LPS and H202. (a) DC were treated 
with various concentrations of LPS and H202 for 60 minutes, lysed and 
analysed by Western blot for total and phosphorylated forms of MAPK or 
total kB-a as indicated, (b) and (c) The density of selected bands from the 
autoradiographs analysed by densitometry. Representative of three 
independent experiments.
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Figure 3.8. Correlation between apoptosis and JNK 
activation induced by H20 2
(a) DC were treated with H202 at the final concentrations shown. At various times post­
stimulation cells were removed, lysed and analysed by Western blot. The density of phospho- 
and total-JNK p54 bands on the autoradiographs were analysed by densitometry. Phospho: 
Total density ratios are shown. Representative of three independent experiments, (b) DC were 
treated for one hour with various concentrations of H202 as shown. Cells were then washed and 
incubated in fresh medium overnight before analysis of total DNA content by propidium iodide 
staining and flow cytometry. Representative of three independent experiments is shown, (c) as 
for panel (b) except cell viability was assessed by annexin V/ propidium iodide staining and 
flow cytometry. Representative of three independent experiments is shown, (d) as for panel
(b) except cell viability was assessed by ability to reduce MTT. Mean of three independent 
experiments is shown, (e) Correlation between JNK activation and DC apoptosis. JNK activation 
is indicated by the ratio of Phospho: Total JNK p54 western blot band density following one- 
hour treatment with H202. The degree of apoptosis indicated is the % sub-G0 DC population as 
shown in (b), or the % PI positive and/or Annexin V positive DC as shown in (c).
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Figure 3.9. Effects of MAPK inhibitors on H20 2- 
induced JNK, p38, and c-jun activation
DC were incubated overnight with CEP11004 (a), SP600125 (b), or 
SB2032580 (c) inhibitor at the concentrations indicated. 1mM H202 was then 
added for 60 minutes prior to lysis and examination by Western blot for 
total or phosphorylated forms of JNK, p38 or c-jun proteins as indicated.
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Figure 3.10. Effects of MAPK inhibitors on H20 2- 
induced DC apoptosis
DC were incubated overnight with CEP11004, SP600125 or SB203580 
inhibitor prior to addition of H202 and incubation for a further 18 hours. Cell 
viability was then assessed by total DNA content by Annexin V/ propidium 
iodide staining and flow cytometry (a), by propidium iodide staining and 
flow cytometry (b), and by MTT reduction (c). (a) and (b) show results from 
one representative experiment of three, while (c) shows the mean of three 
experiments, (d) Mean percentage protection calculated from Annexin V/PI 
apoptosis measurements using the formula [(%LL )nh a  H202 treated " H202
tre a te d )/ (%LL Untreated '  % L L  H202 treated) X 10°] (where LL represents the % DC in
the lower left quadrant) from three experiments at optimal inhibitor 
concentrations.
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Figure 3.11. Effects of MAPK inhibitors on LPS- 
induced CD86 up-regulation
DC were incubated overnight with SB203580 or SP600125 inhibitor prior to 
addition of LPS (where indicated) and incubated for a further 18 hours. 
Expression of surface marker proteins was then analysed by flow cytometry. 
One representative (a), and mean median fluorescent intensities (b), of 
three independent experiments are shown.
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Figure 3.12. Inhibition of Protein Tyrosine 
Phosphatases by H20 2 and Na3V04 in DC
(a) DC were incubated for 15 minutes with various concentrations of H202 
prior to lysis and examination by Western blot for phosphotyrosine residues.
(b) DC were incubated for 15 minutes with 10mM H202 and then transferred 
to fresh medium. Lysates were made at various time points post stimulation 
as indicated and the degree of tyrosine phosphorylation examined by 
Western blot, (c) DC were treated for 15 minutes with various 
concentrations of Na3V04 as shown prior to lysis and examination by 
Western blot for phosphotyrosine, total or phosphorylated forms of MAPK as 
indicated. All blots representative of three independent experiments.
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3.3 Discussion
An important mechanism of innate immune response to invading microorganisms is the 
phagocytic respiratory burst, which results in an elevated level of ROS and H202 at the site of 
inflammation. In the same inflammatory microenvironment, immature DC act as sentinels for 
pathogen-derived molecules that stimulate them, in part via activation of AAAPK pathways, to 
mature, migrate to the draining lymph node and stimulate an adaptive immune response. This 
induction of DC maturation will therefore frequently occur at the site of inflammation, and as 
a result, these DC are likely to be exposed to very high local concentrations of ROS, as well as 
to proteins that have been altered by oxidation (Alderman et al., 2002). The susceptibility of 
DC to deleterious effects of these products is not the same as that of lymphocytes either from 
peripheral blood, or from lymphoid tissue. The situation is further complicated by the fact 
that ROS can have both activating and pro-apoptotic effects depending on target cell type 
and concentration (Kantengwa et al., 2003; Meier, 2001; Carmody and Cotter, 2001).
Although they are well known for their destructive effects on biomolecules, ROS are now 
widely accepted as intracellular second messengers in signaling pathways as modulators of 
physiological as well as pathological stimuli (Allen and Tresini, 2000). ROS production has 
been documented in response to cellular stimulation with ligands including angiotensin 
(Griendling et al., 1994), cytokines such as TNFa (Lo and Cruz, 1995) and TGF8 (Thannickal et 
al., 1998), and many growth factors including nerve growth factor (Sundaresan et al., 1995), 
platelet-derived growth factor (Meng et al., 2002), and fibroblast growth factor (Lo and Cruz,
1995). The precise mechanism of ROS signaling is incompletely understood, however, 
although ROS have been shown to enhance the function of various effector pathways including 
NF-kB (Schreck et al., 1991), AAAPKs (Wang et al., 1998), tyrosine kinases (Hardwick and 
Sefton, 1995), and PKC (Whisler et al., 1994).
Exposure to H202 has been implicated in signaling via AAAPKs in a variety of cell types 
previously. In the immune system there has been detailed analysis of T cell responses using 
cell lines, and T cell receptor (CD3/ CD28) stimulation (Los et al., 1995; Hehner et al., 2000; 
Kwon et al., 2003). In this study we have investigated the effect of H202 on AAAPKs in DC. We 
have also compared this with the response of DC not only to other maturation stimuli alone, 
but also with maturation stimuli and H202 in a synergistic fashion, thereby attempting to 
mimic the in vivo dual stimulation that is likely to be seen in inflammation. Our findings 
confirm that both H202 and LPS activate the p38 AAAPK pathway in DC. Whilst with LPS this 
coincides with DC maturation, no phenotypic changes were seen with H202 (figures 3.3 and 
3.4), in agreement with a recent study (Kantengwa et al., 2003).
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This uncoupling of the DC surface phenotype and p38 activation in DC is unexpected. As 
discussed in section 1.2.2, many previous studies have shown that p38 is part of the pathway 
leading to DC maturation in response to a variety of stimuli (Puig-Kroger et al., 2001; 
Ardeshna et al., 2000; Hacker et al., 1998). Furthermore, activation of p38 in DC by contact 
sensitizers has been shown to be mediated via generation of intracellular ROS (Mizuashi et 
al., 2005b; Bruchhausen et al., 2003; Mizuashi et al., 2005a), and ROS production in DC has 
also been demonstrated during antigen presentation (Matsue et al., 2003). Other studies have 
shown that H202can induce (or amplify) DC cytokine synthesis (Verhasselt et al., 1998), where 
the MAPK pathway may be an upstream component. Indeed, previous investigations have 
suggested a role for ROS in DC phenotypic maturation (Rutault et al., 1999; Basu et al., 2000). 
This latter apparent contradiction can perhaps be reconciled by the fact that in contrast to 
these previous studies data presented here was obtained using a very highly purified 
population of DC based upon an additional immunomagnetic negative selection step on day 4 
of culture (Alderman et al., 2002). DC prepared without this additional purification step do 
show a small upregulation of CD86 and MHC class II molecules in response to H202 (data not 
shown). Therefore we speculate that H202 induces DC maturation indirectly, and that this 
may be via effects on other cells and/ or their protein degradation products within the 
culture. For example, necrosis of lymphocytes in a surrounding microenvironment - and 
subsequent release of heat shock proteins may be a significant variable extrinsic to the DC, 
which has an influence on phenotype (Basu et al., 2000; Vabulas et al., 2002).
Our results confirm that activation of p38, while necessary, is not sufficient to stimulate DC 
maturation, indicating that alternative pathways are required. The activation of the NF-kB 
pathway is an obvious candidate (Rescigno et al., 1998; Yoshimura et al., 2001). NF-kB 
activation has indeed previously been shown to be essential for LPS-induced cytokine 
production (Bondeson et al., 1999). Accordingly, we found that H202 was incapable of 
inducing IkBo degradation and thus activation of NF-k B (figure 3.7a).
A dual p38/ NF-kB requirement is consistent with a recent study demonstrating that 
activation of p38 results in the modulation of chromatin structure and enhanced accessibility 
of NF-kB to the relevant elements in the promoters of cytokine genes and presumably other 
genes involved in DC maturation (Saccani et al., 2002). This model suggests that p38 is the 
coarse control while NF-kB controls the finer elements of the mature phenotype. H202 may 
therefore not activate DC despite inducing p38 phosphorylation because it does not activate 
NF-kB, which is known to be required for DC maturation.
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This hypothesis is supported by the fact that, in contrast to LPS, H202 did not induce IkBo  
degradation (figure 3.7a). Whenever LPS was present in the cultures there was less IkBo; i.e. 
there was more phosphorylation and degradation. Furthermore, H202 did not prevent LPS- 
induced IkBo degradation. Both of these observations correlate with the observed effects on 
DC phenotype; unlike LPS, H202 did not induce upregulation of any of the markers of 
maturation studied (figure 3.3), and moreover H202 did not prevent LPS-induced DC 
phenotypic maturation (figure 3.4a).
This inability of H202 to activate NF-kB is in contrast to many previous findings in other cell 
types. By using metabolic inhibitors and antioxidant enzymes it has been well established that 
oxygen radicals are involved in NF-kB activation, and that H202 alone can activate NF-kB, 
although the mechanism remains unclear. ROS have even been suggested to regulate NF-kB 
activation in response to TLR4 ligation in neutrophils (Asehnoune et al., 2004). Indeed, a 
model has been suggested proposing that NF-kB is redox sensitive and that its activation is 
due to the production of ROS by all agonists (Schreck et al., 1991), however this obligatory 
requirement for ROS has since been shown to be cell- and stimulus-specific (Majumdar et al., 
2002; Li and Karin, 1999; Rahman et al., 2004; Taylor et al., 2004). Alternatively, it remains a 
possibility that H202 does induce NF-kB activation in DC, but in the absence of IkBo 
degradation. Direct studies of NF-kB nuclear translocation and DNA binding capacity will be 
required to answer these questions.
The current molecular model whereby p38 plays a role in facilitating subsequent NF-kB- 
mediated transcription in DC (Saccani et al., 2002) may explain why the activation of p38 by 
H202 does not enhance the maturation activity of LPS. The level of phospho-p38 reaches a 
plateau at 1ng/ml LPS (figure 3.6b and c). However, CD86 levels at this LPS concentration are 
submaximal (figure 3.4), proving that although essential for the process, p38 is not the 
limiting factor in upregulation of this maturation marker. According to the model, p38 may 
not be the limiting factor in CD86 upregulation because p38 is only required to make the 
promoters accessible to NF-kB. Once a level of phospho-p38 is attained at which NF-kB can 
access DNA, an increase in phosphorylated p38 will not necessarily lead to any further 
increase in maturation. Presumably 1ng/ml LPS induces sufficient phospho-p38 to allow CD86 
promoter accessibility, but insufficient activated NF-kB for maximum CD86 transcription. H202 
does not increase CD86 levels because despite phosphorylating p38, it does not induce further 
NF-kB activation.
Due to the availability of the selective inhibitors, the role of p38 in controlling DC maturation 
is well established. At the time of undertaking the experiments presented here, however, the
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role of the JNK pathway in this process had not been studied in human DC. We observed that 
the JNK inhibitor SP does not affect the ability of LPS to upregulate the costimulatory 
molecule CD86, establishing that JNK is not involved in controlling DC phenotypic maturation 
(figure 3.11). These findings have since been confirmed in recent published studies. In
particular, a study by Nakahara et al examines in detail the response of DC to LPS in the
presence of the SP JNK inhibitor (Nakahara et al., 2004). The results must be interpreted with 
care, because up to 20pM of the inhibitor was used, a concentration that we found to have 
non-specific effects (figure 3.9b). In fact, the authors confirm this assessment by 
demonstrating inhibition of JNK phosphorylation at concentrations above 1pM, in agreement 
with our own findings (figure 3.9b), despite the fact that inhibition of JNK itself should not 
prevent JNK phosphorylation. The data they present using 1pM SP is also extremely consistent 
with those presented here. In contrast to the control SB p38 inhibitor, they find no effect of 
JNK inhibition on LPS-induced upregulation of several DC maturation markers, including CD86. 
Expression of CD54 and CD80 demonstrate slightly reduced up-regulation in the presence of 
the inhibitor, suggesting a minor role for JNK in the control of the LPS-induced expression of 
these proteins. Unfortunately, we did not examine the effects of the inhibitor on the
expression of these markers. The authors also found no effect of JNK-inhibition on the
secretion of a panel of cytokines including IL12p70, IL6 and TNFa. Overall, the findings of 
Nakahara et al provide strong support for our conclusion that JNK has little or no role in the 
control of DC maturation in response to LPS.
There is also further support for such an interpretation provided by other studies. For 
example, it has been shown that it is possible to induce DC maturation including expression of 
surface and secreted proteins and T cell proliferation in the absence of JNK activation 
(Brittingham et al., 2005), and furthermore, the regulation of CD86 expression on dendritic 
cells by LIGHT has been shown to be mediated through a JNK-independent signal transduction 
pathway (Zou and Hu, 2005).
In contrast to the absence of synergy between H202 and LPS in terms of upregulation of DC 
phenotype, co-operation between H202 and LPS is clearly observed in both JNK activation 
(figure 3.7) and in the induction of DC apoptosis (figure 3.5). JNK activation induced by H202 
alone correlates well with DC apoptosis (figure 3.8). Furthermore, CEP (figure 3.9a), and SP 
(figure 3.9b) both inhibit JNK and cause significant inhibition of cell death (figure 3.10). In 
contrast, inhibition of p38 had much less effect on H202-induced apoptosis, suggesting a 
limited role for p38 in this process.
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In RAW macrophages, inhibition of RANK-induced JNK by SP prevents apoptosis (Bharti et al., 
2004), and overexpression of a JNK kinase induced apoptosis, supporting the hypothesis that 
JNK regulates apoptosis in myeloid cells. Indeed, a role of JNK in stress-induced pro-apoptotic 
signaling is consistent with much data in other cell types (Chen and Tan, 2000), although the 
precise role of JNK in H202-induced apoptosis is not clear. In some cell types, the pro- 
apoptotic JNK response is modulated, like many JNK-dependent processes, via AP1-dependent 
transcription. Both SP and CEP inhibitors prevented c-jun (and hence AP1) activation by H202, 
indicating that this is a plausible mechanism in this case. One such protein controlled by JNK 
in this fashion is FasL, which is expressed on the cell surface, and mediates autocrine Fas 
ligation, and hence Fas-dependent apoptosis (Suhara et al., 1998). This mechanism is unlikely 
to apply to DC, however, since Fas engagement has been shown to induce DC maturation 
rather than apoptosis (Rescigno et al., 2000). Indeed, DC express high concentrations of cFLIP 
and this is thought to prevent caspase activation by death-domain containing surface 
receptors (Willems et al., 2000).
JNK-induced apoptosis may also occur via transcriptionally independent mechanisms. For 
example, it has recently been shown that JNK activation by TNFa causes processing of the 
Bcl2-related protein Bid into jBid, which then targets the mitochondria to release the 
apoptogenic factor smac/Diablo, which activates caspase-8 (Deng et al., 2003). JNK has also 
been shown to activate the caspase-9 pathway by inducing cytochrome c release from the 
mitochondria (Tournier et al., 2000) in response to UV radiation, although the mechanism for 
this is unclear.
In a recent report it has been shown that DC survival is critically dependent on the relative 
activities of NF-kB, which has a pro-survival function, and JNK/ AP1, which (consistent with 
our own findings) is pro-apoptotic (Kriehuber et al., 2005). Furthermore, these authors 
suggest that DC survival is enhanced by suppression of JNK by NF-k B, and this is achieved by 
NF-KB-dependent suppression of ROS levels, which function to activate JNK (also consistent 
with data presented here). According to this model, ligation of different DC surface receptors 
induces different relative activities of these two transcriptional activation pathways, and thus 
different DC longevities. Indeed, it is suggested that ligation of CD40 at the immunological 
synapse stimulates NF-kB-, but not JNK activation and thus favours DC survival (Kriehuber et 
al., 2005). This model complements our own findings that H202 induces JNK activation and 
thus apoptosis, but also that this outcome is enhanced by the absence of H202-induced NF-kB 
activation.
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The mechanism of ROS-induced MAPK activation is not fully understood (Forman et al., 2004). 
Much of the previous work has been in neurons (Levinthal and Defranco, 2004). With respect 
to H202 specifically, there is much evidence for a role of Apoptosis Signal Regulating Kinase 
(ASK-1) in the induction of JNK activation (Tobiume et al., 2001; Huyer et al., 1997). The 
model proposes that ASK-1 is sequestered in an inactive state by the redox-sensitive 
thioredoxin protein. Upon exposure to oxidative stress, the conformation of thioredoxin is 
altered, since thioredoxin is cysteine rich and its oxidation results in the formation of many 
disulphide bridges. As a consequence, ASK-1 is released and activates JNK, which mediates 
the stress response and apoptosis (Saitoh et al., 1998). However, this model cannot be the 
major pathway for JNK activation in DC since inhibition of an alternative JNK activator, MLK, 
by CEP completely abrogates the activation of JNK by H202 (figure 3.9a). Furthermore, 
apoptosis is prevented by this inhibitor to almost the same degree as by the JNK-specific 
molecule SP, suggesting that upstream JNK activatory proteins, other than MLK, have minimal 
roles in H202-induced JNK activation in DC. MLK has been shown to be important in neuronal 
apoptosis induced by NGF-deprivation (Mota et al., 2001; Xu et al., 2001) supporting the 
hypothesis that MLK is the main regulator of H202-induced DC apoptosis.
H202 is known to be capable of oxidising cysteine residues, for example in the deactivation of 
thioredoxin, but the consequences of this depend on the molecular context, and therefore 
the pKa, of the specific cysteine that is being oxidised. Most cysteines have an alkaline pKa. In 
protein tyrosine phosphatases (PTPs), the catalytic cysteine interacts with other critical 
residues such that i t ’s pKa is reduced to acidic levels (pKa 4.7-5.4), and therefore in these 
proteins, the catalytic cysteines exist as thiolate anions [cys-S ] at neutral (or physiological) 
pH. This species is essential for the catalytic mechanism of phosphate removal in which a 
thiol-phosphate intermediate [cys-S-P03] is formed. Clearly therefore, the reversible 
oxidation of this thiolate by H202 (to sulphenic acid [cys-S-OH] (Salmeen et al., 2003; Forman 
et al., 2004)) will inhibit the action of PTPs transiently (Soberman, 2003).
Inhibition of PTPs allows tyrosine phosphorylation of intracellular proteins to proceed 
unchecked. The importance of this is underlined by the observation that active PTPs have a 
100-1000 times higher turnover rate in comparison to tyrosine kinases (Reth, 2002), and thus 
signal propagation would continue unchecked unless PTPs terminate this signal. Inhibition of 
PTPs is therefore a very efficient mechanism for enhancing kinase signaling, and clearly this 
offers a potential mechanism for signal propagation by H202.
There is much evidence that inhibition of PTPs by H202 is a physiologically important event 
during cell signaling. Transient PTP inhibition by H202 has been suggested to play a
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physiological function in regulating signaling by cell surface receptors in response to mitogens 
such as PDGF (Finkel, 2000), which initiates a signaling cascade involving tyrosine 
phosphorylation of the receptor. However, ligand binding also induces ROS generation, which 
amplifies signal propagation by transiently inhibiting the phosphatases that would otherwise 
terminate the signal prematurely (Meng et al., 2002). H202 has also been shown to inhibit PTP 
activity of CD45 in jurkat T lymphocytes (Secrist et al., 1993), and neutrophils (Fialkow et al., 
1994), and PTP activity of SHP1 is inhibited by H202 (Cunnick et al., 1998).
This mechanism of MAPK activation in DC via PTP inhibition by H202 is supported by the 
extensive tyrosine phosphorylation observed following H202 treatment of DC (figure 3.12a), 
indicating unrestricted tyrosine phosphorylation. Furthermore, Na3V04, an unrelated tyrosine 
phosphatase inhibitor (Huyer et al., 1997), also induces generalized tyrosine phosphorylation 
as well as specific phosphorylation of p38 and JNK (figure 3.12c). As with H202, a lower 
concentration of Na3V04 is required to activate p38 than JNK.
We have examined the ability of three different stimuli to activate MAPKs in DC; LPS, H202, 
and Na3V04, and all induce p38 activation at a lower concentration than JNK (figures 3.6 and 
3.12). Such a pattern of p38 and JNK activation in DC has also been reported with other 
stimuli (Bunyard et al., 2003; Aiba et al., 2003; Nakagawa et al., 2004).
This greater sensitivity of p38 than JNK to external stimuli requires interpretation in a 
physiological context. As has been described, the role of the p38 pathway is to induce DC 
maturation, whereas we have identified a role for JNK in the control of DC apoptosis. Via its 
ability to activate MAPKs, the role of H202 is to enhance the level of activation of these 
pathways induced by conventional stimuli, perhaps by inhibiting the phosphatases that 
deactivate them. Any additive effect of H202 on p38 activation induced by other stimuli is not 
transduced into increased DC maturation due to the inability of H202 to activate NF-kB as 
discussed above. However, in the case of JNK, H202 is capable of synergising with other 
stimuli in the induction of JNK activation (figure 3.7), and there appears to be a threshold 
level of phosphorylated JNK above which death is induced (figure 3.8).
These observations can be extrapolated in to a more general model for the role of ROS and 
stress-induced MAPK activation in DC regulation. In order to optimally perform their sentinel 
role, DC reside at the epicentre of any infectious site, in contact with many different stimuli 
and stresses, including not only microbial stimuli but also more generalized tissue damage 
(Gallucci and Matzinger, 2001; Ibrahim et al., 1995). The DC integrate all of these signals, and
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in the correct conditions, activate a maturation/ migration program. The activation of p38 is 
a key step in this process.
However, inflammation, the hallmark of infection carries its own inherent “dangers” . In 
particular, ROS (and reactive nitrogen species), are likely to be present at significant 
concentrations, and are highly reactive molecules, which can cause alterations to nucleic 
acids, proteins and lipids. These altered moieties will themselves feed back on to the DC. A 
response by a DC that has been too badly damaged by ROS exposure may trigger an 
undesirable, or defective output. Modification of macromolecules by ROS will also lead to the 
formation of many “neo-epitopes” to which the host is not tolerant, and which, if presented 
effectively, will generate an entirely unwanted anti-self response, with possible pathological 
consequences.
Therefore in our model, ROS combine with other stimuli to activate JNK to reflect the level of 
“danger” to which the DC is being exposed. Above a threshold (figure 3.13, right-hand 
pathway) there is a “safety valve” to limit DC function, via the induction of apoptosis.
ROS will be present in the highest concentrations in the very centre of an inflammatory 
microenvironment, and if any DC are induced to undergo JNK-driven apoptosis due to possible 
damage, it will be those located at this site (figure 3.13, right-hand pathway). Due to the 
high reactivity of ROS, they are very short-lived and diffuse only very short distances. 
Therefore at sites adjacent to the area of highest ROS production, there will be less potential 
for damage to DC, or other cells, but significant levels of pathogen-derived material. We 
therefore propose that it is the DC originating from these locations, at much less risk from 
ROS-induced damage, and less likely to internalise the fragments of ROS-damaged self-cells, 
which will undergo p38-driven maturation (figure 3.13, left-hand pathway).
Unfortunately, due to the difficulty in determining the precise site of activation of a 
responding DC, it is not possible to obtain supporting evidence for this model from published 
data in mice or other systems. Indeed, supporting evidence for this model will require 
sophisticated methods to monitor the precise site at which DC are activated to migrate to 
draining lymphoid tissue.
Previous studies have supported a model in which the level of antigen determines the Th1 / 
Th2 bias of the resulting immune response (section 1.3.2.3). Accordingly, low concentrations 
of antigen induce prolonged DC survival and a Th2 response, whereas higher pathogenic doses 
induce p38-driven IL12 production and Th1 responses. We now propose an extension to this
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model, in which, at still higher levels of stimulation, driven by high concentrations of 
inflammatory ROS production, DC do not mature but are induced to undergo JNK-induced 
apoptosis. This mechanism is postulated to limit the dangers of autoimmunity and/ or 
aberrant immune stimulation associated with over-activation of innate immunity.
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Chapter 4
Mixed Lineage Kinases
4. Mixed Lineage Kinases
4.1 Introduction
4.1.1 Mixed Lineage Kinases
In chapter 3 the role of JNK in DC maturation and apoptosis was probed using two small 
molecular weight inhibitors, SP, a direct inhibitor of JNK, and CEP, an inhibitor of an 
upstream kinase family, the mixed lineage kinases (MLKs). As discussed in section 1.3, MLKs 
are a family of serine/ threonine kinases, which act as AAAPK kinase kinases (MAP3K) (Gallo 
and Johnson, 2002). Most previous work on MLK proteins (especially MLK3) has been in 
neuronal cells, limited to their selective activation of JNK, with an important consequent role 
in the regulation of apoptosis (Wang et al., 2004). Accordingly, an analogous role in regulating 
apoptosis in response to oxidative stress was demonstrated in DC in the previous chapter.
More recently, however, MLKs have been implicated in a variety of other cellular functions, 
including cytokine secretion (Falsig et al., 2004), cell division (Swenson et al., 2003), and 
morphology and migration (Hirai et al., 2002). Their involvement in signaling pathways is also 
more complex than was first thought, since MLK3 has also been implicated in the upstream 
regulation of p38 and ERK MAPKs, and even the NF-kB pathway (Hehner et al., 2000), in 
addition to JNK (Chadee and Kyriakis, 2004).
The signaling pathways downstream of TLRs are currently the focus of intense research, and 
many of the components of these pathways have been studied using knockout mice. The vast 
majority of these studies examine the activation of NF-kB as an end-point, and therefore the 
activation of p38 and JNK has only been examined in a relatively limited fashion. As a result, 
the mechanism of activation of these MAPKs by TLR ligands is not fully understood. Many 
MAP3Ks have been implicated in this process, including Tak1, ASK1, MEKK1, and MEKK3, (Irie 
et al., 2000; Into and Shibata, 2005; Matsuguchi et al., 2003; Huang et al., 2004), and we 
therefore decided to investigate whether MLK proteins were also involved in this process.
4.1.2 Chapter aims
In the previous chapter we observed that inhibition of MLK prevented H202-induced p38 
activation in DC (figure 3.9). However, while H202-treatment did not induce DC maturation, 
the activation of p38 is known to be a critical step in the induction of DC maturation by other 
stimuli such as TLR ligands. We therefore wished to examine whether MLK functions in DC to 
activate p38 in response to TLR ligation.
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Three stimuli were chosen, LPS, poly (l:C), and zymosan, due to their strong capacity to 
activate DC, and the known differences in the intracellular signaling mechanisms of their 
receptors. LPS is a constituent of the cell wall of many gram-negative bacteria, and is known 
to ligate TLR4 (Qureshi et al., 1999), in addition to several non-signaling accessory receptors 
such as CD14. The purity of the LPS used in this study was not tested, and it is therefore not 
impossible that additional signaling pathways were not activated in parallel to TLR4.
Poly (l:C) is a synthetic double stranded RNA mimic, which activates TLR3 (Alexopoulou et al., 
2001). It is important to mention that poly (l:C) has also been suggested to induce type I 
interferon production via the cytosolic dsRNA-binding enzyme protein kinase R, independently 
of signalling through TLR3 (Diebold et al., 2005).
Zymosan is an insoluble preparation of yeast cell walls, primarily composed of beta-glucans, 
and activates DC via a heterodimer of TLR2 and TLR6 (Frasnelli et al., 2005). Due to the 
inexact constitution of zymosan preparations, it is likely that several different receptors will 
be stimulated, and in particular lectins which are strongly agonised by beta-glucans. Indeed, 
zymosan has also recently also been demonstrated to signal through the C-type lectin, 
Dectinl (Rogers et al., 2005), although the relative contributions of the lectin and TLR 
receptor systems has not been comprehensively investigated.
Since the expression of MLK proteins in DC has not previously been examined, we also 
investigated the expression of different MLK isoforms in DC.
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4.2 Results
4.2.1 Expression of MLK isoforms in DC
No data on the expression, activation, or function of MLKs in DC has previously been reported. 
We therefore wished to investigate which isoforms of the MLK family are expressed in DC, and 
to do this we used a nested PCR approach.
Our interest in the MLK family of MAP3Ks is largely due to the effects of the CEP inhibitor on 
DC function. As a priority, and a basis for further analysis, we therefore wished to investigate 
the expression of the inhibitor-sensitive MLK proteins rather than every member of the MLK 
family per se. As discussed in section 1.3.2, there are three families of MLK proteins, the 
MLKs, the DLKs, and the ZAKs. The CEP inhibitor is known to inhibit MLK1-3 of the MLK family. 
It also inhibits DLK, but not LZK, of the DLK family, however CEP does not inhibit the ZAK 
proteins, or other less closely related kinases such as PKC (Murakata et al., 2002). MLK4 has 
only recently been discovered. Indeed, it has not yet been shown to exist at the protein level 
in vivo. Because of this, the ability of CEP to inhibit MLK4 is not known. However, based on 
sequence similarity with MLK1-3, it is highly likely that CEP also inhibits MLK4, and for this 
reason we chose to also examine the expression of this enzyme in DC.
The design of the nested primer strategy was such that the PCR product crossed intron/ exon 
boundaries and thus distinguished the cDNA product from products arising from contaminating 
genomic DNA, due to different product sizes (figure 4.1). As a positive control for each PCR 
reaction we also amplified B-actin.
Four PCR experiments were performed in parallel for each MLK protein with different 
templates:
• No template - to confirm the lack of contamination of any of the reagents.
• Genomic DNA - as a positive control to confirm that the primer pairs were all 
functioning correctly.
• Complementary DNA - to investigate the presence of the particular MLK transcript.
• Non-reverse transcribed RNA - to confirm the lack of contamination of the RNA.
A first round of PCR was performed using the outer primer pair on each of the four templates 
in parallel. In the second round, the nested primer pair was used both on the above four 
templates, and on the products of the first round reactions.
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As shown in figure 4.2, PCR products of the correct size were obtained for MLKs 2, 3, 4, and 
DLK, but not MLK1 in immature DC. In each case, the identity of the product was confirmed 
by extraction from the gel and sequence analysis (data not shown).
4.2.2 Effects of TLR ligation on MLK3 phosphorylation
A fundamental question regarding MLK action in DC is whether these proteins are activated in 
response to DC maturation stimuli - this would clearly suggest a role in the regulation of the 
maturation process, and support the observations of the inhibitor studies.
As discussed in section 1.3, the activation of MLK proteins is both more complex and less 
completely understood than that of MAPKs. MLKs are believed to be phosphorylated at 
multiple sites, some of which are associated with enzyme activation while others are 
constitutive.
We next examined the expression and phosphorylation of MLK3, the most ubiquitous and 
extensively studied MLK (and hence the only MLK protein for which the appropriate reagents 
exist). The expression of MLK3 protein in DC was confirmed using polyclonal antibodies 
specific for total- and phosphorylated-MLK3. The antibody specific for phosphorylated-MLK3 
was raised against a short polypeptide containing phosphorylated threonine and serine 
residues. This polypeptide corresponds to a section of the activatory loop of MLK3 at which 
phosphorylation at thr277 and ser281 in a T T X X S motif is thought to result in MLK3 activation 
(Leung and Lassam, 2001). The antibody was tested in a timecourse of DC treated with LPS 
(figure 4.3a), and indicated that MLK3 phosphorylation occurs in response to LPS, and was 
maximal after 45 minutes. This peak occurs slightly more rapidly than maximal 
phosphorylation of p38 or JNK, which is observed after 60 minutes - figure 4.4.
We then examined the ability of different concentrations of the three stimuli, LPS, poly (l:C), 
and zymosan to induce MLK3 phosphorylation. Phosphorylated MLK3 was observed even in 
unstimulated cells. The pattern of bands obtained were interesting, in that two bands were 
consistently observed, possibly representing phosphorylated and hyperphosphorylated forms 
of MLK3 (Swenson et al., 2003). The effect of stimulation upon the intensity of the two bands 
was variable. In response to LPS, the lower band is of a higher intensity than the upper band, 
both in response to a timecourse of stimulation (figure 4.3a) and at all LPS concentrations 
(figure 4.3b). In response to poly (l:C), however, the two bands are of equivalent intensity at 
all concentrations (figure 4.3c). In contrast, little, if any, MLK3 phosphorylation was observed 
with any concentration of zymosan (figure 4.3d).
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4.2.3 Effect of MLK inhibition on activation of signaling pathways
Although originally described as a JNK-specific MAP3K (Rana et al., 1996), MLK3 has since 
been reported to also operate upstream of p38 (Gallo and Johnson, 2002; Tibbies et al.,
1996), ERK (Chadee and Kyriakis, 2004), and NF-kB (Hehner et al., 2000). We therefore 
wished to investigate which of these downstream pathways are regulated by MLK in DC in 
response to different TLR ligands.
To determine the optimum incubation time to induce maximal signal pathway activity, a 
timecourse of LPS stimulation of DC was performed (figure 4.4). The results indicated that 
the p38, ERK, and JNK AAAPK, and the NF-kB pathways were maximally activated 60 minutes 
after cell stimulation, therefore this incubation time was used in subsequent experiments. DC 
were then pre-incubated with 1pM of CEP, and then the ability of different concentrations of 
LPS, poly (l:C), and zymosan to activate the AAAPKs and NF-kB was examined. Control 
experiments indicated that the CEP inhibitor alone had no effects on the activation of any of 
the pathways (data not shown), and did not affect viability of the cells at the concentration 
used (data not shown).
As shown in figure 4.5, MLK inhibition does not prevent activation of the ERK pathway in 
response to LPS, poly (l:C), or zymosan, in fact, slight enhancement of ERK phosphorylation 
was observed in the presence of the inhibitor. The degradation of kBa is also not prevented 
by the inhibitor in response to any of the stimuli, suggesting that MLK does not regulate the 
canonical pathway of NF-kB activation in response to TLR ligation in DC.
Inhibiting MLK did not have the same outcome in terms of p38 and JNK inhibition in response 
to each stimulus. In response to both LPS and poly (l:C), CEP strongly inhibited the activation 
of p38 and JNK, however, in response to zymosan, very little effect on p38 activation was 
observed. JNK activation in response to LPS or poly (l:C) was also inhibited by CEP. 
Interestingly, however, JNK activation was not observed upon zymosan stimulation.
These data therefore suggest that the three stimuli activate AAAPKs via distinct AAAP3K 
pathways.
4.2.4 Effect of MLK inhibition on DC maturation
Given that MLK3 is activated by DC maturation stimuli (figure 4.3), that MLKs are upstream 
regulators of MAPKs in DC (figure 4.5), and that MAPKs have been shown to be important in
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controlling DC maturation, we next investigated the effects of MLK inhibition on DC 
maturation.
DC were stimulated with LPS, poly (l:C), or zymosan and were then examined for surface 
protein expression in the presence of MLK and AAAPK inhibitors. In addition to the CEP MLK 
inhibitor, inhibitors of the three AAAPK pathways were used, SB and SP for p38 and JNK 
respectively, and PD98059 (PD), an inhibitor of ERK-specific AAAP2Ks (Dudley et al., 1995).
Three primary phenotypic markers of DC maturation were chosen, reflecting the primary 
antigen specific signal (HLA-DR), a co-stimulatory signal (CD86) and a terminal 
differentiation/maturation signal (CD83). These cell surface markers have proved very 
consistent and reproducible cell surface indicators of DC maturation.
To determine the optimal concentration of LPS, poly (l:C), and zymosan to induce DC 
maturation, DC were incubated with different concentrations of the three stimuli, and the 
relative levels of maturation were determined by examination of CD86 and HLA-DR expression 
(figure 4.6).
The use of the CEP inhibitor has not been widely reported, therefore various concentrations 
of CEP were tested on LPS-induced CD86 upregulation, and 1pM was found to give maximal 
inhibition (figure 4.7).
The ability of the inhibitors alone to influence the expression of the three surface markers 
was examined, and none of the inhibitors were found to significantly alter the level of 
expression of any of the three proteins (figure 4.8).
The effect of the inhibitors on the expression of the three DC maturation markers, CD83, 
CD86, and HLA-DR, in response to stimulation with LPS, poly (l:C), or zymosan was then 
examined. All three markers were found to behave very similarly, both in terms of response 
to TLR ligation, and in terms of pharmacological intervention (figure 4.9). In response to LPS, 
poly (l:C) and zymosan there was clear evidence of maturation as judged by increase in CD83, 
CD86, and HLA-DR expression. 10pM of p38 inhibitor SB203580 was used as a result of findings 
in Chapter 3 in which this concentration was found to fully inhibit LPS-induced CD86 
upregulation. Consistent with this, inhibition of p38 blocked upregulation of all three of the 
surface markers examined in response to all three stimuli. This observation confirms and 
extends previous studies emphasizing the central role for this AAAPK in controlling DC 
maturation. In contrast, in extension to the observations of chapter 3, blocking the JNK
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pathway did not significantly inhibit upregulation of any marker in response to any of the 
stimuli. ERK inhibition also had no effect on the stimulation-induced level of expression of the 
three markers.
In contrast to the MAPK inhibitors, the inhibitory activity of CEP was highly dependent on 
which TLR stimulus was tested. Upregulation of all three markers induced by LPS or poly (l:C) 
was blocked by the MLK inhibitor, to the same extent as by the inhibitor of p38 (figures 4.9a 
and b). In contrast, MLK inhibition had no effect on the upregulation of surface markers 
stimulated by zymosan (figure 4.9c).
4.2.5 Effect of MLK inhibition on cytokine secretion by DC
To further examine the effect of inhibiting MLK or MAPK on DC maturation, the secretion of 
three cytokines, TNF-a, IL10, and IL6 was studied.
Preliminary studies indicated a requirement for a larger number of DC per group than for the 
phenotype experiments in order for cytokine production to reach the detection limit of the 
assay. For this reason, we decided to examine in parallel the effects of MLK and p38 
inhibition only. These protein families appear to be both linked (figure 4.5), and involved in 
the regulation of DC maturation (figure 4.9). The ERK pathway has been suggested to be 
involved in the regulation of DC cytokine secretion (section 1.2.2.3), however, ERK does not 
appear to be downstream of MLK, since MLK inhibition does not prevent ERK phosphorylation 
(figure 4.5). JNK phosphorylation is regulated by MLK (figure 4.5), but we had thus far 
observed no evidence for a role of JNK in the control of maturation - indeed zymosan did not 
induce JNK phosphorylation (figure 4.5c).
The SB and CEP inhibitors were found to have no significant effect on cytokine secretion when 
added to the DC in the absence of any other stimulus (figure 4.10).
As for cell surface phenotype, p38 inhibition by SB blocked secretion of all cytokines, in 
response to all stimuli, with one exception, i.e. the release of TNFa in response to zymosan 
(figures 4.11a, b, and c). In contrast, inhibition of MLK using CEP blocked cytokine secretion 
in response to LPS and poly (l:C), but had no inhibitory effect on any cytokine secreted in 
response to zymosan. In response to LPS, the degree of inhibition achieved by SB and CEP was 
similar, however, in response to poly (l:C), CEP had a greater inhibitory effect than SB on the 
secretion of all three cytokines.
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To rule out that the selectivity between LPS and zymosan was simply a dose-related effect, 
the release of the three cytokines was tested at a series of different CEP inhibitor 
concentrations (figures 4.11d and e). A reduction in the secretion of all cytokines in response 
to LPS was seen even at the lowest concentration of CEP used. In contrast, no inhibition of 
the zymosan-induced response was seen at any concentration.
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Figure 4.1. PCR Experimental design to assay MLK 
expression in human DC
Primers corresponding to known MLK isoforms were designed spanning small 
intronic regions of the genomic sequences to control for DNA contamination 
of the extracted RNA due to different sized products. To maximise 
stringency and sensitivity of detection of MLK protein synthesis, a nested 
strategy was used whereby one or two primers were designed to be used in 
a second PCR reaction using the first round product as template. B-actin 
primers were used as positive controls.
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Figure 4.2. MLK isoform expression in human DC
Genomic DNA and total RNA were purified from immature DC and total RNA 
was then converted to cDNA. Left panels - first round of PCR (using the 
outer primers), right panels - second PCR cycle (using the nested primers). 
In both cycles the following templates were used: No template (to control 
for contamination of the primers or other components of the PCR reaction 
mixture), gDNA, cDNA, and non-reverse transcribed RNA. In the first PCR 
cycle, p-actin primers were used as control for RNA quality and purity. In 
the second cycle, products of the first cycle were used as templates in 
parallel to the particular template in question.” 1st”  - product of first round 
PCR reaction used as template. Negative images shown.
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Figure 4.3. Induction of MLK3 phosphorylation by 
TLR ligands
(a) DC were treated with LPS (100ng/ml) and at various times post­
stimulation cells were harvested, lysed and analysed by Western blot for 
the total and phosphorylated forms of the MLK3 as indicated, (b-d) DC were 
treated with various concentrations of (b) LPS, (c) Poly (l:C), or (d) Zymosan 
for 45 minutes as indicated and were then harvested, lysed and analysed by 
Western blot for the total and phosphorylated forms of MLK3 as indicated.
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Figure 4.4. LPS-induced p38, JNK, ERK, and NF-kB 
activation in DC
(a) DC were treated with 100ng/ml LPS for various lengths of time as 
indicated. Cells were then harvested, lysed and analysed by Western blot 
for the Total or phosphorylated forms of p38, JNK, ERK, and kBa as 
indicated. Representative of three independent experiments, (b) 
Densitometric analysis of (a). Band intensities were corrected to the 
intensity of the equivalent T-p38 band and then normalised to a value of 1 
for the unstimulated (t=0) density (see materials and methods).
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Figure 4.5. Effect of MLK inhibition on LPS, PI:C, or Zymosan induced AAAPK activation
DC were treated for 18 hours with the MLK inhibitor CEP11004 (1pM) prior to stimulation with various concentrations of LPS 
(a), Poly (l:C) (b), or Zymosan (c) as indicated. At 60 minutes post-stimulation cells were harvested, lysed and analysed by 
Western blot for the phosphorylated forms of p38, ERK, and JNK MAPK, and total-kBa as indicated. Representative of three 
independent experiments.
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Figure 4.6. Effect of LPS, PI:C, and Zymosan on DC expression of CD86 and HLA-DR
DC were treated for 18 hours with various concentrations of LPS (a), Poly (l:C) (b), or Zymosan (c) as indicated. Expression 
of surface marker proteins was then analysed by flow cytometry. One representative (top panel), and normalised mean 
median fluorescent intensities (lower panels), of two independent experiments are shown.
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Figure 4.7. Effect of MLK inhibition on LPS-induced 
CD86 Expression
DC were incubated for 18 hours with various concentrations of CEP11004 
inhibitor prior to addition of LPS and incubation for a further 18 hours. 
Expression of CD86 was then analysed by flow cytometry. Representative of 
at least 3 individual experiments.
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Figure 4.8. Effects of inhibitors on DC surface 
marker expression
DC were incubated overnight with SB203580 (10jjM), PD98059 (10 i^M), 
SP600125 (1|xM), or CEP11004 inhibitor. Expression of CD83, CD86, 
and HLA-DR was then analysed by flow cytometry. Median fluorescence 
intensity data was collected and normalised to a value of 100% for the no 
inhibitor control group. The mean values from at least three individual 
experiments were calculated. Error bars indicate standard error of the 
mean. (SB; SB203580 10pM, PD; PD98059 10 pM, SP; SP600125 1pM, CEP; 
CEP11004 1pM).
Figure 4.9. (Overleaf) Effects of inhibitors on the 
LPS, poly (l:C), or zymosan-induced expression of 
CD83, CD86, and HLA-DR in DC
(a-c) Upper panels; DC were incubated overnight with SB203580 (10pM), PD98059 (10pM), 
SP600125 (1pM), or CEP11004 (1pM) inhibitor prior to addition of LPS (a), poly (l:C) (b), or 
zymosan (c) as indicated and incubated for a further 18 hours. Expression of CD83, CD86, and 
HLA-DR was then analysed by flow cytometry. Representative of at least 3 individual 
experiments. Lower panels; Analysis of the effect of MAPK and MLK inhibition on DC expression 
of CD83, CD86, and HLA-DR. Experiments were performed as described for the upper panels 
and median fluorescence intensity data was collected and normalised to a value of 100% for the 
stimulus control group. The mean values from at least three individual experiments were 
calculated. Error bars indicate standard error of the mean, and asterisks indicate p<0.05 versus 
stimulus control (calculated from pre-normalised MFI values). (SB; SB203580 10pM, PD;
PD98059 10 pMSP; SP600125 1pM, CEP; CEP11004 1pM)
No Stimulus
CD86 
CD83 
□  HLA-DR
con SB PD SP CEP
0 ©
CD83 CD86 HLA-DR CD83 CD86 HLA-DR
No Inhibitor 
No Stimulus
No Inhibitor 
100ng/ml LPS
10|jM SB203580 
100ng/ml LPS
10pM PD98059 
100ng/ml LPS |
1pMSP600125 
100ng/ml LPS |i
1pM CEP11004 
100ng/ml LPS
UQC“1
fD
NO
rt>2 HI fo*
20Qiq» io’ io» io1 104 ”, l<l~ M '
O  120
C  100
0
CD83 CD86 HLA-DR
10° 101
No Inhibitor 11 
10pg/ml Zym
10|jM  SB203580 j 
10ng/ml Zym
10mM PD98059 j j 
10ng/ml Zym
1 |jM SP600125 |f 
10ng/ml Zym I
1(jM CEP11004 |;i 
10pg/ml Zym I
con SB PD SP CEP
0> W 10“ 10' 10* 10J TO*
O 120
c  100
con SB PD SP CEP
No Inhibitor 
No Stimulus
No Inhibitor 
25pg/ml PI:C
10pMSB203580 
25pg/ml PI:C
10pM PD98059 
25pg/ml PI:C
1 |jM SP600125 i 
25|jg/ml PI:C !
h
1mMCEP11004 
25pg/ml PI:C i/
MCD86 
HCD83 
□  HLA-DR
I
120
■  TNFa
100 m \n o
□  l L6
80
co 60
40
0
+ Zymosan 
SB CEP Inhibitor
Figure 4.10. Effects of inhibitors on DC cytokine 
secretion
DC were incubated overnight with no inhibitor, SB203580 (10jaM), or 
CEP11004 (1pM). Supernatants were then harvested and analysed for TNFa, 
IL10, and IL6 content by cytometric bead array assay. For comparison 
purposes, data were adjusted such that cytokine concentrations of DC 
treated with 10pg/ml Zymosan are indicated as 100%. (SB; SB203580 10pM, 
CEP; CEP11004 1pM).
Figure 4.11. (Overleaf) Effects of inhibitors on the 
LPS, poly (l:C), or zymosan-induced secretion of 
cytokines by DC
DC were incubated overnight with no inhibitor, SB203580 (10pM), or CEP11004 (1pM) 
prior to addition of LPS (a), poly (l:C) (b), or zymosan (c) as indicated and incubated 
for a further 18 hours. Supernatants were then harvested and analysed for TNFa, IL10, 
and IL6 content by cytometric bead array assay. For comparison purposes, data were 
adjusted such that cytokine concentrations of the stimulus control group were 
indicated as 100%. Absolute values of cytokines are indicated above the control bars in 
pg/ml. Note; absolute values for LPS groups are not comparable with poly (l:C) or 
zymosan groups. Mean of 3 independent experiments. Error bars indicate standard 
error of the mean, and asterisks indicate p<0.05 versus stimulus control (calculated 
from raw cytokine concentration values). DC were incubated overnight with various 
concentrations of CEP11004 as indicated prior to addition of 100ng/ml LPS (d) or 
10pg/ml Zymosan (e) and incubation for a further 18 hours. Supernatants were 
harvested and analysed for TNFa, IL10, and IL6 content by cytometric bead array 
assay. For comparison purposes, data were adjusted such that cytokine concentrations 
of the stimulus control group were indicated as 100%. Absolute values of cytokines are 
indicated above the control bars. Representative of three independent experiments.
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Figure 4.11.
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4.3 Discussion
The identity of the MAP3Ks involved in TLR signaling and DC maturation remains poorly 
defined. Previous studies have implicated TGFp-activated kinase 1 (TAK1), although it 
remains unclear whether the major function of this kinase is to activate p38 MAPK, or to 
regulate NF-kB directly (Jiang et al., 2004; Irie et al., 2000; Irie et al., 2000). Several other 
MAP3Ks have been implicated in p38 and JNK MAPK activation downstream of TLRs including, 
MEKK1 (Matsuguchi et al., 2003), MEKK3 (Huang et al., 2004), and ASK1 (Into and Shibata, 
2005). The expression and function of other MAP3Ks, and specifically the MLK family of 
proteins in DC has not been investigated previously.
In this study we found that of the five MLK enzymes investigated, mRNA for four was 
expressed in DC. Only MLK1 was not detected. In the only other study investigating MLK 
expression in haematopoietic cells, MLK1 was found to be present in the monocytic THP1 cell 
line, but at the lowest abundance of the three MLK proteins examined (Ciallella et al., 2005). 
We were not anticipating observing the expression of such a large proportion of MLK isoforms, 
because the different isoforms have previously been shown to display relatively limited 
patterns of expression. In contrast to the ubiquitous MLK3, MLK1 has only been observed in 
epithelial cells and, consistent with this observation, we did not find it in DC. As previously 
described, MLK4 has only very recently been identified and thus its pattern of expression is 
unknown, although we can now state that its message at least, is present in DC. Surprisingly, 
we observed expression of MLK2 and DLK proteins, and yet both isoforms are thought to be 
essentially neuronally restricted. A plausible explanation for this is that these proteins are in 
some way involved in the regulation of cellular morphology, as has previously been suggested 
(section 1.3.5). Dendritic cells share with neurones the ability to extend long projections, or 
dendrites, and indeed when DC were first identified, they were thought to be a type of nerve 
cell. It would therefore be interesting to investigate whether the formation of these 
projections is regulated by the MLK2 and DLK proteins.
The mechanism of MLK proteins in TLR signalling has not been reported, although inhibitor 
studies have recently suggested the involvement of MLK in both cytokine secretion and p38 
and JNK activation in response to LPS in other cell types (Ciallella et al., 2005; Lund et al., 
2005; Lund et al., 2005). However, there is no existing evidence for a mechanism of signal 
transmission between TLRs and MLKs, and a speculative discussion of potential mechanisms 
can be found in Chapter 6.
In this study a link between at least one member of the MLK family, MLK3, and TLR signaling 
was demonstrated by showing that MLK3 is phosphorylated in response to the TLR4 ligand LPS,
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and the TLR3 ligand poly (l:C). In contrast, the TLR2/6 ligand zymosan showed only a very 
slight transient effect on MLK3 phosphorylation. The precise role of phosphorylation in 
controlling MLK3 activity is complex and not well understood, and may reflect a combination 
of auto-phosphorylation and para-phosphorylation by kinases including AKT2 (Figueroa et al., 
2003) and germinal centre kinases (Chadee et al., 2002). The phosphorylation induced in 
response to TLR ligation, was not blocked by the MLK inhibitor CEP (not shown) suggesting 
that an additional kinase was involved linking the ligation of TLR to MLK activation, rather 
than simply an autophosphorylation event. An alternative explanation is that the CEP inhibitor 
functions in such a way that autophosphorylation of MLK proteins is not prevented, whereas 
the subsequent phosphorylation of substrate proteins is inhibited. We consistently observed 
two bands when immunoblotting for phosphorylated MLK3. It is possible that one of these 
bands represents a non-MLK3-specific target of the antiserum. However, 12 potential 
phosphorylation sites have been observed in MLK3 (Vacratsis et al., 2002), and so it is possible 
that phosphorylation at the activatory loop induces further phosphorylation events, resulting 
in a hyperphosphorylated MLK3 species possessing a slightly different electrophoretic 
mobility. Indeed, hyperphosphorylation of MLK3 has previously been demonstrated (Swenson 
et al., 2003).
The timecourse of activation, which peaked after approximately 45 minutes (figure 4.3), was 
consistent with a function in downstream activation of MAPKs, since maximal phosphorylation 
of p38 and JNK is observed slightly later, at around 60 minutes post-stimulation (figure 4.4). 
The temporal link between MLK and MAPK activity was further supported by pharmacological 
studies using the selective MLK inhibitor CEP. In agreement with several other studies, 
inhibition of MLKs interfered with downstream signaling via both the p38 and JNK MAPK 
pathways (figure 4.5). Remarkably, the involvement of MLK was again very stimulus 
dependent. Inhibition of MLK blocked p38 and JNK activation in response to both LPS and poly 
(l:C), but had little or no effect on p38 activation by zymosan. Thus activation of p38 is a 
common end-point in signaling via TLR3 and 4, and TLR2/6, but is mediated via different up­
stream pathways.
MLK inhibition did not prevent ERK activation in response to any of the stimuli, indicating that 
MLK does not regulate the activation of ERK in DC. Previous reports have also implicated MLK 
in the induction of kBa degradation and consequent activation of NF-kB (Hehner et al., 
2000), and we therefore investigated the ability of CEP to prevent kBa degradation. CEP did 
not prevent degradation of kBa, suggesting that in DC, MLK proteins do not regulate NF-kB 
activity.
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The fact that JNK phosphorylation was not observed in response to zymosan (figure 4.5) lends 
support to the theory outlined in chapter 3 that the role of the JNK pathway in the control of 
DC maturation is minimal. Furthermore, whilst LPS and poly (l:C) induced a significant degree 
of apoptosis at the highest concentrations tested, no apoptosis was observed in response to 
zymosan at any concentration (data not shown), consistent with the hypothesis that JNK is 
involved in controlling stress-induced DC apoptosis (chapter 3). However, in the previous 
chapter, JNK activation was observed at higher concentrations than p38 in response to both 
LPS and H202 treatment of DC, so it may be that higher concentrations of zymosan than those 
used here are required to activate JNK. JNK, and in particular the JNK-sensitive transcription 
factor AP1 has been implicated in zymosan-dependent transcription in other cell types (Tran- 
Thi et al., 1995).
The bifurcation between TLR ligation and downstream signaling is further reinforced by 
examining the selective effects of the MLK inhibitor on DC function. Consistent with previous 
reports, no reduction of expression of CD83, CD86, or HLA-DR was observed in the presence of 
the ERK inhibitor PD, and indeed LPS-induced surface marker expression was enhanced, as has 
been reported previously (Puig-Kroger et al., 2001). In extension to the observations of 
chapter 3, JNK inhibition did not significantly inhibit upregulation of any of the surface 
markers in response to any of the stimuli, supporting the idea that JNK plays only a minimal 
role in controlling DC maturation. Inhibition of p38, however, reduces the upregulation of 
surface markers and the secretion of all cytokines in response to all three stimuli. The only 
exception was the induction of TNFa by zymosan on which p38 inhibition had no effect. This 
was a surprising observation given the apparently ubiquitous role of p38 in the control of DC 
maturation in response to all the stimuli that we had investigated. Further quantitative 
differences can be observed between the pharmacological profiles of all three stimuli (LPS, 
poly (l:C), and zymosan) suggesting the picture is even more complex, but these will require 
more detailed future analysis. Indeed, the regulation of cytokine production is multifaceted, 
and known to occur at several levels, including transcriptionally and post-transcriptionally, 
and therefore probably also includes cell-type-specific regulatory mechanisms. The CEP 
inhibitor prevented both the upregulation of surface markers and the secretion of cytokines 
induced by LPS and poly (l:C), and this is consistent with a previous report in which this 
inhibitor was shown to inhibit LPS-induced TNFa and IL6 secretion from THP1 monocytes, and 
in vivo (Ciallella et al., 2005). In contrast, pre-treatment of cells with the MLK inhibitor did 
not affect the ability of zymosan to induce upregulation of surface markers or cytokine 
secretion. Thus, whereas inhibition of p38 MAPK inhibits both cell surface phenotype changes 
and cytokine secretion in response to LPS, poly (l:C) and zymosan, inhibition of MLK blocks 
the responses to LPS and poly (l:C), but not Zymosan.
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The difference in MLK dependence of different TLR pathways remains to be explained at a 
molecular level. It is important to emphasise that although the three stimuli used in this 
study are known to be strong TLR agonists, they may not be exclusively targeting TLR-induced 
signaling pathways (as outlined above). Indeed, this is one possible explanation for the 
dichotomy in outcomes obtained with the different stimuli. Assuming the ligands used are 
specifically stimulating TLRS, one attractive hypothesis is that the differences in MLK 
utilisation by LPS and poly (l:C) versus zymosan may reflect the utilization of different 
intracellular adaptor proteins by the TLRs. Analysis of mice deficient for different adaptor 
proteins indicates that TLR3 and TLR4, but not TLR2, posses a strong signaling requirement 
for the TIR-domain-containing adaptor inducing IFN-p (TRIF) protein (Yamamoto et al., 2003) 
(section 1.2.2.4). The observed effects are similar to those reported here and suggest that 
TRIF-dependent MAPK activation may operate via MLK. This hypothesis will be discussed in 
more detail in chapter 6.
Another explanation for the different MLK dependency of the three stimuli is that zymosan is 
known to ligate a second receptor on the surface of DC in addition to TLR2/6, called Dectin-1 
(Rogers et al., 2005). Dectin-1 is a C-type lectin, which recognises carbohydrate moieties of 
zymosan and has been shown to be essential for IL2 and IL10 production via syk tyrosine 
kinase-induced intracellular signaling. The full implications of this signaling pathway in DC are 
not known, however it is clearly possible that by using this parallel pathway zymosan is able 
to by-pass MLK in activating p38.
The involvement of the MLK family in the regulation of DC maturation has not been previously 
reported. Our results are consistent with a role for MLKs as MAP3Ks, inducing the 
phosphorylation and activation of the downstream kinases p38 and JNK. However, the 
majority of the data presented in this chapter are based upon inhibitor studies, and thus 
require confirmation using alternative approaches. For example, RNAi technology may be 
used to delete specific MLK isoforms and thus further dissect the role of MLK proteins in the 
control of DC maturation. Such studies have previously been used to identify roles for MLK3 in 
ERK activation (Chadee and Kyriakis, 2004) and cell cycle regulation (Swenson et al., 2003). 
However, the homology between the members and the functional degeneracy that this 
homology may permit will make this approach very difficult. Indeed, an MLK3-deficient mouse 
has recently been reported, and demonstrated far fewer phenotypic aberrations than one 
might expect given the number and variety of putative MLK3 functions (Brancho et al., 2005). 
This clearly reflects the ability of the MLK proteins to functionally compensate for one 
another.
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Despite the fact that the use of inhibitors is not without limitations (section 1.2.1), 
phosphorylation of MLK3 was observed in response to DC stimulation using phospho-specific 
antibodies. We feel that this observation underpins the data obtained with the CEP inhibitor. 
In particular, we found a much lower degree of MLK3 phosphorylation in response to zymosan 
relative to LPS or poly (l:C), and this complements the inhibitor data, which reflects a 
significant role for MLK in the induction of DC maturation by LPS and poly (l:C), but not 
zymosan.
The most important finding, however, is the demonstration that different TLRs utilize 
different MAP3K to activate their respective intracellular pathways. The identity of the TLR 
agonist is one of several factors important in determining the T cell polarization of the 
resulting immune response and clearly the differential involvement of signal transduction 
proteins such as the MLKs may regulate the polarity of this outcome. TLR2 ligands have 
previously been implicated in the induction of Th2 responses (Agrawal et al., 2003; Re and 
Strominger, 2001), although many other environmental and stimulus-specific factors are 
known to be important. It is noteworthy that LPS and poly (l:C) induced the secretion of a 
larger amount of the proinflammatory cytokine TNFa than the regulatory factor IL10, whereas 
in contrast zymosan induced the production of more IL10 than TNFa (figure 4.11). This 
suggests that LPS and poly (l:C) are responsible for the induction of proinflammatory Th1-type 
responses, whereas zymosan has a more regulatory, or possibly Th2-inducing effect, as has 
previously been described (Qi et al., 2003). To confirm this, it would be interesting to 
examine the ability of the three stimuli to induce IL12 production, and also examine the 
cytokine secretion profiles of responding T cells. However, with the regards the data 
presented here, it is tempting to speculate that the differential role for MLK proteins that we 
have observed in the responses to LPS and poly (l:C) versus zymosan in some way mediates 
this effector T cell bias. Further studies, in particular using a larger selection of stimuli, 
including Th2-inducing ligands such as SEA or Pam-3-cys, would be required to investigate this 
hypothesis further.
In support of the observations presented here regarding the utilisation of different signaling 
pathways by zymosan and LPS, these stimuli have previously been shown to induce TNFa and 
IL6 by different mechanisms. While LPS-induced TNFa and IL6 production in macrophages is 
inhibited by overexpression of kBa and thus NF-kB inhibition, the zymosan-induced 
production of these cytokines is not, although both stimuli induce significant amounts of both 
cytokines (Bondeson et al., 1999).
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Both functional studies and transcriptional profiling (Kaisho and Akira, 2004; Moschella et al., 
2001; Messmer et al., 2003) have clearly documented that the response to different 
pathogens in DC involves a common "core” response, but also a degree of plasticity capable 
of tailoring the response to the pathogen. Other studies have demonstrated that different 
TLRs associate preferentially with different adaptors. The present study suggests a possible 
role for MLKs as another intracellular step defining the specificity of different TLR signals.
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5. Morphology
5.1 Introduction
5.1.1 Introduction
In chapter 4 we found that inhibiting MLK proteins using the CEP inhibitors prevented LPS- 
induced DC maturation in terms of both upregulation of surface markers and secretion of 
cytokines. As described in section 1.1.3, however, DC maturation in vivo is also accompanied 
by changes in DC morphology, with initial retraction of processes, followed by migration to 
lymphoid tissue, and then formation of the typical dendrites, seen in interdigitating DCs 
(Steinman et al., 1997). The ability of DC to endocytose and phagocytose is reduced during 
this maturation phase. In vitro this morphological maturation is reflected by an increased 
capacity to extend dendritic projections.
The cells used in this thesis as a DC model are differentiated from peripheral blood 
mononuclear cells (PBMCs) (Sallusto and Lanzavecchia, 1994), and as demonstrated in chapter 
3, these cells closely resemble immature DC. In the quest to model the in vivo scenario as 
closely as possible, an experimental protocol was recently described whereby these DC were 
cultured on the extracellular matrix (ECM) protein fibronectin (FN) coated on glass coverslips. 
Under these conditions these cells show a greater capacity to adhere than to glass or to tissue 
culture plastic alone. Furthermore, a greater proportion of cells display long dendritic 
processes, closely resembling the in vivo morphology (Swetman et al., 2002).
5.1.2 Chapter aims
In chapter 4, the effects of MLK and MAPK inhibitors on DC maturation in terms of altered 
phenotype and cytokine secretion were described. In this chapter, we aimed to investigate 
the effects of these inhibitors on the maturation of DC adhered to FN substratum with respect 
to morphology and endocytic capacity.
To facilitate these investigations, a subsidiary aim arose, because it was necessary to develop 
a novel method of analysing the capacity of DC to bind and internalise antigen in different 
morphological phases.
Correlative quantitative analysis of binding and internalisation by monocyte-derived myeloid 
DC as used in these studies is sparse. DC adhered to FN substratum and exhibiting a typical in 
vivo morphology provide a very useful starting point for such studies. Most current approaches 
to assaying endocytic/ phagocytic capacity of DC are based upon on flow cytometric analyses 
of cells in suspension that have internalised fluorescent material such as opsonised latex
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beads or FITC-conjugated dextran (Lehmann et al., 2000; Dunn and Tyrer, 1981). However, 
these assays do not permit correlation of uptake with morphology.
Although the advent of confocal microscopy has made this an easier task than previously, 
nevertheless, current in situ fluorescent microscopy techniques are not quantified easily. Due 
to the small size of the particles used, most are limited to distinction between cells that are 
positive and negative for uptake (Hampton and Winterbourn, 1999). Furthermore, it is often 
difficult to discriminate between internalised and externally bound particles (Hampton and 
Winterbourn, 1999). An additional drawback of most current assays of phagocytosis is that 
degradation of probes in the endocytic pathway can result in artificially low measurements of 
phagocytic capacity, as measured either by flow cytometry or fluorescent microscopy 
(Lehmann et al., 2000). To overcome this problem, fluorescent dyes may be rendered 
insensitive to pH by incorporation into polystyrene beads; however, this involves a complex 
spray-drying technique (Thomasin et al., 1998).
In brief outline (see section 2.9 for details), coating of microbeads with PE-conjugated anti- 
DC-SIGN antibody enhances targeting to the surface of cells. Following an incubation period, 
secondary staining with a FITC-conjugated antibody allows distinction between internal and 
external beads. The microbeads used have a larger diameter (4.5pm) than conventional latex 
beads (0.75pm), and are clearly labelled, which allows individual beads to be distinguished 
and ensures rapid quantification of uptake. Furthermore, direct visualisation of cells allows 
various uptake parameters to be quantified and correlated directly with DC morphology.
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5.2 Results
5.2.1 Effect of MAPK inhibitors on DC morphology
In initial control experiments, the effects of the inhibitors were investigated with respect to 
DC morphology. Treatment with the p38 or JNK inhibitors SB or SP had no effect on 
morphology. The DC resembled untreated, immature DC. Remarkably however, cells treated 
with the MLK inhibitor CEP had a pronounced dendritic morphology and resembled DC 
stimulated with LPS (figure 5.1).
Close inspection reveals that all five populations of DC shown in figure 5.1 contain two 
qualitatively distinct morphological populations. Firstly “ round” cells that are approximately 
spherical with many small spiky projections, and secondly “dendritic” shaped cells, which are 
more extended and are characterised by long dendritic projections.
In the untreated, SB and SP groups, the vast majority of DC are round while a small 
proportion are dendritic shaped. However, upon treatment with LPS or CEP this equilibrium of 
morphologies is altered and the dendritic shaped cells become the predominant population, 
while a minority of cells remain round.
These observations suggest that MLK is involved in controlling DC morphology, and more 
specifically, that MLK activity biases the DC towards the rounded and “ immature” 
morphology. However, this property of MLK appears to be independent of its MAP3K role 
upstream of p38 and JNK, since inhibiting these enzymes has no effect on DC morphology. To 
investigate whether this was a concentration-dependent effect, DC were treated with a 
titration of each inhibitor. The number of dendritic- and round-shaped cells in each field was 
quantified and the proportion of dendritic shaped cells calculated (figure 5.2). Even at the 
highest concentrations, SB and SP did not induce an increase in the proportion of dendritic 
shaped cells, indicating that the ability of MLK to induce morphological alteration of DC is a 
MAPK-independent function.
5.2.2 Effect of MLK inhibition on endocytic capacity of DC
In the next experiments the effect of the MLK and MAPK inhibitors was investigated with 
respect to the ability of DC to internalise FITC-conjugated dextran (figure 5.3). FN-adhered 
DC were studied; dextran was added to the adherent DC, and then following appropriate 
stimulation, the cells were de-adhered by trypsinisation and analysed by flow cytometry.
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In parallel to the morphological analysis, the SB and SP inhibitors did not alter the endocytic 
capacity of DC. In contrast, the endocytic capacity of CEP-treated DC was reduced to a level 
identical to that of LPS-treated cells.
CEP- and LPS-treated DC demonstrate both an increased proportion of dendritic-shaped cells 
and a reduced capacity to internalise FITC-conjugated dextran. We therefore hypothesised 
that these two phenomena are linked; induction of dendritic-shaped cells resulting in loss of 
antigen-internalisation capacity. We could not investigate this hypothesis however using 
current techniques, and therefore we were required to design a novel assay.
5.2.3 Optimisation of bead internalisation
Preliminary studies examined the binding of uncoated microbeads. These microbeads were 
considered to be an ideal tool to investigate the antigen uptake capacity of DC due to the 
ease with which DC internalised the beads, the ideal size of the beads relative to the DC and 
their visibility under the microscope. However, DC bound uncoated beads inefficiently and, as 
a result, the proportion of beads internalised was low. The beads were therefore targeted to 
the DC using the cell surface receptor, DC-SIGN (Geijtenbeek et al., 2000). This C-type lectin 
was chosen due to its specificity for the cell type, its high and relatively constant level of 
expression upon maturation and its role in binding and internalisation of viruses and bacteria 
(van Kooyk and Geijtenbeek, 2003; Steinman, 2000). A diagram of the experimental protocol 
is shown in figure 5.4 and examples of images obtained in figure 5.5.
5.2.4 Optimisation of microbead targeting to DC
Initial experiments confirmed the stable expression of DC-SIGN on DC, both with and without 
LPS (figure 5.6).
To analyse and quantify the microbead experiments, six parameters were calculated for each 
field; the total number of DC, the number of dendritic-shaped DC, the number of DC 
containing one or more microbeads, the total number of microbeads in the field, the number 
of cell-associated (internal and external) microbeads, and the number of internal microbeads. 
From these raw data, the ability of DC to bind microbeads was examined by calculating the 
percentage of microbeads that are cell associated. Three parameters were calculated to 
analyse the capacity of DC to internalise microbeads; the percentage of DC with one or more 
internalised microbeads, the mean number of beads internalised per cell in the field, and the 
percentage of the total cell associated microbeads that are internal (section 2.9.6).
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We first examined the ability of anti-DC-SIGN antibodies to target microbeads to DC, relative 
to an isotype control antibody (figure 5.7). As expected, DC-SIGN targeting enhanced both the 
percentage of total beads that were cell associated (figure 5.7a), and the proportion of cells 
that had taken up beads (figure 5.7b) significantly. Interestingly, although the mean number 
of beads taken up per cell was far greater in the presence of DC-SIGN antibody (figure 5.7c), 
the percentage of cell-associated beads that were internalised was identical for DC-SIGN and 
isotype-labelled beads (figure 5.7d). DC-SIGN targeting therefore enhanced binding of 
microbeads to the DC surface, but not internalisation.
To optimise the targeting of microbeads further, PE-conjugated anti-DC-SIGN antibodies were 
titrated and the ability of DC to bind and phagocytose the resulting beads was quantified. As 
expected, the percentage of beads that were cell-associated increased in proportion to the 
concentration of targeting antibody (figure 5.8a). This correlation was also observed in the 
mean number of beads internalised per cell (figure 5.8b). The proportion of cells containing 
one or more beads also increased with antibody concentration (figure 5.8c), although even 
the lowest concentration of targeting antibody used was sufficient to induce bead 
internalisation in greater than 75% of the cells. Strikingly, as noted in figure 5.7d, the 
percentage of cell-associated beads internalised was independent of antibody concentration 
(figure 5.8d).
5.2.5 Effects of LPS treatment on phagocytic capacity and dendrite pattern of DC
LPS is a well-characterised TLR4 ligand that induces DC maturation (Ardeshna et al., 2000; De 
Smedt et al., 1996) and has been shown to induce downregulation of antigen uptake by DC. 
Therefore LPS-treated DC were used to explore microbead internalisation further in a 
quantitative fashion.
To determine the optimum period of incubation of cells with beads we examined the ability 
of control versus LPS-treated DC to internalise beads over time. Three parameters of 
microbead uptake capacity were recorded; the mean number of beads internalised per cell 
(figure 5.9a), the percentage of cells containing beads (figure 5.9b), and the ability of cells to 
internalise cell-associated beads (figure 5.9c). All three techniques yielded a remarkably 
similar pattern of microbead internalisation. In each case control DC were approximately 
twice as proficient at microbead uptake compared to LPS-treated at any given time-point.
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The effects of LPS concentration and temperature on microbead uptake by DC were analysed 
(figures 5.10a-c). All three measures of microbead uptake capacity showed a dramatic 
downregulation of internalisation in response to LPS treatment.
To validate bead internalisation as a measure of the capacity of DC to internalise antigen, the 
ability of control and LPS-treated DC to internalise microbeads also was compared to the 
more established technique of FITC-conjugated dextran uptake. FITC-conjugated dextran is 
known to bind to the mannose receptor, a lectin that is related to DC-SIGN. Analysis of 
uptake of FITC-conjugated dextran by DC reveals a dose dependent decrease in dextran 
internalisation with increasing LPS concentration (figure 5.10d).
The downregulation demonstrated by all three assays of microbead internalisation was more 
striking than that measured by FITC-conjugated dextran uptake (figure 5.10a-c versus 5.10d). 
As observed for microbead internalisation, incubation at 4°C completely abrogates FITC- 
conjugated dextran uptake (figure 5.10d).
5.2.6 Correlation between dendritic morphology and internalisation capacity of DC
The quantification of antigen uptake by direct visualisation of cells allows the examination of 
the relationship between morphology and internalisation capacity. Therefore, in parallel to 
examining microbead uptake, the effect of LPS on the morphology of DC adhered to FN was 
studied. LPS induced an increase in the proportion of dendritic-shaped cells (defined as cells 
possessing dendritic projections of greater than twice the cell body in length) (figure 5.11.1).
Since LPS induces an increase in dendritic morphology (figure 5.11.1) in parallel to a 
downregulation of uptake capacity (figure 5.10), we hypothesised that dendritic-shaped DC 
are less proficient at internalising microbeads compared to round cells. Therefore the relative 
ability of round versus dendritic shaped cells to engulf microbeads was examined. A ten- 
minute incubation period was used in contrast to the ninety minutes used in other 
experiments because DC are known to be dynamic in shape and may alter their morphology 
between round and dendritic. In both control and LPS-treated groups, round cells were more 
proficient at internalising microbeads than those that had a pronounced dendritic 
appearance, and this difference was significant (figure 5.11.2), indicating that the shape of 
the cells is an important determinant of the ability of DC to internalise microbeads.
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5.2.7 Use of alternative antibodies to target microbeads to DC
Given that the percentage of cell-associated beads internalised appeared to be independent 
of the avidity of DC for the microbeads, (figures 5.7d and 5.8d), we investigated whether 
microbead targeting to receptors other than DC-SIGN would give equivalent phagocytic 
efficiency. In particular, we wondered whether the levels of receptors whose expression are 
susceptible to LPS-induced regulation correlate to uptake efficiency.
The surface marker proteins CD80, CD83, and MHC Class I were selected as prototypic LPS- 
regulated molecules (figure 3.2a), while the pseudo-MHC Class I molecule CD1a (figure 3.1b), 
and DC-SIGN (figure 5.6) were tested as receptors whose level of expression is independent of 
LPS treatment. Strikingly, analysis of the percentage of cell-associated beads internalised 
indicates a consistent reduction of around 50% in uptake by LPS-treated DC relative to 
untreated, irrespective of the surface molecule targeted by the bead.
5.2.8 Effects of CEP treatment on microbead uptake capacity of DC
Having designed an assay to investigate the correlation between the morphology and antigen 
uptake capacity of DC, and examined the robustness of this assay, we wished to use this 
strategy to investigate the effects of CEP treatment on DC.
In figures 5.1 and 5.2, it was shown that CEP induces an increase in the proportion of 
dendritic-shaped DC, identical to the morphological effects of LPS treatment. Incubation with 
CEP or LPS also reduced the capacity of DC to internalise FITC-conjugated dextran (figure 
5.3). It was subsequently shown that in response to LPS treatment, the morphology and 
antigen uptake capacity of DC are linked and reduction in antigen internalisation by LPS is in 
fact a consequence of the increase in the proportion of DC with dendritic morphology (figure 
5.11.2). Analogous to this, as shown in figure 5.13, treatment of DC with CEP (or LPS as a 
positive control) had no effect on the underlying ability of the DC to internalise antigen 
relative to control-treated DC.
In an identical manner to LPS, therefore, data presented in this chapter suggests that the 
ability of CEP to downregulate antigen internalisation (figure 5.3) is an indirect phenomenon 
occurring as a result of the ability of CEP to increase the proportion of dendritic-shaped DC.
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Figure 5.1. Effect of MAPK pathway inhibitors on DC 
morphology
Immature DC were incubated on FN-coated glass coverslips overnight, prior 
to addition of: (a) no stimulus, (b) 100ng/ml LPS, (c) 10pM SB203580, (d) 
1pM SP600125, (e) 1pM CEP11004. They were then incubated for a further 
18hrs prior to examination by confocal microscopy. Representative of three 
individual experiments is shown. Scale bar represents 50 pm.
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Figure 5.2. Quantification of the effect of MAPK 
pathway inhibitors on DC morphology
Images of DC were were obtained as described in figure 5.1. The 
percentages of dendritic shaped cells were then calculated. “ Dendritic 
shaped cells” defined as possessing at least one dendritic process of greater 
than twice the cell body in length. Mean of three individual experiments. 
Error bars indicate standard error of the mean, and asterisks indicate 
p<0.05 versus untreated control.
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Figure 5.3. Uptake of FITC-conjugated dextran by 
LPS and inhibitor-treated DC
Immature DC were incubated on FN-coated glass coverslips overnight, prior 
to addition of lO^M SB203580, 1pM SP600125, 1pM CEP11004, or 1000ng/ml 
LPS as indicated and incubation for a further 18hrs. FITC-conjugated 
dextran was then added to a final concentration of 30pg/ml for 90 minutes 
at 37°C or 4°C as indicated. Cells were then de-adhered by trypsinisation 
and washed before analysis by flow cytometry. Mean of three individual 
experiments is shown. Error bars indicate standard error of the mean, and 
asterisks indicate p<0.05 versus untreated control (calculated from raw 
median fluorescent intensity values).
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Figure 5 .4 . Experimental procedure to quantify 
antigen uptake capacity of adherent cells
Diagram outlining experimental protocol. Adherent DC are incubated with 
PE-labelled anti-human-DC-SIGN rat antibody coated microbeads for 90 
minutes. They are then fixed and stained with FITC-labelled polyclonal anti­
rat antibodies. Internalised microbeads appear red, whereas microbeads 
accessible to the extracellular milieu fluoresce in both red and green 
channels and thus appear yellow.
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Figure 5.5. Example of images produced for 
quantification of microbead uptake
Internalised microbeads appear red, whereas externally accessible 
microbeads are also stained with FITC-conjugated antibody, thus appear 
yellow.
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Figure 5.6. DC-SIGN Expression in DC
Immature DC were incubated with or without 1000ng/ml LPS for 18 hours 
prior to analysis of DC-SIGN expression by flow cytometry. One 
representative of three experiments is shown.
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Figure 5.7. Quantification of microbead 
internalisation capacity using DC-SIGN targeted 
versus non-targeted (isotype matched control 
antibody-coated) microbeads
Immature DC were incubated on FN-coated glass coverslips overnight, prior 
to addition of microbeads and further incubation for 90 minutes before 
fixation and staining. Representative of three individual experiments is 
shown. Error bars indicate standard error of the mean, and asterisks 
indicate p<0.05.
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Figure 5.8. Comparison of cell binding and 
internalisation of microbeads coated with different 
anti-DC-SIGN antibody concentrations
Indicated are the antibody concentrations in which 1 x 106 microbeads were 
incubated during antibody coating. Immature DC were incubated on FN- 
coated glass coverslips overnight, prior to addition of microbeads and 
further incubation for 90 minutes before fixation and staining. 
Representative of three individual experiments is shown. Error bars indicate 
standard error of the mean.
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Figure 5.9. Ability of control versus LPS-treated DC 
to internalise microbeads over time
Immature DC were incubated on FN-coated glass coverslips overnight, prior 
to addition of 1000ng/ml LPS as indicated and incubation for a further 
18hrs. DC-SIGN-coated microbeads were then added and cells incubated for 
a further period as indicated before fixation and staining. Representative of 
three individual experiments is shown. Error bars indicate standard error of 
the mean.
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Figure 5.10. Analysis of antigen uptake capacity of 
control versus LPS-treated DC
Immature DC were incubated on FN-coated glass coverslips overnight, prior 
to addition of LPS as indicated and incubation for a further 18hrs. Antigen 
uptake capacity was then assessed by internalisation of DC-SIGN targeted 
microbeads (a-c) or FITC-conjugated Dextran (d). (a-c) Microbeads were 
added and cells incubated for a further 90 minutes at 37°C or 4°C as 
indicated before fixation and staining. Representative of three individual 
experiments is shown. Error bars indicate standard error of the mean, (d) 
FITC-conjugated dextran was added to a final concentration of 30^ig/ml for 
90 minutes at 37°C or 4°C as indicated. Cells were then de-adhered by 
trypsinisation and washed before analysis by flow cytometry. Mean of three 
individual experiments is shown.
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Figure 5.11.1. Morphological analysis of LPS-treated 
DC
Immature DC were incubated on FN-coated glass coverslips overnight, prior 
to addition of LPS as indicated and incubation for a further 18hrs. 
Representative of three individual experiments is shown. Error bars indicate 
standard error of the mean.
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Figure 5.11.2. Ability of round versus dendritic DC 
to internalise microbeads
Cells were incubated on FN-coated glass coverslips overnight, prior to 
addition of 1000ng/ml LPS as indicated and incubation for a further 18hrs. 
Microbeads were then added and cells incubated for a further 10 minutes 
before fixation and staining. Indicated is the percentage of cell-associated 
beads internalised for the round and dendritic cells in each field and 
expressed with the standard error of the mean. Mean of three individual 
experiments is shown. Asterisks indicate p<0.05 versus equivalently treated 
dendritic cells.
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Figure 5.12. Internalisation of microbeads targeted 
to alternative surface marker proteins
Analysis of the ability of DC to internalise bound microbeads targeted to 
various surface proteins as indicated. Immature DC were incubated on FN- 
coated glass coverslips overnight, prior to addition of 10OOng/ml LPS as 
indicated and incubation for a further 18hrs. Microbeads were then added 
and cells incubated for a further 90 minutes before fixation and staining. 
Mean of three or five (DC-SIGN group) individual experiments is shown. Error 
bars indicate standard error of the mean.
% Cell Associated Beads Internalised
25
20  -
15  -
10 -
5 -
■ Control 
□ CEP 
MIPS
*  *
Round Dendritic
Figure 5 .13 . Ability of round versus dendritic DC to 
internalise microbeads
Cells were incubated on FN-coated glass coverslips overnight, prior to 
addition of 1^ iM CEP11004 or 1000ng/ml LPS as indicated and incubation for 
a further 18hrs. Microbeads were then added and cells incubated for a 
further 10 minutes before fixation and staining. Indicated is the percentage 
of cell-associated beads internalised for the round and dendritic cells in 
each field and expressed with the standard error of the mean. Mean of at 
least three individual experiments is shown. Error bars indicate standard 
error of the mean, and asterisks indicate p<0.05 versus untreated control.
5. Morphology
5.3 Discussion
DCs in vivo, such as LCs, exhibit a more dendritic morphology than DC observed in vitro. This 
is probably due to an increased availability of ligands (in three dimensions) to which the cells 
can anchor. Indeed the use of FN as a substratum induces an in vitro scenario which may be 
more like that seen in vivo when compared to that seen when DC adhered to plastic alone, 
presumably due to the increased ability of the cells to adhere (Swetman et al., 2002). Using a 
FN substratum to model the in vivo environment, we have observed that despite phenotypic 
uniformity, two cellular morphologies exist within the DC population: a spiky round 
morphology, and dendritic-shaped DC, characterised by long dendritic projections. The 
balance between these different morphologies is probably a function of expression of fa 
integrins, which mediate FN binding (Burns et al., 2004), and the relative activities of Rho, 
rac and cdc42 proteins, which have been shown to control dendrite formation (Swetman et 
al., 2002). Upon maturation with LPS, a radical alteration in the balance of these 
morphologies was observed from predominantly round cells in the immature DC population to 
an excess of dendritic-shaped DC upon maturation (figure 5.1). In parallel with this shift in 
morphology, the ability of DC to internalise dextran was dramatically reduced (figure 5.3).
Unexpectedly, a shift to a dendritic cell morphology and reduced uptake of dextran was also 
seen in the presence of the MLK inhibitor CEP (figures 5.1 to 5.3). In contrast, DC treated 
with the p38- or JNK-specific inhibitors were identical to the untreated cells in that they 
were predominantly round, and had a high endocytic capacity (figures 5.1 to 5.3). The 
effects of MLK inhibition on morphology (in contrast to the effects on DC maturation) were 
therefore not mediated via the downstream activity of MAPKs. Importantly, the CEP-treated 
DC are not mature in terms of surface phenotype (figure 4.7), and indeed are unable to 
mature phenotypically when treated with maturation stimuli such as LPS (figure 4.8). This 
suggests that MLK proteins are involved in controlling DC morphology and antigen uptake via a 
mechanism that is independent of MAPKs. Evidence for possible mechanisms of MAPK- 
independent regulation of cellular morphology by MLK proteins will be discussed in Chapter 6. 
However, CEP is therefore a tool with which the phenotypic and morphological aspects of DC 
maturation can be separated - offering an exciting novel avenue for future investigation.
Studies correlating morphological parameters and antigen uptake capacity of DC have not 
previously been published. To measure the antigen internalisation capacity of DC under 
conditions where they retain their characteristic morphology, we have had to overcome 
several technical issues. Current methods of analysing antigen uptake by DC involve the 
internalisation of fluorescently labelled molecules such as dextran, which is then quantified 
by flow cytometric or fluorescent microscopic methods. Obviously flow cytometric
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measurement uses non-adherent cells, preventing the concurrent analysis of cellular 
morphology. Many microscopic techniques, on the other hand, also have drawbacks. For 
example, it is difficult to conclusively distinguish between internal and externally bound 
probe. The method outlined in this chapter facilitates simple distinction between internal and 
external beads without complex washing or quenching steps, while maintaining the ability to 
undertake parallel morphological analyses. In addition, microbeads are easily visualised and 
thus quantified, and provide stable, non-degradable probes for internalisation.
The mechanism by which the microbeads are internalised has not been investigated in detail 
in this study. In vivo, DC are known to internalise antigen via several mechanisms (section 
1.1.3.1), including both receptor-ligation-induced, and non-specific uptake systems. Initially, 
beads were targeted to DC-SIGN, which is a C-type lectin related to the mannose receptor, 
and has been shown to function as an endocytic receptor (Guo et al., 2004). As expected, the 
anti-DC-SIGN antibody greatly enhanced the number of DC-associated beads and the 
proportion of DC which had bound microbeads. However, it does not appear that the 
internalization of anti-DC-SIGN-coated microbead requires specific receptor-induced signals, 
since the internalisation of DC-associated DC-SIGN-coated microbeads, as a proportion of cell 
associated beads, is no more efficient than the uptake of isotype control antibody-coated 
microbeads (see Figs 5.7d, 5.8d, and 5.12). Since DC take up microbeads independently of the 
mechanism by which they are bound to the cell, internalisation of cell-associated microbeads 
may occur as a result of membrane invagination during macropinocytosis engulfing the cell- 
associated microbead. In support of this hypothesis, macropinosomes are known to be much 
larger than vesicles formed as a result of other forms of uptake such as clathrin-associated 
endocytosis, or lipid raft-mediated uptake (Johannes and Lamaze, 2002). Macropinosomes are 
known to be of the same approximate size as the microbeads, suggesting that uptake of 
volumes of this size is a physiologically relevant phenomenon. Indeed, we have observed cells 
(including dendritic-shaped cells) containing in excess of 20 microbeads upon longer 
incubation periods and at high bead densities (data not shown), illustrating that the size of 
the microbeads is not a limiting factor in their internalisation. Inhibition of PI3K using 
wortmannin has been shown to inhibit the formation of macropinosomes by DC (West et al., 
2000), so it would be interesting to investigate whether this treatment prevents microbead 
internalisation. The receptor-independence of microbead internalisation is therefore a 
further strength of the assay, which is not dependent upon a particular receptor or 
mechanism of uptake, but rather reflects the inherent capacity of the cells to internalise 
antigen. Analysis of targeted microbeads therefore provides a novel and useful way to 
approach dynamic structure-function relationships that has not been possible in previous DC 
studies.
176
5. Morphology
Microbead uptake was quantified in terms of three main parameters, the mean number of 
beads internalised per cell, the percentage of cells containing one or more internalised 
beads, and the percentage of cell-associated beads that have been internalised. The first two 
measures showed similar patterns of relative uptake capacities between groups (figure 5.7b 
versus 5.7c, figure 5.8b versus 5.8c, figure 5.9b versus 5.9c, and figure 5.10b versus 5.10c). 
The agreement between these two parameters supports the interpretation that the changes 
seen reflected the population of DC as a whole, rather than very large changes in a very small 
proportion of cells. In immature unstimulated DC populations, one can envisage that most 
cells possess a high antigen uptake capacity, while some possess a low antigen uptake 
capacity. Upon maturation with LPS, the balance is shifted, and most cells possess a low 
capacity to uptake (figures 5.9 and 5.10). This equilibrium in microbead internalisation 
capacity of both immature and mature DC is reminiscent of the balance of round and 
dendritic DC morphologies, whereby in the unstimulated population, most cells are round, 
and, following maturation, most cells have dendritic morphologies (figures 5.1 and 5.2). 
Indeed, the down-regulation of the internalisation capacity of DC (figure 5.10), and the 
increase in the proportion of DC with a dendritic morphology (figure 5.11.1), both closely 
correlate with the concentration of LPS. The novel phagocytic assay described here permitted 
us to test the relationship between uptake and morphology at a single cell level.
Examining the ability of round and dendritic shaped immature DC to engulf microbeads 
indeed confirmed that round cells were significantly better at internalising cell-associated 
microbeads (figure 5.11.2), suggesting the possibility that the ability of LPS to induce 
dendrite formation and to reduce antigen uptake may be related. Indeed, the data presented 
here indicate that the reduction in microbead uptake observed following LPS treatment is a 
function of the change in the proportion of the different shaped cells; from a population of 
predominantly round cells (with high phagocytic capacity) to a vast majority of dendritic 
shaped cells (with a reduced phagocytic capacity). At a single cell level, LPS has little effect 
on uptake by either round or dendritic shaped cells, and may even enhance this property 
slightly for both cell morphologies (figure 5.11.2). An objection to this interpretation might 
be that dendritic shaped cells in the immature population may represent a small 
contaminating population of DC that have become matured (and therefore show low uptake). 
Likewise, the round cells in the mature population may be DC that have remained immature 
despite LPS treatment (and therefore retain high uptake). When examined by time-lapse 
microscopy, DC in vitro can be observed to continually extend and retract dendrites as they 
randomly migrate and thus alternate between apparent round and dendritic morphologies 
(Swetman et al., 2002). Time-lapse microscopy of cells during bead uptake would confirm
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whether the avidly phagocytic cells are indeed permanently “ immature” , or simply reflect 
the round morphology at the particular instant at which they take up beads.
The mechanism underlying why round cells phagocytose more efficiently than dendritic cells 
remains unknown, and requires further investigation. We would like to propose a hypothesis, 
however, that seems to account for all of the data presented in this chapter. The formation 
of the relatively large vesicles required to encapsulate the microbeads presumably requires 
the rapid commitment of a significant proportion of the cell membrane. A very fundamental 
reason why round DC take up antigen more efficiently than dendritic shaped DC may 
therefore be their smaller surface area to volume ratio, which results in their having more 
‘spare’ membrane with which to invaginate and internalise antigens. The reduced uptake by 
LPS treated population may therefore directly result from altered morphology of most of the 
cells, rather than reflecting specific changes in the biochemical steps of endocytosis. In 
particular, this hypothesis is attractive because it could explain why CEP inhibitor-treated 
cells, although showing an immature phenotype, nevertheless show reduced bead uptake, 
reflecting their very enhanced dendritic morphology.
The model of cells oscillating between different morphologies and the relationship between 
these morphologies and phagocytic capacities may also apply in vivo. This is indeed supported 
by the observation that Langerhans cells endocytose substrates such as FITC-conjugated 
dextran with a much lower efficiency than immature DC in culture (Steinman et al., 1999), 
and furthermore, macrophages, which resemble round DC, phagocytose in vitro with a 
greater capacity than DC (Kiama et al., 2001; Thiele et al., 2001). Upon receipt of a 
maturation stimulus in vivo, DC must de-adhere and adopt a round morphology as they begin 
a program of migration to the lymph nodes. It is attractive to speculate that during this round 
phase, DC possess an increased capacity to phagocytose in an attempt to maximise their 
antigen load prior to departing the infected area. This would correlate with the observations 
that TLR or CCR7 ligation on DC results in a transient increase in endocytic capacity in vitro 
(Blander and Medzhitov, 2004; Yanagawa and Onoe, 2003).
The morphology of DC is unique, in showing very long cellular processes (more neuronal-like 
than monocyte/macrophage like), but the dendrites are short-lived and highly dynamic 
structures. Using two photon imaging to visualise DC and lymphocytes in an ex w'vo lymph 
node, Miller et al observed that mature DC extended long agile dendrites and these 
projections were the site of T cell interaction. The possession of dendrites therefore 
increases the surface area of DC, and indeed, an individual DC was observed to be capable of 
interaction with up to 5000 T cells per hour. The dynamic nature of the dendrites also
178
5. Morphology
increased the ability of DC to find and interact with T cells (Miller et al., 2004). It is therefore 
reasonable to speculate that in an analogous fashion, the possession of dendrites by DC in the 
periphery increases the surface area of these cells, optimising antigen detection. The model 
proposed in this chapter suggests that this unusual morphology may be required to allow DC 
to perform their function in an optimal way. The presence of long cellular processes greatly 
increases the overall area that is efficiently scanned for antigen or invading microbes. 
However, process formation may inhibit uptake, as proposed above. Rapid dynamic 
conversion between extended and rounded forms may thus be optimal for the sentinel 
function of immature DC. This model suggests that DC morphology, and in particular the 
flexibility of this morphology, as much as surface phenotype and cytokine secretion, may 
determine their remarkable efficiency in antigen processing and presentation.
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Chapter 6 
General Discussion
6. Discussion
6.1 Overview
The initial objective of the study was to investigate the roles of the JNK and p38 pathway in 
the response of DC to oxidative stress. The hypothesis was based upon the fact that p38 is 
known to be involved in the control of DC maturation, and is also activated by ROS in many 
cell types. We therefore speculated that p38 activation by oxidative stress (modelled by H202) 
could influence DC maturation. Furthermore, the JNK pathway had not previously been 
investigated in DC, is also known to be activated by oxidative stress in other cell types, and 
might therefore also be involved in this process.
We found that despite activating both p38 and JNK, no DC maturation was observed in 
response to H202, although we did observe the induction of apoptosis, and this correlated 
closely with the degree of JNK activation. H202 was also incapable of modulating the ability of 
LPS to induce DC maturation, although a synergistic effect on both JNK activation and 
apoptosis was observed in response to dual stimulation with H202 and LPS, further suggesting 
a role for JNK in the control of DC apoptosis. The use of newly available pharmacological 
reagents; a JNK-specific inhibitor (SP600125), and an inhibitor of a supposedly JNK-specific 
MAP3K, MLK (CEP11004), confirmed a role for JNK in this process.
The inhibitors also permitted an investigation into the role of JNK in DC maturation in 
response to strong stimuli such as LPS, and interestingly, JNK was found not to be essential 
for this process. This observation was reinforced in later studies examining a greater selection 
of DC maturation markers and cytokines, and supported by the observation that some stimuli, 
which induce DC maturation, such as zymosan, do not activate JNK in DC.
Given that p38 is an important regulator of DC maturation and JNK is essential for apoptosis, 
it was interesting that JNK activation was consistently observed to occur at higher 
concentrations than p38. This suggests that there is a window of stimulation intensity in 
response to which DCs are induced to mature. Above this level of stimulation however, such 
as might be expected at highly inflammatory loci, apoptosis is induced via JNK activation. 
This mechanism probably serves to protect against the possibility of antigen presentation by 
DC that have been damaged by the highly reactive oxygen and nitrogen radicals found in the 
inflammatory environment.
During the course of these investigations it was observed that inhibiting MLK also prevented 
LPS-induced DC maturation, suggesting JNK-independent functions for this protein. A role for 
MLK proteins in the control of p38 activation in vitro had been reported, and (consistent with 
such a function) we observed that the MLK inhibitor prevented LPS-induced p38 activation.
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This therefore introduced a second aim into the project; to investigate the role of MLK 
proteins in DC maturation induced by TLR ligands.
In addition to LPS, the TLR3 ligand poly (l:C), and TLR2/ TLR6 ligand zymosan were examined 
for their MLK requirement in the induction of DC maturation. Remarkably, the 
phosphorylation of p38, the upregulation of surface markers, and the secretion of cytokines in 
response to LPS and poly (l:C) was markedly diminished in the presence of the MLK inhibitor, 
whereas in contrast, zymosan-induced maturation demonstrated no requirement for MLK 
activity. This dichotomy in MLK dependency indicates the complexity of the regulation of DC 
maturation, which is crucial to the central role of these cells in the induction of highly 
optimised pathogen-specific immune responses.
Interestingly, upon the use of the MLK inhibitor we immediately observed a dramatic effect 
on the morphology of DC, a large proportion of the DC adopting an apparently mature 
morphology with long dendrites. In parallel to this was a concomitant reduction in the ability 
to internalise antigen, and using specific inhibitors we established that both of these effects 
were independent of p38 and JNK. We formulated a hypothesis that the two observations 
were linked and that the reduction in antigen uptake was due to the altered morphology of 
the cells. However, it was not possible to test the hypothesis using the available techniques. 
Therefore the design and optimisation of a novel assay permitting the parallel investigation of 
DC morphology and antigen uptake capacity, and the utilisation of this assay to investigate 
our hypothesis became a final aim of the project.
We found that DC morphology and antigen uptake were indeed linked, and that round cells 
possess a greater capacity to internalise antigen than extended dendritic-shaped cells. Based 
upon this result and the observation that DC are highly dynamic in their morphology, we 
suggest that this unique morphology optimises these cells for antigen processing. A dendritic 
phase facilitates optimal environment sensing and antigen capture, and a more rounded 
phase permits highly efficient uptake of bound antigen.
6.2 Activation of mixed lineage kinases
It is significant that the data presented in this thesis indicate diverse roles for MLK proteins in 
DC in the regulation of apoptosis, maturation, and morphology. However, there is 
accumulating evidence in other cell types, including the use of non-inhibitor-based 
approaches, to support roles for MLK proteins in these processes.
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An example of this is the considerable evidence that supports a role for MLK proteins in the 
induction of apoptosis in other cell types (Wang et al., 2004). NGF-deprivation-induced 
neuronal apoptosis has been shown to proceed via rac1/cdc42-induced MLK activation (Mota 
et al., 2001; Harris et al., 2002; Xu et al., 2001). In fact, the MLK inhibitor used in this study 
was derived from a screen for compounds capable of preventing neuronal apoptosis. Studies 
in neuronal cell lines have indicated that the proapoptotic effects of MLK are mediated via 
the activation of JNK, which is known to induce apoptosis by transcription-dependent and 
independent mechanisms. Our data support a JNK-dependent mechanism of MLK-induced DC 
apoptosis in response to oxidative stress. The mechanism by which oxidative stress induces 
MLK activation is not clear. However, in support of the data presented in this thesis, oxidative 
stress-induced apoptosis of human mesencephalic neuron-derived cells has recently been 
demonstrated to proceed via an MLK-dependent pathway (Lotharius et al., 2005), and 
furthermore the antioxidant N-acetylcysteine prevents MLK3 membrane translocation and 
activation (Pei et al., 2005; Tian et al., 2003). We observed that treatment with H202 induces 
transient inhibition of tyrosine phosphatases, resulting in MLK-dependent JNK activation. This 
suggests that a mechanism exists by which MLKs are activated by tyrosine kinases. However, 
activation of MLK proteins occurs on threonine and serine residues, suggesting that this action 
of tyrosine kinases is probably indirect. It would be very interesting to investigate whether 
the activation of tyrosine kinases occurs upstream of rac and cdc42, or whether this 
represents an alternative mechanism of MLK activation that is independent of these GTPases.
MLK activation downstream of TLRs has not been formally reported previously, although the 
CEP inhibitor has been shown to prevent LPS-induced functional outcomes in other cell types 
(Lund et al., 2005; Ciallella et al., 2005). Consequently, the means by which TLRs induce MLK 
activation is not clear. There are, however, several possible mechanisms. The conventional 
picture of AAAPK activation upon TLR ligation as outlined in sections 1.2.2.4 to 1.2.2.6 does 
not suggest a mechanism for MLK involvement in this process, but, several lines of evidence 
suggest that this picture of TLR signaling is not complete. For example, transfection of IRAKI - 
deficient cells with mutant IRAK proteins indicated that certain regions of IRAKI were 
required for NF-kB, but not JNK activation. This suggests that these two pathways must 
diverge at, or upstream of, IRAKI (Li et al., 2001). Another insight into this controversial issue 
of IRAKI-induced JNK activation is provided by an LPS-inducible splice variant of the adaptor 
protein MyD88, called MyD88s. This splice variant can bind IRAKI but is unable to bind IRAK4. 
As a result there is no IRAKI phosphorylation and consequently there is a strong inhibition of 
IL1-induced NF-kB activation in the presence of MyD88s, confirming the importance of IRAKI 
phosphorylation in NF-kB activation (Burns et al., 2003). Interestingly, however, it has been 
shown that MyD88s prevents NF-kB but not AP1 reporter gene expression, and in line with this
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observation, IL1-induced JNK phosphorylation is not diminished in the presence of MyD88s 
(Janssens et al., 2003). Clearly the precise mechanism of this signal transduction complex has 
not yet been fully elucidated. Mice deficient in MyD88, TIRAP, IRAKI, IRAK4 or TRAF6 have 
been engineered (Kawai et al., 1999; Yamamoto et al., 2002; Swantek et al., 2000; Suzuki et 
al., 2002; Lomaga et al., 1999). However NF-kB has been the major signaling protein of 
interest in these investigations, and LPS-induced activation of JNK and p38 has been 
investigated only in limited studies using these knockout mice.
Many signaling proteins have been suggested to be involved in TLR-mediated responses. With 
reference to the mechanism outlined above in which MLK proteins are activated as a result of 
the inhibition of tyrosine phosphatases, ROS production upon TLR4 ligation has previously 
been demonstrated (Ryan et al., 2004; Matsuzawa et al., 2005; Asehnoune et al., 2004; Hsu 
and Wen, 2002), although the mechanism of this unclear. It is therefore possible that the 
mechanism of MLK activation in response to TLR ligation and oxidative stress is identical. This 
is a particularly attractive model, since in this scenario MLK activation by oxidative stress is 
simply an extreme version of MLK activation by TLR ligation. ASK1 has been shown to be 
important for TLR signaling downstream of TLR4 in mice (Matsuzawa et al., 2005). It has been 
suggested that ASK1 is a critical AAAP3K in the activation of JNK and p38 by ROS, both in 
apoptotic signaling and downstream of TLR4 (Liu and Min, 2002; Matsuzawa et al., 2005). 
However, we have shown that in DC, inhibition of MLK prevents H202-induced JNK activation, 
suggesting that ASK1 does not play a major role in MAPK activation in response to ROS in 
these cells. Importantly, the CEP inhibitor has been demonstrated to have no inhibitive effect 
on ASK1 (Harris et al., 2002; Xu et al., 2001). It is therefore possible that in human monocyte- 
derived DC, MLK proteins, and not ASK1, are the major MAPK activators in response to ROS, in 
the induction of both apoptosis and maturation.
An alternative mechanism of MLK activation by TLR ligation is suggested by the observation 
that the scaffold protein JIP3, which binds MLK3, MKK7, and JNK, (section 1.3.3.6) has been 
shown to bind to TLRs 2, 4, and 9. Obviously this suggests the existence of a single complex 
mediating direct signal transduction from LPS to JNK via MLK3 (Matsuguchi et al., 2003), 
although the pattern of TLR association does not correlate with the MLK3 dependency of TLR3 
and TLR4, but not TLR2, which we observed. Furthermore, JIP3 is thought to be expressed 
exclusively in neurones, although expression in DC has not been investigated (Kelkar et al., 
2000). MEKK1 binds JIP3 and is an important kinase in the activation of NF-kB, so it is possible 
that the true function of this complex is to facilitate MEKK1-mediated NF-kB activation.
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In addition to the mechanism of MLK activation upon TLR ligation, the difference in MLK 
dependence of different TLR pathways also remains to be explained at a molecular level. One 
attractive hypothesis is that these differences may reflect the utilization of different 
intracellular adaptor proteins by the TLRs. Analysis of mice deficient for different adaptor 
proteins indicates that TLR3 and TLR4, but not TLR2, possesses a strong signaling requirement 
for the TIR-domain-containing adaptor inducing IFN-p (TRIF) protein (Yamamoto et al., 2003) 
(section 1.2.2.4). The observed effects are similar to those reported here in that CD86 and 
MHC class II molecules are not upregulated in response to LPS or poly (l:C), and TNFa and IL6 
release in response to LPS are completely abrogated in the absence of TRIF (Yamamoto et al., 
2003). Unfortunately the authors did not discuss the effect TRIF deficiency on poly (l:C)- 
induced MAPK activation. Indeed, TRIF signaling studies are predominantly focused upon the 
induction of IRF3-dependent interferon-inducible gene expression. Rip kinases have been 
shown to function in NF-kB activation downstream of TRIF; but, in contrast to NF-kB, JNK 
activation is not diminished in the absence of Rip1 (Meylan et al., 2004). The pathways 
leading to MAPK activation downstream of TRIF remain ill defined; even the requirement of 
TRIF for TRAF6 has not yet been conclusively established (Gohda et al., 2004). Nonetheless, 
this report suggests that TRIF-dependent MAPK activation may operate via MLK, and it would 
be very interesting to investigate this hypothesis further. In initial studies, a cell line would 
be a more appropriate model for these studies due to the relative ease of biochemical 
manipulation. It would also be interesting to investigate poly (l:C)-induced MLK3 
phosphorylation in the TRIF-deficient cells.
The PI3K pathway may also play an important role in the regulation of MLK signaling. In 
HepG2 cells, Akt1, a PI3K effector, has been shown to interact with the C terminal portion of 
MLK3, and phosphorylate MLK3 in this region, which results in inhibition of MLK3-mediated 
JNK activation (Barthwal et al., 2003). Inhibitor studies have indicated a role for PI3K in DC in 
a pro-survival and anti-apoptotic capacity, and with regards data presented in this thesis, it is 
possible that these effects are mediated via inhibition of MLK proteins. Pointedly, H202- 
induced fibroblast apoptosis has been associated with a reduction in Akt activity (Taylor et 
al., 2004), and Akt1 binding to JIP1 has been shown to reduce JNK activation and consequent 
apoptosis in neurones and this was associated with the disruption of JIP1 binding to MLK3 
(Kim et al., 2002). Furthermore, JIP1 binding to Akt1 has been shown to promote Akt1 
activation (Kim et al., 2003; Kim et al., 2002). Clearly this could be a form of negative 
regulation of MLK3. In concert with our observation that MLK is involved in both apoptosis and 
maturation, there is evidence that Akt-mediated inhibition may also regulate both of these 
processes. PI3K-deficient DC demonstrate defective IL12 production in response to various 
stimuli (Fukao et al., 2002). Interestingly, there was also significant enhancement of p38
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activation in response to stimuli including LPS in the PI3K-deficient DC. It is clearly an 
attractive hypothesis that the observed effects of PI3K on p38 activity are mediated via MLK3, 
and this obviously requires future investigation. In further support of this hypothesis, Akt2 has 
been shown to negatively regulate the assembly of the POSH-MLK-JNK signaling complex, 
suggesting that Akt proteins function to negatively regulate MLK signaling in general (Figueroa 
et al., 2003).
The prototypical mechanism of MLK activation is via release of autoinhibition upon binding to 
the GTP-associated forms of rac or cdc42 (section 1.3.3.1), and indeed there is evidence, 
albeit limited, suggesting that this mechanism may apply downstream of TLRs. Stimulation of 
TLR2 has been shown to induce transient activation of rac1 and cdc42 (Arbibe et al., 2000), 
and a signaling complex containing TLR2, rac1, and PI3K was demonstrated. Furthermore, 
LPS-induced activation of p38 and JNK has been shown to be rad-dependent in Rat-2 
fibroblasts (Woo and Kim, 2002).
Important roles for rac and cdc42 in DC have been demonstrated in the regulation of 
morphology (Jaksits et al., 2004), with the activation of rac and cdc42 being associated with 
dendrite extension (Swetman et al., 2002). This is consistent with roles for these proteins in 
the control of morphology in other cell types. The precise mechanism of morphological 
control downstream of these GTPases is complex, but has not been proposed to require MLKs. 
It was therefore interesting to discover that treatment of DC with the CEP inhibitor induced a 
dramatic extension of dendrites by a majority of the cells (figure 5.1), and this process was 
not mediated by MAPKs. By time-lapse microscopy, DC in vitro can be observed to oscillate 
between dendritic and round morphologies. The cytoskeletal architecture of DC dendrites has 
been shown to be maintained in part by microtubules (Swetman, submitted for publication), 
and depolymerisation of microtubules is presumably required for the transition from dendritic 
to round-shaped DC. MLK proteins have previously been shown to be localised to microtubules 
(Rasmussen et al., 1998; Nagata et al., 1998; Swenson et al., 2003), and destabilise 
microtubules during the cell cycle (Swenson et al., 2003; Cha et al., 2005). We have observed 
an increase in the proportion of dendritic shaped DC upon MLK inhibition, suggesting that MLK 
may also function in DC to induce microtubule destabilisation. Therefore the accumulation of 
dendritic shaped cells that we observe upon MLK inhibition probably reflects the equivalent of 
cell-cycle blockade, whereby round cells extend dendrites that they are unable to retract due 
to a lack of MLK activity resulting in an accumulation of cells with a dendritic morphology. To 
investigate whether CEP induces microtubule stabilisation, it would be interesting to compare 
the sensitivity of CEP-treated versus control DC to the microtubule stabilising agent taxol. 
Intracellular staining studies to examine the subcellular localisation of cytoskeletal
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components and MLK proteins in both round and dendritic DC upon treatment with LPS or CEP 
would also provide an interesting insight into this issue.
6.3 Limitations and Future Directions
In the preceding chapters, we have proposed a role for JNK in the control of DC apoptosis 
(chapter 3), and roles for MLK proteins in DC in the regulation of apoptosis (chapter 3), the 
control of maturation in response to a selection of TLR ligands (chapter 4), and in the 
induction of increased dendritic morphology (chapter 5). It is important to note, however, 
that these conclusions are based, in part, on experiments utilising pharmacological inhibitors. 
A limitation of studies utilising such inhibitors is that it is impossible to be certain that the 
inhibitor is binding exclusively to the molecule of interest. Indeed, the p38 inhibitor 
SB203580, which has been studied extensively and used here as a positive control, may also 
inhibit phosphoinositide-dependent protein kinase 1, and activate Raf-1, at the concentration 
used in this study (Lali et al., 2000; Kalmes et al., 1999). All of the findings in this thesis 
therefore need to be confirmed using alternative experimental approaches.
In addition to issues regarding the specificity of the inhibitors used, it is also possible that the 
TLR agonists used in the study; LPS, poly (l:C), and zymosan are not necessarily TLR-specific 
agonists. Indeed, poly (l:C) has previously been suggested to stimulate protein kinase R 
[Diebold], whilst zymosan may activate one or a combination of different C-type lectins, and 
has recently been shown to agonise Dectin-1 (Rogers et al., 2005). It would be interesting to 
repeat the experiments of Chapter 4 in TLR-, protein kinase R-, or Dectin-1-deficient DCs to 
examine the relative contribution of these additional pathways to the effects poly (l:C) and 
zymosan reported here. Furthermore, the purity of all three stimuli was not examined, and 
therefore additional receptors may also be stimulated. Experiments with these knockout 
models would also prove useful in clarifying this issue.
Primary cells such as the monocyte-derived dendritic cells used in this study are difficult to 
manipulate genetically. Indeed, we have attempted to verify the observations reported in this 
thesis by expressing mutant MLK3 proteins in DC. However, technical difficulties prevented us 
from retaining the immature state of the cells following transfection. Furthermore, the 
process of transfection of human DNA itself has been shown recently to be immunostimulatory 
in a macrophage-like cell line (Jiang et al., 2004). Biochemical analysis of MLK3 was 
hampered by technical difficulties in successful immunoprecipitation due to the unavailability 
of suitable antibodies. This approach will clearly become possible in the future as reagents 
become available. Therefore, despite their limitations, inhibitors remain a key tool for
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studying intracellular signaling in DC. Better methods of genetic manipulation of DC, and 
better reagents will allow further investigation based on the results of current inhibitor 
studies.
An obvious approach to verify our observed roles of the JNK and MLK pathways in DC is to 
repeat the experiments in mice deficient for the appropriate genes. Knockout mice with 
deletions of both the Jnk1 and Jnk2 loci have been reported. Individually, neither of these 
mutations are lethal and do not result in obvious defects. Mice lacking both JNK1 and JNK2 
isoforms, however, do not survive beyond the late embryonic stage. DC from mice lacking 
either JNK1 or JNK2 have not been examined, and it would be interesting to determine the 
resistance of these DC to oxidative stress in comparison to wild-type littermate controls, 
although the lack of a phenotype in these single knockout mice suggests that each isoform is 
redundant. This “compensatory” mechanism is likely to also operate in the response to 
oxidative stress and therefore it may be difficult to interpret the results of such studies in DC. 
The optimal approach would be to engineer mice with a DC-specific deficiency for both JNK 
isoforms. More recently, MLK3 knockout mice have been generated, and these also 
demonstrated little phenotypic abnormality (Brancho et al., 2005). Again, this is probably a 
result of functional reconstitution by other MLK isoforms; and DC were not examined.
An important aspect of pharmacological studies is to correlate the biological and biochemical 
dose response profile of the inhibitors. An intriguing observation within the data presented 
here is that the concentration of the CEP inhibitor at which inhibition of hydrogen peroxide- 
induced DC apoptosis is observed is 0.03pM. In contrast to this, the maximal inhibition of TLR- 
induced maturation and the greatest dendrite extension are observed at 1pM. It is possible 
that the effects observed at the higher inhibitor concentration are non-specific, although 1pM 
CEP is consistent with the concentrations used in most other studies (Ciallella et al., 2005; 
Hidding et al., 2002). Furthermore, a function for MLK downstream of TLRs is suggested by 
the observation that TLR ligation induces MLK3 phosphorylation (figure 4.3), and biochemical 
studies have indicated a role for MLK3 in p38 activation (Kim et al., 2004).
An explanation for the discrepancy in optimal CEP inhibitor concentration is that partial 
inhibition of JNK (such as is observed at low CEP inhibitor concentrations) may be sufficient 
to prevent cell death. Such an interpretation is consistent with the data presented in figure 
3.9a, in which only partial inhibition of JNK phosphorylation is observed at 0.03pM CEP, 
despite strong inhibition of apoptosis at this inhibitor concentration (figure 3.10). An 
alternative, but not mutually exclusive explanation is the possibility that the control of 
apoptosis and TLR-induced maturation are mediated by different MLK isoforms. We
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demonstrated that four different MLK isoforms are expressed in DC (figure 4.2), and three of 
these are known to be inhibited by the CEP inhibitor (and the fourth, MLK4, has not been 
tested). The MLK proteins are similar, but not identical. Hence the efficacy of the inhibitor 
for each protein is likely to differ. It is therefore possible that the CEP inhibitor inhibits the 
MLK protein involved in the apoptotic pathway with a higher efficiency than the MLK protein 
activated downstream of the TLRs, for example. Such an interpretation of different MLK 
isoforms operating upstream of p38 and JNK MAPKs in DC is reinforced by the observation that 
in figure 3.9, JNK inhibition and p38 inhibition occur at slightly different inhibitor 
concentrations. This is consistent with a model in which JIP scaffolds, with different MLK 
isoform affinities, selectively bind p38 or JNK and are used to maintain signal pathway 
specificity. The idea of different MLK proteins controlling apoptosis and maturation also 
solves another apparent paradox of the thesis - that MLK is activated by TLR ligands (chapter 
4), and induces apoptosis (chapter 3), but TLR ligation does not necessarily result in 
apoptosis.
6.4 Conclusions
In this study we have demonstrated that JNK activation regulates the apoptosis of DC, and 
this represents a potentially important mechanism limiting unwanted specific immune 
responses. Maturation of DC is controlled in part by p38, and the data presented in this thesis 
indicates that by operating upstream of these MAPKs, MLKs play an important role in the 
regulation of apoptosis and maturation. We believe that the identification of the capacity of 
MLK inhibitors to dissociate the functional and morphological maturation of DC makes them a 
useful tool in future studies dissecting the process of DC maturation. A more detailed 
examination of the functional implications of MLK inhibition of TLR signaling may lead to the 
wider use of these drugs in an anti-inflammatory capacity. Furthermore, the identification of 
proteins globally regulating DC maturation in response to some but not all stimuli indicates a 
potential avenue for therapeutic intervention in a stimulus-specific manner.
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